View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 7, 2005 (June 7, 2005)
Kaman Corporation
(Exact name of registrant as specified in its charter)
Connecticut
(State or other jurisdiction of incorporation)
0-1093 06-0613548
(Commission File Number) (IRS Employer
Identification No.)
1332 Blue Hills Avenue,
Bloomfield, Connecticut 06002
(Address of principal executive offices) (Zip Code)
(860) 243-7100
Registrant's telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[x] Written communication pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
INFORMATION TO BE INCLUDED IN THE REPORT
Item 1.01. Entry Into A Material Definitive Agreement.
On June 7, 2005, Kaman Corporation ("Kaman" or the "Company")
entered into an Agreement (the "Agreement") with certain members of the Kaman
family (the "Shareholders") that contemplates a proposed recapitalization which
would simplify the Company's capital structure and enhance its corporate
governance by eliminating the existing two-class structure of common stock.
In the proposed recapitalization, a single class of voting common
stock will replace the existing non-voting Class A common stock and voting
Class B common stock. Specifically, the approximately 22.1 million shares of
Class A common stock would each remain outstanding as one share of voting
common stock and the approximately 668,000 shares of Class B common stock would
each be converted into 1.95 shares of voting common stock. Alternatively, the
Class B common stockholders would be able to elect instead to convert each of
their Class B shares into one share of the new voting common stock and $14.76
(which represents .95 times the average closing price of one share of Class A
common stock over the last ten trading days).
At the closing of the proposed recapitalization, the holders of the
existing Class A non-voting common stock will own approximately 94.5% to 97.1%
of the then outstanding voting common stock of Kaman, depending on the extent
to which holders of the Class B common stock make the part stock/part cash
election. The proposed recapitalization is anticipated to be completed by the
end of the third quarter of 2005.
The proposed recapitalization is subject to customary closing
conditions, including the vote of more shares of Class A common stock in favor
than against the recapitalization and the vote of more shares of Class B common
stock in favor than against the recapitalization, each such class voting
separately. The Shareholders have agreed to vote all of their shares of Kaman
stock, representing approximately 81.5% of the outstanding shares of Class B
common stock and approximately 2.7% of the outstanding shares of Class A common
stock, in favor of the transaction. They have also agreed to vote their Class B
common stock in favor of certain amendments to the Company's certificate of
incorporation that would become effective only if the recapitalization were to
be completed and as to which only Class B shareholder approval would be
required, and the Kaman family's approval would be sufficient to assure
approval.
Until Kaman distributes the proxy statement/prospectus for the
proposed recapitalization to shareholders (but in any event for a period of
not less than 35 days), and subject to certain conditions, the Shareholders
would be permitted under the Agreement to withdraw their support of the
proposed recapitalization in order to accept a qualifying alternative
transaction that provides, among other things, a minimum value in cash or
marketable publicly traded securities of not less than $46.62 per Class B
common share. Prior to being permitted to do so, however, the Company's
Board of Directors would be given the opportunity to approve a substitute
recapitalization proposal with a minimum value per Class B common share of
at least the value per share of the qualifying alternative transaction plus
$0.65, with both all stock and part cash/part stock alternatives and
subject to the same shareholder class votes as noted above. The
Shareholders have agreed to support any substitute recapitalization
proposal approved by the Company's Board of Directors.
The Company has agreed to indemnify the Shareholders for any
out-of-pocket attorneys' fees and related expenses incurred by them in
defending any third party claim alleging any wrongful action or inaction by any
Shareholder in his or her capacity as a shareholder of Kaman in connection with
the execution, delivery and performance of the Agreement. In the event that the
Shareholders decide to pursue an alternative transaction, the Company will no
longer be obligated to provide such indemnification unless the Company
announces a substitute recapitalization proposal or such termination is
rescinded pursuant to the Agreement. However, C. William Kaman II, a member of
the Company's Board of Directors and a Shareholder, will retain his right to
indemnification by the Company for actions taken in his capacity as a director
of the Company.
The Company also has agreed to provide registration rights for one
year following the recapitalization with respect to the shares of new voting
common stock issued to members of the Kaman family pursuant to the proposed
recapitalization.
The Company may terminate the Agreement if the Company's Board of
Directors determines in good faith that termination is appropriate in the
exercise of its fiduciary duties because of a material change occurring after
the Board of Directors approves the proposed recapitalization. In the event the
Company terminates the Agreement prior to seeking the required stockholder
vote, the Company has agreed to reimburse the Shareholders for certain of their
out-of-pocket expenses incurred in connection with the negotiation of the
Agreement and pursuit of any alternative transaction. These reimbursable
expenses would be limited to $750,000 unless the Board subsequently approves a
"substitute recapitalization proposal", in which case they would be limited to
$1,250,000. However, the Kaman family would be required to repay to the Company
these reimbursed expenses to the extent of the amount received by the Kaman
family from selling some or all of their shares of Class B common stock within
six months following termination of the recapitalization agreement at prices
exceeding then prevailing trading prices for the Class A common stock.
The Agreement will automatically terminate (i) in the event that
the holders of the shares of Class A common stock do not approve the proposed
recapitalization or "substitute recapitalization proposal", if appropriate, at
the shareholders' meeting called for that purpose or (ii) on the day that is
six months after the date of the Agreement (subject to a possible extension
under specified circumstances in the event that there is an arbitration under
the Agreement).
In connection with the recapitalization, the Company has agreed to
enter into Indemnification Agreements (each, an "Indemnification Agreement"),
the forms of which are attached hereto as Exhibits 10.1 and 10.2, for the
benefit of those officers and directors or former officers and directors of the
Company (other than officers and directors who are members of the Kaman family)
who currently serve at the request of the Company as voting trustees under a
Voting Trust Agreement, dated August 14, 2000, and/or attorneys-in-fact under a
Durable Power of Attorney, dated May 7, 1996, in each case which governs the
voting of a portion of the Class B common stock owned by Charles H. Kaman. The
covered individuals are Paul Kuhn, Robert Garneau, Jack Cahill, Wanda Rogers
and John Murtha.
Pursuant to the Indemnification Agreements and subject to certain
conditions, the Company will indemnify such officers and directors for any and
all expenses and damages, including attorney's fees, settlements and judgments,
incurred in connection with a claim arising from any action or inaction taken
in their capacity as an attorney-in-fact or voting trustee.
The foregoing description of the Agreement, the proposed
recapitalization and the Indemnification Agreements does not purport to be
complete and is qualified in its entirety by reference to the Agreement and
forms of Indemnification Agreements, which are filed as Exhibits 2.01, 10.1 and
10.2 and incorporated herein by reference.
Item 8.01. Other Events
On June 7, 2005, Kaman's Board of Directors announced an increase
in its expected annual dividend from $.44 to $.50 per share and declared a
$.125 per share dividend, which is scheduled to be paid on July 11, 2005 to
holders of record on June 27, 2005. The dividend increase is not contingent on
the completion of the proposed recapitalization. The Company expects that the
annual dividend will be declared and paid in quarterly dividends of equal
amounts, subject to the Board of Director's periodic review of its dividend
policy and consistent with Kaman's recent dividend payment schedule.
On June 7, 2005, Kaman issued a press release announcing that its
Board of Directors had approved the Agreement and declared a quarterly dividend
at the increased rate. A copy of the press release is being filed as Exhibit
99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit 2.1 Agreement, dated as of June 7, 2005, by and among Kaman
Corporation, Newgate Associates Limited Partnership, Oldgate
Limited Partnership, Charles H. Kaman, C. William Kaman II,
Roberta C. Kaman, Steven W. Kaman and Cathleen H. Kaman.
Exhibit 10.1 Form of individual Indemnification Agreements, dated
as of June 7, 2005, entered into with Paul Kuhn, Jack
Cahill and Wanda Rogers.
Exhibit 10.2 Form of individual Indemnification Agreement, dated as
of June 7, 2005, entered into with Robert Garneau and
John Murtha.
Exhibit 99.1 Press Release, dated June 7, 2005, relating to the proposed
recapitalization.
Exhibit 99.2 Kaman Employee Communication, dated June 7, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
KAMAN CORPORATION
By: /s/ Robert M. Garneau
-------------------------------
Robert M. Garneau
Executive Vice President and
Chief Financial Officer
Dated: June 7, 2005
INDEX TO EXHIBITS
Exhibit 2.1 Agreement, dated as of June 7, 2005, by and among Kaman
Corporation, Newgate Associates Limited Partnership, Oldgate
Limited Partnership, Charles H. Kaman, C. William Kaman II,
Roberta C. Kaman, Steven W. Kaman and Cathleen H. Kaman.
Exhibit 10.1 Form of individual Indemnification Agreements, dated
as of June 7, 2005, entered into with Paul Kuhn, Jack
Cahill and Wanda Rogers.
Exhibit 10.2 Form of individual Indemnification Agreement, dated as
of June 7, 2005, entered into with Robert Garneau and
John Murtha.
Exhibit 99.1 Press Release, dated June 7, 2005, relating to the proposed
recapitalization.
Exhibit 99.2 Kaman Employee Communication, dated June 7, 2005.
Exhibit 2.1
AGREEMENT
THIS AGREEMENT (this "Agreement"), dated as of June 7, 2005, is by and
among (i) Kaman Corporation, a Connecticut corporation (the "Company"), (ii)
Newgate Associates Limited Partnership, a Connecticut limited partnership
("Newgate"), in its capacity as a shareholder of the Company, (iii) Oldgate
Limited Partnership, a Connecticut limited partnership ("Oldgate"), in its
capacity as a shareholder of the Company, (iv) Charles H. Kaman ("Kaman"), in
his capacity as a shareholder of the Company, (v) C. William Kaman II ("CWK"),
in his capacity as (A) as a shareholder of the Company, (B) the sole general
partner of Newgate and Oldgate, (C) a voting trustee (a "Voting Trustee") under
the Voting Trust Agreement, dated August 14, 2000 and as amended as of June 7,
2005 (as so amended, the "Voting Trust Agreement"), (D) an attorney-in-fact (a
"DPA Attorney-in-Fact") under a Durable Power of Attorney, dated May 4, 1996
(the "Durable Power of Attorney"), and (E) the trustee on behalf of his
children, Charles Tyson Kaman ("CTK") and Kathryn S. Kaman ("KSK"), as
shareholders in the Company, (vi) Roberta C. Kaman ("RCK"), in her capacity as
(A) a shareholder of the Company, (B) a DPA Attorney-in-Fact, and (C) a Voting
Trustee, (vii) Steven W. Kaman ("SWK"), in his capacity as (A) a shareholder of
the Company, (B) a DPA Attorney-in-Fact, (C) a Voting Trustee and (D) the
trustee on behalf of his child, Cameryn H. Kaman, as a shareholder of the
Company, and (viii) Cathleen H. Kaman ("CHK"), in her capacity as (A) a
shareholder of the Company, (B) a DPA Attorney-in-Fact, (C) a Voting Trustee
and (D) the trustee on behalf of her child, Zane N. Kaman-Wood, as a
shareholder in the Company. The Company, Newgate, Oldgate, Kaman, CWK, RCK, SWK
and CHK are referred to herein individually as a "Party" and collectively as
the "Parties", and the Parties other than the Company are referred to herein
collectively as the "Shareholders".
W I T N E S S E T H
-------------------
WHEREAS, a Special Committee of the Board of Directors of the Company
(the "Special Committee") was appointed by the Board of Directors of the
Company (the "Board") on April 15, 2003 to consider alternatives to the current
capital structure of the Company;
WHEREAS, the Special Committee and its legal and financial advisors on
the one hand, and the representatives and agents of the Shareholders, as
holders of (i) Class A Common Stock, par value $1.00 per share (the "Class A
Stock"), of the Company and (ii) Class B Common Stock, par value $1.00 per
share (the "Class B Stock"), of the Company and their legal and financial
advisors on the other hand, have been in discussions and negotiations regarding
the material terms of the Proposed Transaction (as defined below);
WHEREAS, the Special Committee has recommended to the Board and the
Board has approved the adoption of an amendment to the Company's Amended and
Restated Certificate of Incorporation (the "Charter") in the form set forth in
Article Fourth of the proposed Amended and Restated Certificate of
Incorporation of the Company attached as Exhibit A-1 hereto (the "Proposed
Recapitalization Amendments") whereby each share of (i) Class A Stock will
become one share of Common Stock authorized by Paragraph A of the Proposed
Recapitalization Amendments, and (ii) Class B stock will be reclassified into
1.95 shares of Common Stock authorized by Paragraph A of the Proposed
Recapitalization Amendments, except that each share of Class B Stock issued and
outstanding and held by recordholder(s) who have, not later than the third
business day immediately preceding the date of the Shareholders' Meeting (as
defined in Paragraph 21), validly elected to accept alternative consideration
as to such shares of Class B Stock (the "Alternative Class B Stock
Consideration") shall be reclassified into one share of validly issued, fully
paid and nonassessable Common Stock authorized by Paragraph A of the Proposed
Recapitalization Amendments and the right to receive an amount in cash equal to
$14.76 (collectively, the "Proposed Recapitalization"), which amount of cash
equals .95 times the Class A Share Deemed Value (as defined in Paragraph
16(d));
WHEREAS, the Special Committee has recommended to the Board and the
Board has approved, contingent upon the completion of the Proposed
Recapitalization or the Substitute Recapitalization Proposal (as defined in
Paragraph 16(a)), the adoption of amendments to (i) the Charter (collectively,
the "Proposed Charter Governance Amendments") in the forms set forth in the
Amended and Restated Certificate of the Company attached as Exhibit A-1 hereto
(other than Paragraph C of Article Fourth thereto), and (ii) the Company's
Bylaws (collectively, the "Proposed Bylaw Governance Amendments" and together
with the Proposed Recapitalization and the Proposed Charter Governance
Amendments, the "Proposed Transaction") in the form set forth in Exhibit A-2
hereto, relating to certain governance matters;
WHEREAS, Houlihan Lokey Howard & Zukin Financial Advisors, Inc., a
financial advisor to the Special Committee, has delivered its opinion to the
Special Committee that the consideration to be received by the holders of the
Class B Stock in the Proposed Recapitalization is fair, from a financial point
of view, to the holders (including the Shareholders) of the Class B Stock
(solely with respect to such Class B Stock);
WHEREAS, Evercore Group Inc., a financial advisor to the Special
Committee, has delivered its opinion to the Special Committee that the Proposed
Recapitalization is fair, from a financial point of view, to the holders of the
Class A Stock (solely with respect to such Class A Stock);
WHEREAS, (i) the Class B Stock is currently the only class of capital
stock of the Company entitled pursuant to the terms of the Charter to vote
generally on matters submitted to the Company's shareholders and (ii) the
holders of Class B Stock will be (a) entitled to vote on the Proposed
Recapitalization or the Substitute Recapitalization Proposal as a separate
class and (b) the only class of capital stock of the Company entitled to vote
on the Proposed Charter Governance Amendments;
WHEREAS, the holders of Class A Stock will (i) have the right to vote
on the Proposed Recapitalization or the Substitute Recapitalization Proposal as
a separate class and (ii) not have the right to vote on the Proposed Charter
Governance Amendments;
WHEREAS, none of the holders of the Class B Stock or the Class A Stock
will have the right to vote on the Proposed Bylaw Governance Amendments;
WHEREAS, subject to Paragraph 21(b), the Board expects to make a
recommendation to the holders of the Class A Stock and the Class B Stock in the
proxy materials sent to the holders of such shares that the holders of each
such class approve the Proposed Recapitalization or the Substitute
Recapitalization Proposal;
WHEREAS, subject to Paragraph 21(b), the Board expects to make a
recommendation to the holders of the Class B Stock in the proxy materials sent
to the holders of such shares that the holders of the Class B Stock approve the
Proposed Charter Governance Amendments;
WHEREAS, (i) the Durable Power of Attorney governs the power to vote
258,375 shares of the Class B Stock, evidenced by the certificate numbers set
forth on Schedule A-1, registered in the name of Kaman on the books and records
of the Company (the "Directly Owned Kaman Class B Shares"), (ii) the Voting
Trust Agreement governs the power to vote 96,601 shares of the Class B Stock,
evidenced by (A) the stock certificate number set forth on Schedule A-2,
registered in the name of John C. Yavis, Jr. as Custodian under the Voting
Trust Agreement on the books and records of the Company, and (B) the voting
trust certificate number set forth on Schedule A-2, registered in the name of
Kaman under the Voting Trust Agreement, any such disposition to be subject to
the Voting Trust Agreement (the "Indirectly Owned Kaman Class B Shares" and,
together with the Directly Owned Kaman Class B Shares, the "Kaman Class B
Shares"), and (iii) the General Power of Attorney governs the power to dispose
or to direct the disposition of (but not the vote of) the Kaman Class B Shares;
WHEREAS, the General Power of Attorney, dated February 11, 1998,
granted by Kaman (the "General Power of Attorney") governs the power to vote
and to dispose or to direct the disposition of 234,626 shares of the Class A
Stock, evidenced by the certificate numbers set forth on Schedule A-3,
registered in the name of Kaman on the books and records of the Company (the
"Kaman Class A Shares" and, together with the Kaman Class B Shares, the "Kaman
Shares");
WHEREAS, CWK, as the sole general partner of Newgate, has investment
power, which includes the power to dispose or to direct the disposition of, (i)
103,201 shares of Class B Stock, evidenced by (A) the stock certificate number
set forth on Schedule B-1, registered in the name of John C. Yavis, Jr. as
Custodian under the Voting Trust Agreement on the books and records of the
Company, and (B) the voting trust certificate number set forth on Schedule B-1,
registered in the name of Newgate under the Voting Trust Agreement, any such
disposition to be subject to the Voting Trust Agreement (the "Newgate Class B
Shares"), and (ii) 95,264 shares of Class A Stock, evidenced by the certificate
numbers set forth on Schedule B-2, registered in the name of Newgate on the
books and records of the Company (the "Newgate Class A Shares" and, together
with the Newgate Class B Shares, the "Newgate Shares"), pursuant to Section
4.01 of the Limited Partnership Agreement, dated December 23, 1992, as amended
on June 16, 1999, on July 16, 2004 and June 7, 2005 (as so amended, the
"Newgate Partnership Agreement");
WHEREAS, CWK, as the sole general partner of Oldgate, has investment
power, which includes the power to dispose or to direct the disposition of,
148,850 shares of Class A Stock, evidenced by the certificate numbers set forth
on Schedule C, registered in the name of Oldgate on the books and records of
the Company (the "Oldgate Shares"), pursuant to Sections 4.01 and 4.02 of the
Oldgate Limited Partnership Agreement of Limited Partnership, dated December
18, 1996 (the "Oldgate Partnership Agreement");
WHEREAS, CWK has investment power, which includes the power to dispose
or to direct the disposition of, (i) 69,246 shares of Class B Stock, evidenced
by the certificate numbers set forth on Schedule D-1, registered in the name of
CWK, either individually or as trustee, on the books and records of the Company
(the "CWK Class B Shares"), and (ii) 152,277 shares of Class A Stock, evidenced
by the certificate numbers set forth on Schedule D-2, registered in the name of
CWK, either individually or as trustee, on the books and records of the Company
(the "CWK Class A Shares" and, together with the CWK Class B Shares, the "CWK
Shares");
WHEREAS, RCK has investment power, which includes the power to dispose
or to direct the disposition of, (i) 1,471 shares of Class B Stock, evidenced
by the certificate numbers set forth on Schedule E-1, registered in the name of
RCK on the books and records of the Company (the "RCK Class B Shares"), and
(ii) 23,132 shares of Class A Stock, evidenced by the certificate numbers set
forth on Schedule E-2, registered in the name of RCK on the books and records
of the Company (the "RCK Class A Shares" and, together with the RCK Class B
Shares, the "RCK Shares");
WHEREAS, SWK has investment power, which includes the power to dispose
or to direct the disposition of, (i) 10,183 shares of Class B Stock, evidenced
by the certificate numbers set forth on Schedule F-1, registered in the name of
SWK, either individually or as trustee, on the books and records of the Company
(the "SWK Class B Shares"), and (ii) 4,151 shares of Class A Stock, evidenced
by the certificate numbers set forth on Schedule F-2, registered in the name of
SWK on the books and records of the Company (the "SWK Class A Shares" and,
together with the SWK Class B Shares, the "SWK Shares");
WHEREAS, CHK has investment power, which includes the power to dispose
or to direct the disposition of, (i) 12,634 shares of Class B Stock, evidenced
by the certificate numbers set forth on Schedule G-1, registered in the name,
either individually or as trustee, of CHK on the books and records of the
Company (the "CHK Class B Shares"), and (ii) 43,397 shares of Class A Stock,
evidenced by the certificate numbers set forth on Schedule G-2, registered in
the name of CHK on the books and records of the Company (the "CHK Class A
Shares" and, together with the CHK Class B Shares, the "CHK Shares");
WHEREAS, entitlement to vote (i) the Kaman Class A Shares is held by
John C. Yavis, Jr., in his capacity as the Attorney-in-Fact (the "GPA
Attorney-in-Fact") under the General Power of Attorney, (ii) the Newgate Class
A Shares is held by CWK, as the sole general partner of Newgate, under Section
4.01 of the Newgate Partnership Agreement, (iii) the Oldgate Shares is held by
CWK, as the sole general partner of Oldgate, under Sections 4.01 and 4.02 of
the Oldgate Partnership Agreement, (iv) the CWK Class A Shares is held by CWK
either individually or as trustee, (v) the RCK Class A Shares is held by RCK
individually, (vi) the SWK Class A Shares is held by SWK either individually or
as trustee, and (vii) the CHK Class A Shares is held by CHK either individually
or as trustee;
WHEREAS, entitlement to vote (i) the Kaman Class B Shares is held by
the DPA Attorneys-in-Fact under the Durable Power of Attorney, (ii) the Newgate
Class B Shares is held by the Voting Trustees party to this Agreement under the
Voting Trust Agreement, (iii) the CWK Class B Shares is held by CWK
individually or as trustee, (iv) the RCK Class B Shares is held by RCK
individually, (v) the SWK Class B Shares is held by SWK individually, and (vi)
the CHK Class B Shares is held by CHK individually or as trustee; and
WHEREAS, the Parties intend that this Agreement shall be a "voting
agreement" created under and pursuant to Section 33-716 of the Connecticut
Business Corporation Act and that the irrevocable appointments of proxies by
the Shareholders pursuant to this Agreement are intended to be coupled with an
interest by virtue of the Shareholders entering into this Agreement.
NOW THEREFORE BE IT RESOLVED, that in consideration of the foregoing
and other mutually satisfactory consideration, the receipt and sufficiency of
which has heretofore been acknowledged by the Parties, the Parties hereby agree
as follows:
1. Subject to and in accordance with the other provisions of this
Agreement, the Shareholders and the Company agree to recapitalize the capital
stock of the Company whereby each share of (i) Class A Stock will become one
share of Common Stock authorized by Paragraph A of the Proposed
Recapitalization Amendments, and (ii) Class B stock will be reclassified into
1.95 shares of Common Stock authorized by Paragraph A of the Proposed
Recapitalization Amendments, except that each share of Class B Stock issued
and outstanding and held by recordholder(s) who have, not later than the third
business day immediately preceding the date of the Shareholders' Meeting,
validly elected to accept the "Alternative Class B Stock Consideration" as to
such shares of Class B Stock shall be reclassified into one share of validly
issued, fully paid and nonassessable Common Stock authorized by Paragraph A of
the Proposed Recapitalization Amendments and the right to receive an amount in
cash equal to $14.76, in each case without any further action by the holder
thereof other than as set forth in the Proposed Recapitalization Amendments.
2. Each of the DPA Attorneys-in-Fact hereby agrees (i) that commencing
upon the expiration of the Permitted Termination Period (as defined in
Paragraph 12(a)) and until the Expiration Date (as defined in Paragraph 12(b)),
at any meeting of the shareholders of the Company, however called, or in
connection with any written consent of the holders of capital stock of the
Company, each such DPA Attorney-in-Fact shall appear at each such meeting, in
person or by proxy, or otherwise cause the Kaman Class B Shares to be counted
as present thereat for purposes of establishing a quorum, and, subject to
Paragraph 21(b), each such DPA Attorney-in-Fact shall vote (or cause to be
voted) or act (or cause to be acted) by written consent with respect to all of
the Kaman Class B Shares (a) in favor of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with this Agreement and all other
actions required in furtherance thereof, (b) in favor of the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(c) against any proposal that (I) is inconsistent with or contrary to the terms
and conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of such DPA
Attorneys-in-Fact or any other Party contained in this Agreement, and (ii)
within two business days following the expiration of the Permitted Termination
Period, to cause to be provided to the Company a fully executed copy of the
irrevocable proxy in the form attached as Exhibit B hereto; provided, that such
proxy need not be so provided if the Expiration Date shall have occurred and
this Agreement shall not have been reinstated pursuant to Paragraph 14(b).
3. Each of the Voting Trustees hereby agrees (i) that commencing upon
the expiration of the Permitted Termination Period and until the Expiration
Date, at any meeting of the shareholders of the Company, however called, or in
connection with any written consent of the holders of capital stock of the
Company, each such Voting Trustee shall appear at each such meeting, in person
or by proxy, or otherwise cause the Newgate Class B Shares and the Indirectly
Owned Kaman Class B Shares to be counted as present thereat for purposes of
establishing a quorum, and, subject to Paragraph 21(b), each such Voting
Trustee shall vote (or cause to be voted) or act (or cause to be acted) by
written consent with respect to all of the Newgate Class B Shares and the
Indirectly Owned Kaman Class B Shares (a) in favor of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with this Agreement and all other
actions required in furtherance thereof, (b) in favor of the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(c) against any proposal that (I) is inconsistent with or contrary to the terms
and conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of such Voting
Trustees or any other Party contained in this Agreement and (ii) within two
business days following the expiration of the Permitted Termination Period, to
cause to be provided to the Company a fully executed copy of the irrevocable
proxy in the form attached as Exhibit C hereto; provided, that such proxy need
not be so provided if the Expiration Date shall have occurred and this
Agreement shall not have been reinstated pursuant to Paragraph 14(b).
4. Kaman hereby agrees (i) that commencing upon the expiration of the
Permitted Termination Period and until the Expiration Date, at any meeting of
the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, the DPA
Attorneys-in-Fact and the GPA Attorney-in-Fact, acting on behalf of Kaman,
shall appear at each such meeting, in person or by proxy, or otherwise cause
the Directly Owned Kaman Class B Shares (in the case of the DPA
Attorneys-in-Fact) and the Kaman Class A Shares (in the case of the GPA
Attorney-in-Fact) to be counted as present thereat for purposes of establishing
a quorum, and, subject to Paragraph 21(b), the DPA Attorneys-in-Fact and the
GPA Attorney-in-Fact, acting on behalf of Kaman, shall vote (or cause to be
voted) or act (or cause to be acted) by written consent with respect to all of
the Directly Owned Kaman Class B Shares (in the case of the DPA
Attorneys-in-Fact) and the Kaman Class A Shares (in the case of the GPA
Attorney-in-Fact) (a) in favor of whichever of the Proposed Recapitalization or
the Substitute Recapitalization Proposal is then recommended by the Board in
accordance with this Agreement and all other actions required in furtherance
thereof, (b) in the case of the Directly Owned Kaman Class B Shares, in favor
of the Proposed Charter Governance Amendments and all other actions required in
furtherance thereof and (c) against any proposal that (I) is inconsistent with
or contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with this Agreement, the Proposed
Charter Governance Amendments or the Proposed Bylaw Governance Amendments or
(II) would result in a breach of any covenant, representation or warranty or
any other obligation or agreement of Kaman or any other Party contained in this
Agreement and (ii) within two business days following the expiration of the
Permitted Termination Period, to cause to be provided to the Company a fully
executed copy of the irrevocable proxy in the form attached as Exhibit D
hereto; provided, that such proxy need not be so provided if the Expiration
Date shall have occurred and this Agreement shall not have been reinstated
pursuant to Paragraph 14(b).
5. Newgate hereby agrees (i) that commencing upon the expiration of
the Permitted Termination Period and until the Expiration Date, at any meeting
of the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, Newgate shall
appear at each such meeting, in person or by proxy, or otherwise cause the
Newgate Class A Shares to be counted as present thereat for purposes of
establishing a quorum, and, subject to Paragraph 21(b), Newgate shall vote (or
cause to be voted) or act (or cause to be acted) by written consent with
respect to all of the Newgate Class A Shares (a) in favor of whichever of the
Proposed Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with this Agreement and all other
actions required in furtherance thereof and (b) against any proposal that (I)
is inconsistent with or contrary to the terms and conditions of whichever of
the Proposed Recapitalization or the Substitute Recapitalization Proposal is
then recommended by the Board in accordance with this Agreement, the Proposed
Charter Governance Amendments or the Proposed Bylaw Governance Amendments or
(II) would result in a breach of any covenant, representation or warranty or
any other obligation or agreement of Newgate or any other Party contained in
this Agreement and (ii) within two business days following the expiration of
the Permitted Termination Period, to cause to be provided to the Company a
fully executed copy of the irrevocable proxy in the form attached as Exhibit E
hereto; provided, that such proxy need not be so provided if the Expiration
Date shall have occurred and this Agreement shall not have been reinstated
pursuant to Paragraph 14(b).
6. Oldgate hereby agrees (i) that commencing upon the expiration of
the Permitted Termination Period and until the Expiration Date, at any meeting
of the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, Oldgate shall
appear at each such meeting, in person or by proxy, or otherwise cause the
Oldgate Shares to be counted as present thereat for purposes of establishing a
quorum, and, subject to Paragraph 21(b), Oldgate shall vote (or cause to be
voted) or act (or cause to be acted) by written consent with respect to all of
the Oldgate Shares (a) in favor of whichever of the Proposed Recapitalization
or the Substitute Recapitalization Proposal is then recommended by the Board in
accordance with this Agreement and all other actions required in furtherance
thereof, and (b) against any proposal that (I) is inconsistent with or contrary
to the terms and conditions of whichever of the Proposed Recapitalization or
the Substitute Recapitalization Proposal is then recommended by the Board in
accordance with this Agreement, the Proposed Charter Governance Amendments or
the Proposed Bylaw Governance Amendments or (II) would result in a breach of
any covenant, representation or warranty or any other obligation or agreement
of Oldgate or any other Party contained in this Agreement and (ii) within two
business days following the expiration of the Permitted Termination Period, to
cause to be provided to the Company a fully executed copy of the irrevocable
proxy in the form attached as Exhibit F hereto; provided, that such proxy need
not be so provided if the Expiration Date shall have occurred and this
Agreement shall not have been reinstated pursuant to Paragraph 14(b).
7. CWK hereby agrees (i) that commencing upon the expiration of the
Permitted Termination Period and until the Expiration Date, at any meeting of
the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, CWK shall
appear at each such meeting, in person or by proxy, or otherwise cause the CWK
Shares to be counted as present thereat for purposes of establishing a quorum,
and, subject to Paragraph 21(b), CWK shall vote (or cause to be voted) or act
(or cause to be acted) by written consent with respect to all of the CWK Shares
(a) in favor of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement and all other actions required in furtherance thereof, (b) in
the case of the CWK Class B Shares, in favor of the Proposed Charter Governance
Amendments and all other actions required in furtherance thereof and (c)
against any proposal that (I) is inconsistent with or contrary to the terms and
conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of CWK or any
other Party contained in this Agreement and (ii) within two business days
following the expiration of the Permitted Termination Period, to cause to be
provided to the Company a fully executed copy of the irrevocable proxy in the
form attached as Exhibit G hereto; provided, that such proxy need not be so
provided if the Expiration Date shall have occurred and this Agreement shall
not have been reinstated pursuant to Paragraph 14(b).
8. RCK hereby agrees (i) that commencing upon the expiration of the
Permitted Termination Period and until the Expiration Date, at any meeting of
the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, RCK shall
appear at each such meeting, in person or by proxy, or otherwise cause the RCK
Shares to be counted as present thereat for purposes of establishing a quorum,
and, subject to Paragraph 21(b), RCK shall vote (or cause to be voted) or act
(or cause to be acted) by written consent with respect to all of the RCK Shares
(a) in favor of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement and all other actions required in furtherance thereof, (b) in
the case of the RCK Class B Shares, in favor of the Proposed Charter Governance
Amendments and all other actions required in furtherance thereof and (c)
against any proposal that (I) is inconsistent with or contrary to the terms and
conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of RCK or any
other Party contained in this Agreement and (ii) within two business days
following the expiration of the Permitted Termination Period, to cause to be
provided to the Company a fully executed copy of the irrevocable proxy in the
form attached as Exhibit H hereto; provided, that such proxy need not be so
provided if the Expiration Date shall have occurred and this Agreement shall
not have been reinstated pursuant to Paragraph 14(b).
9. SWK hereby agrees (i) that commencing upon the expiration of the
Permitted Termination Period and until the Expiration Date, at any meeting of
the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, SWK shall
appear at each such meeting, in person or by proxy, or otherwise cause the SWK
Shares to be counted as present thereat for purposes of establishing a quorum,
and, subject to Paragraph 21(b), SWK shall vote (or cause to be voted) or act
(or cause to be acted) by written consent with respect to all of the SWK Shares
(a) in favor of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement and all other actions required in furtherance thereof, (b) in
the case of the SWK Class B Shares, in favor of the Proposed Charter Governance
Amendments and all other actions required in furtherance thereof and (c)
against any proposal that (I) is inconsistent with or contrary to the terms and
conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of SWK or any
other Party contained in this Agreement and (ii) within two business days
following the expiration of the Permitted Termination Period, to cause to be
provided to the Company a fully executed copy of the irrevocable proxy in the
form attached as Exhibit I hereto; provided, that such proxy need not be so
provided if the Expiration Date shall have occurred and this Agreement shall
not have been reinstated pursuant to Paragraph 14(b).
10. CHK hereby agrees (i) that commencing upon the expiration of the
Permitted Termination Period and until the Expiration Date, at any meeting of
the shareholders of the Company, however called, or in connection with any
written consent of the holders of capital stock of the Company, CHK shall
appear at each such meeting, in person or by proxy, or otherwise cause the CHK
Shares to be counted as present thereat for purposes of establishing a quorum,
and, subject to Paragraph 21(b), CHK shall vote (or cause to be voted) or act
(or cause to be acted) by written consent with respect to all of the CHK Shares
(a) in favor of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement and all other actions required in furtherance thereof, (b) in
the case of the CHK Class B Shares, in favor of the Proposed Charter Governance
Amendments and all other actions required in furtherance thereof and (c)
against any proposal that (I) is inconsistent with or contrary to the terms and
conditions of whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
this Agreement, the Proposed Charter Governance Amendments or the Proposed
Bylaw Governance Amendments or (II) would result in a breach of any covenant,
representation or warranty or any other obligation or agreement of CHK or any
other Party contained in this Agreement and (ii) within two business days
following the expiration of the Permitted Termination Period, to cause to be
provided to the Company a fully executed copy of the irrevocable proxy in the
form attached as Exhibit J hereto; provided, that such proxy need not be so
provided if the Expiration Date shall have occurred and this Agreement shall
not have been reinstated pursuant to Paragraph 14(b).
11. The Company and the Shareholders approve of the issuance of the
public announcement of this Agreement as previously reviewed and agreed among
them and to consult with, and obtain the approval of, each other before issuing
any other press release or making any other public announcement with respect to
this Agreement, except in each such case as may be required by applicable law
or the Company's listing agreement with Nasdaq Stock Market, Inc.
12. For purposes of this Agreement, the following terms shall have the
specified definitions:
(a) the "Permitted Termination Period" shall be the period
beginning from the later of (i) the date of this Agreement and (ii) the date of
public announcement of this Agreement, and, unless sooner ended under Paragraph
14(b) or 15(d), continuing until the later of (i) 35 days after the beginning
of the Permitted Termination Period and (ii) five days following written notice
by the Company to the Shareholders that the Company has received confirmation
by the Staff of the Securities and Exchange Commission (the "SEC") that it will
act promptly on a request by the Company for acceleration of effectiveness of
the registration statement containing the Meeting Documents (as defined in
Paragraph 22);
(b) the "Expiration Date" shall be the earliest to occur of the
following: (i) the termination of this Agreement by the Shareholders as
permitted in Paragraph 14(a) unless this Agreement shall have been reinstated
pursuant to Paragraph 14(b); (ii) the consummation of the Proposed
Recapitalization or the Substitute Recapitalization Proposal; (iii) the holders
of Class A Stock shall have failed to approve the Proposed Recapitalization or
the Substitute Recapitalization Proposal at the Shareholders' Meeting (it being
understood that other matters unrelated to this Agreement may be set forth on
the meeting agenda); (iv) the Board shall have determined not to proceed with
the Proposed Recapitalization or the Substitute Recapitalization Proposal as
permitted in Paragraph 21(b); (v) in the event that no Amendment Notice shall
be given under Paragraph 15(b) or a second arbitration commenced under
Paragraph 15(c), the day that is six months after the date of this Agreement;
and (vi) in the event that an Amendment Notice shall be given under Paragraph
15(b) or a second arbitration commenced under Paragraph 15(c), the date
determined under clause (v) plus the number of days by which the Arbitration
Period shall have been extended beyond the Arbitration Period that would have
applied had there been no Amendment Notice and no second arbitration;
(c) "affiliate" of any person shall mean another person that
directly, or indirectly through one or more intermediaries, controls, is
controlled by, or is under common control with, such first person, where
"control" means the possession, directly or indirectly, of the power to direct
or cause the direction of the management policies of a person, whether through
the ownership of voting securities, by contract, as trustee or executor, or
otherwise; and
(d) "person" means an individual, corporation, partnership,
limited liability company, joint venture, association, trust, unincorporated
organization or other entity.
13. (a) The Shareholders hereby represent and warrant to the
Company that they have delivered to Thomas Groark of Day, Berry & Howard, as
custodian, fully executed copies of the irrevocable proxies to be delivered
pursuant to Paragraphs 2 through 10 of this Agreement and the share
certificates to be delivered by them pursuant to the next sentence. Not more
than two business days following the expiration of the Permitted Termination
Period, the Shareholders shall cause to be presented to the Company the stock
certificates representing the Shares held by them for the purpose of placing an
appropriate legend concerning the restrictions on transfer and voting imposed
hereby and noting the existence of an irrevocable proxy with respect to the
Shares represented by such certificate; provided, that such stock certificates
need not be so presented if the Expiration Date shall have occurred and this
Agreement shall not have been reinstated pursuant to Paragraph 14(b). Unless
otherwise permitted under this Agreement, none of the Shareholders shall
request that the Company register the transfer (book-entry or otherwise) of any
certificate or uncertificated interest representing any of their Shares.
(b) The Company agrees that if the Expiration Date occurs and
neither the Recapitalization Proposal nor the Substitute Recapitalization
Proposal shall have been consummated, the Company shall within two business
days thereafter deliver to Thomas Groark of Day, Berry & Howard, as custodian,
(i) any irrevocable proxies previously delivered by the Shareholders under
Paragraph 13(a) and (ii) either any share certificates previously delivered by
the Shareholders under Paragraph 13(a) or replacement share certificates in the
same amounts and with the same registered holders as any share certificates so
previously delivered by the Shareholders, in each case without any legend.
14. (a) Notwithstanding any other provisions contained in this
Agreement, the Shareholders, or any of them, may until the expiration of the
Permitted Termination Period engage in discussions concerning any transaction
involving the possible sale or other disposition of their Class B Shares,
whether or not such transaction might result in a Business Combination (as
defined in Paragraph 17) (any such sale or other disposition an "Alternative
Transaction"), and terminate this Agreement to complete an Alternative
Transaction, if (i) such Alternative Transaction constitutes a "Qualifying
Alternative Transaction" (as defined in Paragraph 14(c)), (ii) none of the
Shareholders or their representatives or agents shall have taken any action
from and after the date of this Agreement to solicit either such Qualifying
Alternative Transaction or any other Alternative Transaction, it being agreed,
however, that engaging in discussions or negotiations with a third party with
whom or with which discussions concerning a possible sale of their Class B
Shares have been held by or on behalf of Kaman or any of the other Shareholders
prior to November 15, 2004, all such parties having been separately identified
in writing by the Shareholders to the Company, or with a third party that shall
have proposed to a Shareholder a Qualifying Alternative Transaction without
having been approached by a Shareholder on or after the date of this Agreement,
shall not be deemed to have violated this clause (ii), (iii) within two
business days following any such discussions having reached a stage that the
Shareholders reasonably believe in good faith are likely to result in an
agreement with the third party proposing such possible Qualifying Alternative
Transaction, the Shareholders shall have given to the Company written notice
that the Shareholders are in discussions concerning a possible Qualifying
Alternative Transaction, (iv) the Shareholders shall have given to the Company
a written notice of their intent to terminate this Agreement to complete such
Qualifying Alternative Transaction (a "QAT Termination Notice) and the Company
shall not have publicly announced a "Substitute Recapitalization Proposal" (as
defined in Paragraph 16(a)) within the Match Period (as defined in Paragraph
16(b)), and (v) the Reimbursement Parties (as defined in Paragraph 25(a)) shall
have fully reimbursed the Company for any and all Defense Costs (as defined in
Paragraph 25(a)) theretofore reimbursed by the Company not later than the time
of the giving of the QAT Termination Notice (whether such reimbursement
obligation arose under Paragraph 25 or otherwise); provided, that such
reimbursement obligation shall not include any Defense Costs attributable to
counsel representing the directors of the Company generally. Notwithstanding
the foregoing, the Shareholders shall not enter into any agreement under this
Paragraph 14 contemplating a transaction that would be restricted under
Paragraphs 17 through 20 unless such agreement shall specifically provide that
it shall not be a breach thereunder for the Company to make and consummate a
Substitute Recapitalization Proposal.
(b) In the event that the Shareholders shall terminate this
Agreement pursuant to Paragraph 14(a) but such Qualifying Alternative
Transaction shall not have been completed on the stated terms as to all of the
shares of Class B Stock owned by the Shareholders (the "Covered Class B
Shares") within ten business days following the earlier to occur of the end of
the Match Period and the Company's written notice to the Shareholders that it
does not intend to announce a Substitute Recapitalization Proposal, the
Shareholders shall immediately abandon such Qualifying Alternative Transaction
and such termination of this Agreement shall be deemed immediately rescinded
with the effect that this Agreement shall be immediately reinstated and the
Permitted Termination Period shall be deemed to have ended. In the event of
such reinstatement, the Reimbursement Parties' right to reimbursement for
Defense Costs under this Agreement shall also be reinstated, retroactive to the
date of the QAT Termination Notice, and the Company shall be required to repay
to the Reimbursement Parties Defense Costs reimbursed by the Reimbursement
Parties to the Company within two business days following receipt by the
Company of written notice from the Shareholders that such Qualifying
Alternative Transaction shall have been abandoned.
(c) In order to be a "Qualifying Alternative Transaction" for
purposes of this Agreement, a proposed transaction must (i) have proposed
consideration to be paid that is clearly specified and not dependent upon
determinations by the Arbiter (as defined in Paragraph 15(a)) and consists
solely of cash and/or freely marketable, publicly traded securities, with all
outstanding shares of Class B Stock being offered the same consideration, (ii)
have a "Class B Share Deemed Value" (as defined in Paragraph 16(d)) of not less
than $46.62, (iii) offer to purchase not less than all of the outstanding
shares of Class B Stock (including shares held by persons other than the
Shareholders) by a third party that is not an affiliate of any Shareholder (the
"Third Party Offeror"), (iv) have no conditions as to the purchase of the
Covered Class B Shares other than the delivery to the Third Party Offeror of
title to the Covered Class B Shares, subject to no liens or transfer
restrictions other than those created by the Third Party Offeror or imposed by
the securities laws, (v) have no termination right on the part of the Third
Party Offeror other than (A) in the event of an "act of God" such as a plant
explosion or a strike materially adversely affecting the Company (a "Covered
Act of God"), the first public disclosure or written notice to the Third Party
Offeror of which occurs after the giving of the QAT Termination Notice and
prior to the giving of the last Reaffirmation (as defined below) by the Third
Party Offeror, or (B) the Company entering into a material acquisition or
divestiture agreement, declaring an extraordinary dividend or issuing shares of
Class B Stock (a "Company Action"), the first public disclosure or written
notice to the Third Party Offeror of which occurs after the giving of the QAT
Termination Notice, (vi) be required to close on the stated terms or abandoned
as to the Covered Class B Shares within ten business days following the Company
notifying the Shareholders that the Board has determined not to approve a
Substitute Recapitalization Proposal and (vii) include an undertaking from the
Third Party Offeror that the offer to holders of Class B Stock other than the
Shareholders will comply with any relevant securities laws and that the Third
Party Offeror will accept such shares for purchase as promptly as the
securities laws permit. In order for a proposed transaction to be a "Qualifying
Alternative Transaction" for purposes of this Agreement, the Shareholders and
the Third Party Offeror each must (i) at the time of the giving of the QAT
Termination Notice, certify that the proposed transaction has been entered into
with a good faith intention that it be completed on the stated terms promptly
in the event that the Company were not to announce a Substitute
Recapitalization Proposal and, in the case of the Third Party Offeror, also
certifying as to the sufficiency and prompt availability of any required funds
and the due authorization, validity and eligibility for immediate trading of
any freely marketable, publicly traded securities proposed to be included as
consideration (each, an "Initial Certificate"), and (ii) promptly following a
request therefor by the Company, reaffirm in writing the substance of its
Initial Certificate and, in the case of the Third Party Offeror, covenant to
the Shareholders and the Company that it will not exercise its termination
right in respect of any Covered Act of God or Company Action as to which there
shall have been public disclosure or written notice provided to the Third Party
Offeror prior to the giving of such reaffirmation and covenant (each such
reaffirmation and/or covenant, a "Reaffirmation"). The Shareholders must also
submit to the Company (and to the Arbiter if an arbitration is commenced under
Paragraph 15) (i) a complete and accurate copy of all agreements between the
Shareholders and the Third Party Offeror relating to the proposed transaction
(the "Third Party Agreements"), (ii) the Shareholders' calculation of the Class
B Share Deemed Value for the purpose of such proposed transaction (the
"Proposed Deemed Value Calculation") and (iii) in the event that the Company
and CWK shall not theretofore have reached an agreement as to the extent of
CWK's right to indemnification as a director under Connecticut law, the Charter
and the Company's Bylaws in respect of any Claims (as defined in Paragraph
25(a)) that may have been made (the "CWK Claim Coverage"), the Shareholders'
position as to the extent of the CWK Claim Coverage for such Claims.
15. (a) Should the Company determine to do so, within five
business days following its receipt of a QAT Termination Notice, it may submit
to one of the arbiters previously agreed upon between the Company and the
Shareholders (the "Arbiter") the following issue(s): (i) whether a proposed
transaction meets the standard of a Qualifying Alternative Transaction; (ii)
whether the Proposed Deemed Value Calculation is correct; (iii) whether the
Shareholders and Reimbursement Parties have met the other conditions of
terminating this Agreement under clauses (ii), (iii) and (v) of Paragraph
14(a); and/or (iv) the extent of the CWK Claim Coverage, after taking into
account the nature of the Claims, including whether the Claims relate to
actions or failures to act by CWK as a director, a shareholder or otherwise. If
it does so, the Company shall provide in its submission to the Arbiter its
position as to those issues submitted for arbitration. The Shareholders shall
then have two business days in which to provide a submission to the Arbiter and
the Company explaining their positions as to those issues submitted for
arbitration. The Arbiter shall be directed to make a determination as to each
of the issues submitted for arbitration within ten business days following the
receipt of such submission by the Shareholders (the "Arbitration Period"). In
the event that the Arbiter determines that the proposed transaction is a
Qualified Alternative Transaction but the Proposed Deemed Value Calculation is
not correct, the Arbiter shall also determine the Class B Deemed Share Value.
In the event that the Arbiter is asked to make a determination as to the extent
of the CWK Claim Coverage, the Arbiter shall in his determination distinguish
between indemnifiable Claims for actions or failures to act as a director and
non-indemnifiable Claims for actions or failures to act as a shareholder or
other capacity and provide a detailed explanation as to how he distinguished
such Claims.
(b) If the Company determines to submit the matter to arbitration,
the Shareholders shall have a single opportunity to amend the Third Party
Agreements in order to meet the requirements of a Qualifying Alternative
Transaction. Written notice of any such amendment (an "Amendment Notice") must
be given to both the Company and the Arbiter not later than one business day
following the Arbiter having issued his determination and be accompanied by
complete and accurate copies of the amended agreements, an updated Proposed
Deemed Value Calculation and updated Initial Certificates from the Shareholders
and the Third Party Offeror. The Company shall have five business days
following its receipt of an Amendment Notice to determine whether to submit the
proposed transaction, as amended, to arbitration. In the event that an
Amendment Notice is given prior to the Arbiter having issued a determination
and the Company determines to submit the amended transaction for arbitration,
the Arbiter's determination will be then due ten business days following the
receipt of notice of the Company's determination. In the event that an
Amendment Notice is given following the Arbiter having issued a determination
and the Company determines to submit the amended transaction for arbitration,
the Arbiter's determination will be then due five business days following the
receipt of notice of the Company's determination. If the amendment as to which
an Amendment Notice relates changes the Class B Deemed Value of the proposed
transaction, then the Arbiter shall determine the Class B Deemed Value for the
transaction as originally proposed and the Class B Deemed Value for the
transaction as amended, and the average of the two shall be used for purposes
of establishing the minimum value of a Substitute Recapitalization Proposal
under Paragraph 16.
(c) In the event that the initial Arbiter fails to render a
determination by the end of the Arbitration Period, and the Parties shall not
otherwise have agreed, as to all matters that have been submitted for
arbitration, the services of the initial Arbiter shall be immediately
terminated and only those matters as to which the Arbiter shall have rendered a
determination shall be deemed to be settled. In the event that any of the
Parties determines to do so, a new arbitration process as to all such items
neither so determined or agreed between the Parties shall be commenced promptly
with one of the substitute arbiters agreed by the Parties serving as the
Arbiter. At the time of or promptly following commencement of such new
arbitration process, the Parties will submit to the Arbiter the materials
submitted by them in the first arbitration. Such new arbitration shall have a
ten business day Arbitration Period beginning to run from the date of receipt
by the Arbiter of submissions from both the Company and the Shareholders and
the same procedural requirements as set forth above. In the event that the
second Arbiter fails to render a determination by the end of the new
Arbitration Period and the Parties shall not otherwise have agreed as to all
such items, the services of the second Arbiter shall be immediately terminated
and only those matters as to which the Arbiter shall have rendered a
determination shall be deemed to be settled; provided, that, unless the Arbiter
shall have determined otherwise, the proposed transaction shall be deemed to be
a Qualifying Alternative Transaction and the other conditions to the
Shareholders' termination of this Agreement under Paragraph 14(a) shall be
deemed to be met. Notwithstanding the foregoing, only those proposed arbiters
who actually confirm their engagement and accept submissions under Paragraph
15(a) or this Paragraph 15(c) shall be deemed to have been the Arbiter for
purposes of determining application of the proviso to the immediately preceding
sentence.
(d) In the event that an Amendment Notice is given or a second
arbitration process is commenced under Paragraph 15(c), the Permitted
Termination Period shall be deemed to end on (i) the earlier to occur of the
date determined under Paragraph 12(a) and 75 days following the initial filing
with the SEC of the registration statement containing the Meeting Documents or
(ii) the day the arbitration process is completed, if later than the date
determined under clause (i).
(e) Each of the Company and the Shareholders agrees (i) to comply
promptly with requests from the Arbiter for information or to schedule any oral
presentations to the Arbiter, (ii) that all submissions to the Arbiter will be
provided at the same time to the other party and that all contacts with the
Arbiter will be made jointly, and (iii) that the Arbiter's fee and expenses
will be paid 50% by the Shareholders and 50% by the Company. It is agreed that
each arbiter engaged under this Paragraph 15 shall be treated as the Arbiter
for purposes of this provision.
(f) The Parties acknowledge that public disclosure would need to
be made as to the specifics of a proposed transaction promptly following a QAT
Termination Notice being given and as to the Arbiter's determinations when they
are made.
16. (a) In the event that the Shareholders were to propose a
termination of this Agreement to complete a Qualifying Alternative Transaction
by giving a QAT Termination Notice under Paragraph 14(a), the Company would
have the right to leave this Agreement in place and retain the Shareholders'
contractual support thereunder by publicly announcing its revision of the
Proposed Recapitalization such that the number of shares of Class A Stock to be
received upon exchange of each share of Class B Stock would be increased to the
number of shares needed for the "Class B Share Deemed Value" of the revised
proposed recapitalization (as so revised, the "Substitute Recapitalization
Proposal") to be equal to the Class B Share Deemed Value in the Qualified
Alternative Transaction, plus $.65. There would also be a revised part
cash/part stock alternative which would have the same Class B Share Deemed
Value as the revised all stock alternative and the same proportion of stock and
cash as under the current recapitalization proposal (i.e., 48.7% cash and 51.3%
stock). For such purposes, share amounts will be rounded to the nearest 1/100
of a share and dollar amounts will be rounded to the nearest cent. In
connection with any Substitute Recapitalization Proposal, the Shareholders
agree to elect to take the part cash/part stock alternative to the extent
requested to do so by the Company, following the advice of its counsel, to
avoid application of the higher vote requirement of Section 33-841 of the
Connecticut Business Corporation Act to the Substitute Recapitalization
Proposal.
(b) The Company may exercise the right to substitute a revised
recapitalization proposal under Paragraph 16(a) during the "Match Period",
which would commence upon the Company's receipt of the QAT Termination Notice
and end on the close of business on the later to occur of (i) the tenth
business day following the Company's receipt of the QAT Termination Notice and
(ii) the fifth business day following a determination by the Arbiter (or a
deemed determination under Paragraph 15(c)) that a proposed transaction meets
the requirements of a Qualified Alternative Transaction. The Substitute
Recapitalization Proposal would include the same proposed governance provisions
and be subject to the shareholder approval requirements as contemplated for the
Recapitalization Proposal. If the Company were to so exercise the right of
substitution, the Shareholders' right to Defense Costs under this Agreement
would be reinstated, retroactive to the date of the QAT Termination Notice, and
the Company would be required to repay to the Shareholders Defense Costs
reimbursed by the Shareholders to the Company on the same day that the Company
notifies the Shareholders that the Company has exercised such right of
substitution.
(c) In the event that the Company were to publicly announce a
Substitute Recapitalization Proposal, the Shareholders would not be permitted
to complete the Qualified Alternative Transaction unless this Agreement were to
be later terminated without the Substitute Recapitalization Proposal having
been completed other than by reason of a failure of the Shareholders to have
performed their obligations under this Agreement.
(d) For purposes of this Agreement, the "Class A Share Deemed
Value" of one share of Class A Stock to be received under the Substitute
Recapitalization Proposal would be equal to $15.54. If a proposed transaction
includes only the purchase of shares of Class B Stock and is solely for cash,
the "Class B Share Deemed Value" of the shares of Class B Stock in such
transaction will be the aggregate amount of cash proposed to be paid to the
Shareholders for the Covered Class B Shares divided by the number of Covered
Class B Shares proposed to be purchased from the Shareholders. If a proposed
transaction includes only the purchase of shares of Class B Stock and if the
consideration includes freely marketable, publicly traded securities, the
"Class B Share Deemed Value" of the shares of Class B Stock will be the
aggregate amount of cash and the aggregate Fair Market Value (as defined below)
of such securities proposed to be paid to the Shareholders for the Covered
Class B Shares divided by the number of Covered Class B Shares proposed to be
purchased from the Shareholders. If a proposed transaction also includes the
purchase of any shares of Class A Stock from the Shareholders, (i) such shares
of Class A Stock shall be valued at the greater of the value per share ascribed
to them in such proposed transaction (determined using the same methodology as
above for valuing shares of Class B Stock) and the Class A Share Deemed Value,
and (ii) all remaining consideration shall be allocated to the Covered Class B
Shares proposed to be purchased from the Shareholders to determine the "Class B
Share Deemed Value" of the Covered Class B Shares proposed to be purchased from
the Shareholders.
(e) The "Fair Market Value" of freely marketable, publicly traded
securities proposed as consideration for the shares of Class B Stock and/or
Class A Stock shall be established by reference to the average closing sale
prices for such securities on the principal exchange or quotation system where
they are traded over the ten trading day period ending on the trading day prior
to the giving of the QAT Termination Notice. Publicly traded securities shall
be deemed to be "freely marketable" for such purposes if (i) there is no
restriction on the trading of such securities other than compliance with the
securities laws and (ii) the issuer of such securities has (A) effected
Securities Act of 1933, as amended (the "Securities Act"), registration of such
securities at the time of issuance, (B) agreed to promptly effect Securities
Act registration of such securities on a resale basis as promptly as
practicable following the time of issuance or (C) represented that no
Securities Act registration is needed for either the issuance or resale of such
securities.
(f) For example, assume that the "Class A Share Deemed Value" is
$15.00 and, to make the math simpler, the Shareholders have 500,000 shares of
Class B Stock and 700,000 shares of Class A Stock. Also assume that as part of
a proposed transaction the proposed purchase price to be paid for the
Shareholders' 500,000 shares of Class B Stock is $20.0 million in cash and
publicly traded securities with a Fair Market Value of $3.5 million and the
proposed purchase price to be paid for the Shareholders' 700,000 shares of
Class A Stock is $5.0 million and publicly traded securities with a Fair Market
Value of $2.0 million. The average stated price for the shares of Class A Stock
is $10.00 per share (the sum of $5.0 million plus $2.0 million, divided by
700,000 shares of Class A Stock). Since this is less than the Class A Share
Deemed Value of $15.00, the difference of $3.5 million ($5.00 per share times
700,000 shares of Class A Stock) needs to be deducted from the $23.5 million
otherwise attributed to the shares of Class B Stock ($20.0 million plus $3.5
million). This leaves $20.0 million attributable to the 500,000 shares of Class
B Stock, for a "Class B Share Deemed Value" of $40.00 ($20.0 million divided by
500,000 shares of Class B Stock). Since the minimum level for a Qualifying
Alternative Transaction is $45.00 ($15.00 times three), this proposed
transaction would not be a Qualifying Alternative Transaction. If, on the other
hand, the average stated price for the shares of Class A Stock had been $15.00
or more and the proposed consideration cash and non-cash for the Class B shares
remained the same as in the example, there would be no adjustment for the
consideration proposed to be paid for the shares of Class A Stock and the
"Class B Share Deemed Value" of the proposed transaction would be $47.00 ($23.5
million divided by 500,000 shares of Class B Stock) and accordingly it would
qualify as a Qualifying Alternative Transaction and the minimum "Class B Share
Deemed Value" for a revised recapitalization proposal would need to be $47.65.
17. Kaman hereby agrees, and hereby agrees on behalf of his
representatives and agents, except as permitted under Paragraph 14 or 15 or as
otherwise specifically contemplated by this Agreement, not to directly or
indirectly at any time prior to the Expiration Date (i) sell, transfer, tender,
exchange, offer a right of first refusal, assign, pledge, encumber (including,
without limitation, a mortgage, security interest, charge or lien), gift or
otherwise dispose of the Kaman Shares, (ii) grant a voting interest in or
deposit into a voting trust any of the Kaman Shares, (iii) grant a proxy or
power of attorney with respect to the Kaman Shares, (iv) agree (whether or not
contingent upon the termination of this Agreement or any other event or passage
of time) to take any of the foregoing actions in this Paragraph 17, except for
the arrangements granting power to the DPA Attorneys-in-Fact under the Durable
Power of Attorney and the GPA Attorney-in-Fact under the General Power of
Attorney existing as of the date of this Agreement without giving effect to any
arrangements or transactions undertaken by or on behalf of the DPA
Attorneys-in-Fact or the GPA Attorney-in-Fact under such instrument occurring
on or after the date of this Agreement (whether or not entered into prior to
the date of this Agreement), or (v) enter into or continue any discussions or
negotiations with, or provide information, advice, aid, cooperation or
assistance to, or explore, initiate, solicit or facilitate interest from, or
enter into or consummate any transaction with, any third party or its
representatives and agents relating to the foregoing matters in this Paragraph
17 or a merger, business combination, consolidation, share exchange, tender
offer or a recapitalization involving the Company or any of its subsidiaries or
a sale of all or substantially all of the assets of the Company or any of its
subsidiaries, taken as a whole, in a single transaction or series of related
transactions or any public announcement of a proposal, plan or intention to do
any of the foregoing or any agreement to engage in any of the foregoing
(individually, a "Business Combination").
18. Newgate hereby agrees, and hereby agrees on behalf of its
representatives and agents, except as permitted under Paragraph 14 or 15 or as
otherwise specifically contemplated by this Agreement, not to directly or
indirectly at any time prior to the Expiration Date (i) sell, transfer, tender,
exchange, offer a right of first refusal, assign, pledge, encumber (including,
without limitation, a mortgage, security interest, charge or lien), gift or
otherwise dispose of the Newgate Shares, (ii) grant a voting interest in or
deposit into a voting trust any of the Newgate Shares, (iii) grant a proxy or
power of attorney with respect to the Newgate Shares, (iv) agree (whether or
not contingent upon the termination of this Agreement or any other event or
passage of time) to take any of the foregoing actions in this Paragraph 18,
except for the arrangements granting power to Newgate under the Newgate
Partnership Agreement existing as of the date of this Agreement without giving
effect to any arrangements or transactions undertaken by or on behalf of
Newgate under such agreement occurring on or after the date of this Agreement
(whether or not entered into prior to the date of this Agreement), or (v) enter
into or continue any discussions or negotiations with, or provide information,
advice, aid, cooperation or assistance to, or explore, initiate, solicit or
facilitate interest from, or enter into or consummate any transaction with, any
third party or its representatives and agents relating to the foregoing matters
in this Paragraph 18 or a Business Combination.
19. Oldgate hereby agrees, and hereby agrees on behalf of its
representatives and agents, except as permitted by Paragraph 14 or 15 or as
otherwise specifically contemplated by this Agreement, not to directly or
indirectly at any time prior to the Expiration Date (i) sell, transfer, tender,
exchange, offer a right of first refusal, assign, pledge, encumber (including,
without limitation, a mortgage, security interest, charge or lien), gift or
otherwise dispose of the Oldgate Shares, (ii) grant a voting interest in or
deposit into a voting trust any of the Oldgate Shares, (iii) grant a proxy or
power of attorney with respect to the Oldgate Shares, (iv) agree (whether or
not contingent upon the termination of this Agreement or any other event or
passage of time) to take any of the foregoing actions in this Paragraph 19,
except for the arrangements granting power to Oldgate under the Oldgate
Partnership Agreement existing as of the date of this Agreement without giving
effect to any arrangements or transactions undertaken by or on behalf of
Oldgate under such agreement occurring on or after the date of this Agreement
(whether or not entered into prior to the date of this Agreement), or (v) enter
into or continue any discussions or negotiations with, or provide information,
advice, aid, cooperation or assistance to, or explore, initiate, solicit or
facilitate interest from, or enter into or consummate any transaction with, any
third party or its representatives and agents relating to the foregoing matters
in this Paragraph 19 or a Business Combination.
20. Each of the Shareholders (other than Kaman, Newgate and Oldgate)
hereby agrees, and hereby agrees on behalf of its representatives and agents,
except as permitted by Paragraph 14 or 15 or as otherwise specifically
contemplated by this Agreement, not to directly or indirectly at any time prior
to the Expiration Date (i) sell, transfer, tender, exchange, offer a right of
first refusal, assign, pledge, encumber (including, without limitation, a
mortgage, security interest, charge or lien), gift or otherwise dispose of the
Shares held by them, (ii) grant a voting interest in or deposit into a voting
trust any of the Shares held by them, (iii) grant a proxy or power of attorney
with respect to the Shares held by them, (iv) agree (whether or not contingent
upon the termination of this Agreement or any other event or passage of time)
to take any of the foregoing actions in this Paragraph 20, or (v) enter into or
continue any discussions or negotiations with, or provide information, advice,
aid, cooperation or assistance to, or explore, initiate, solicit or facilitate
interest from, or enter into or consummate any transaction with, any third
party or its representatives and agents relating to the foregoing matters in
this Paragraph 20 or a Business Combination.
21. (a) A special meeting of the Company's shareholders (the
"Shareholders' Meeting") shall be held as soon as reasonably practicable after
the expiration of the Permitted Termination Period for the purpose of obtaining
approval of (i) whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal as is then recommended by the Board in accordance
with this Agreement, by the affirmative vote of the votes cast within the
voting group favoring the Proposed Recapitalization or the Substitute
Recapitalization Proposal exceeding the votes cast opposing the Proposed
Recapitalization or the Substitute Recapitalization Proposal, with respect to
the Class A Stock and Class B Stock each voting as a separate class and (ii)
the Proposed Charter Governance Amendments, by the affirmative vote of the
holders of at least 66-2/3% of the outstanding shares of the Class B Stock
(collectively, the "Shareholder Approval"), and the Company shall use its
commercially reasonable efforts to obtain the Shareholder Approval, including
the use of a proxy statement reflecting this Agreement and setting forth the
manner in which holders of Class B Stock may elect to receive the Alternative
Class B Stock Consideration and in which the Board recommends (a) to the
holders of the Class B Stock to vote for the approval of the Proposed
Recapitalization or the Substitute Recapitalization Proposal as contemplated by
this Agreement and the Proposed Charter Governance Amendments and (b) to the
holders of the Class A Stock to vote for the approval of the Proposed
Recapitalization or the Substitute Recapitalization Proposal as contemplated by
this Agreement. The Proposed Charter Governance Amendments and the Proposed
Bylaw Governance Provisions, by their terms, shall not take effect if the
Proposed Recapitalization or the Substitute Recapitalization Proposal does not
occur.
(b) Notwithstanding the foregoing, either of the Special Committee
or the Board may (w) withdraw, modify or propose to withdraw or modify its
recommendation of, or fail to implement one or more of the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Provisions, (x)
withdraw, modify or propose to withdraw or modify its recommendation of the
Proposed Recapitalization or the Substitute Recapitalization Proposal, (y) fail
to call, delay or cancel the Shareholders' Meeting, and/or (z) in the case of
the Board, terminate this Agreement, in each case if it determines in good
faith it would be appropriate to do so in the exercise of its fiduciary duties;
provided, that (i) no such modification or proposal to modify under clause (w)
may add proposed amendments or have the reasonably likely effect of reducing
shareholder influence unless such modification or proposal to modify is
required by a change in law or regulation or NASDAQ listing rules, and (ii) any
such action under clause (x), (y) or (z) must be based principally on a
material change or development or material information coming to the attention
of the Special Committee or the Board following the date of this Agreement or,
if there is a Substitute Recapitalization Proposal, the date of Board approval
of such Substitute Recapitalization Proposal.
(c) In the event that the Company shall terminate this Agreement
under Paragraph 21(b)(z) before either the Proposed Recapitalization or the
Substitute Recapitalization Proposal has been submitted for Shareholder
Approval, the Company shall reimburse the actual, out of pocket expenses of the
Shareholders incurred in connection with negotiating this Agreement and in
pursuing a Qualifying Alternative Transaction; provided, that (w) such
reimbursement obligation shall not include Defense Costs, any amounts paid to
satisfy judgments or settlements of Claims, any amounts paid to Compass
Partners or other financial advisor or any amounts paid in respect of fees or
expenses of the Arbiter, (x) the Shareholders must provide reasonable
documentation as to such expenses, including a reasonably detailed description
of the hours worked and services provided by counsel or other advisors, (y)
such reimbursement obligation shall be limited to $750,000 in the aggregate if
there shall not have been a Substitute Recapitalization Proposal and $1,250,000
in the aggregate if there shall have been a Substitute Recapitalization
Proposal and (z) the Shareholders agree to return to the Company within two
business days the amount so reimbursed in the event that, within six months
following termination under Paragraph 21(b)(z), the Shareholders sell any of
their Covered Class B shares at an average price in excess of the then current
market price for the shares of Class A Common Stock, it being agreed that, if
both shares of Class A Stock and shares of Class B Stock are sold in the same
transaction (or a series of related transactions), the shares of Class A Stock
so sold shall be deemed to be sold at the then current market price for such
shares and the Covered Class B Shares so sold shall be deemed to be sold for
the balance of the gross sale proceeds; provided, that the amount to be so
reimbursed shall be limited to the aggregate amount of excess proceeds received
for the Class B Stock over the then current trading price for the Class A
Stock.
22. Each of the Shareholders agrees, and agrees to cause its, his or
her representatives and agents, to provide all information and materials and
take all such action as may be required in order to permit the Company to
promptly comply with all applicable requirements of the SEC with respect to the
relevant documents prepared for the Shareholders' Meeting (the "Meeting
Documents"), including its identity and ownership of Shares and the nature of
its commitments, arrangements and understandings under this Agreement. The
Shareholders shall not be responsible for the description of the terms of this
Agreement in the Meeting Documents. Each of the Shareholders and its counsel
shall be given a reasonable opportunity to review and comment on the Meeting
Documents before the filing thereof with the SEC, and the Meeting Documents as
filed with the SEC shall be reasonably satisfactory, in form and substance, to
the Shareholders and their counsel. The Company disclaims any liability for
statements made or incorporated by reference in the Meeting Documents based on
information and materials provided by or on behalf of the Shareholders
expressly for inclusion or incorporation by reference therein.
23. For so long as this Agreement shall remain in effect, each of the
Shareholders agrees, and shall cause its, his or her representatives and
agents, not to, (i) act in concert with any other person (other than the other
Shareholders in a manner consistent with the terms of this Agreement) by
becoming a member of a 13D Group (as defined below), (ii) solicit, initiate or
participate in any "solicitation" of "proxies" or become a "participant" in any
"election contest" (as such terms are defined or used in Regulation 14A under
the Securities Exchange Act of 1934, as amended (the "Exchange Act")), (iii)
call, or participate in a call for, any special meeting of shareholders of the
Company, (iv) participate in or solicit shareholders of the Company for the
approval of, one or more shareholder proposals or (v) assist, advise or act in
concert with any person (other than the Company or its advisors) with respect
to, or seek to do, any of the foregoing. For purposes of this Paragraph 23,
"13D Group" shall mean any group of persons acquiring, holding, voting or
disposing of Class A Stock that would be required under Section 13(d) of the
Exchange Act and the rules and regulations thereunder (assuming the Class A
Stock is an "equity security" within the meaning of Rule 13d-1(i) of the
Exchange Act) to file a statement on Schedule 13D with the SEC as a "person"
within the meaning of Section 13(d)(3) of the Exchange Act if such group
beneficially owned Class A Stock representing more than 5% of the Class A Stock
then outstanding; provided that nothing in this Agreement shall limit the
rights and obligations of the Shareholders set forth herein, including
concerning a Qualifying Alternative Transaction, or the ability of the
Shareholders to confer and communicate with each other and their
representatives and agents with regard to the Class A Stock and the Class B
Stock.
24. The Company agrees, subject to applicable law and the provisions
of this Paragraph 24, to (i)(a) file a post-effective amendment to the
registration statement that will be filed with the SEC to register the shares
of Class A Stock distributed by the Company in the Proposed Recapitalization or
the Substitute Recapitalization Proposal, as well as other shares of Class A
Stock held by the Shareholders (collectively, the "Subject Shares") within 15
days after the consummation of the Proposed Recapitalization or the Substitute
Recapitalization Proposal to convert it to a shelf registration statement
covering resales of the Subject Shares, or (b) file a shelf registration
statement with the SEC covering resales of the Subject Shares within 30 days
after the consummation of the Proposed Recapitalization or the Substitute
Recapitalization Proposal, (ii) use its commercially reasonable efforts to seek
prompt effectiveness of such registration statement, (iii) prepare and file
with the SEC such amendments and supplements to such registration statement and
the prospectus used in connection therewith as may be necessary to keep such
registration statement effective and to comply with the provisions of the
Securities Act with respect to the sale or other disposition of the Subject
Shares thereunder, (iv) furnish to the Shareholders such number of conformed
copies of such registration statement and each amendment and supplement thereto
(including in each case all exhibits), and of a summary prospectus or other
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents, as the
Shareholders may reasonably request, (v) use its commercially reasonable
efforts to register or qualify the Subject Shares under securities or "blue
sky" laws of jurisdictions within the United States as the Shareholders shall
reasonably request, to keep such registration or qualification in effect for so
long as such registration statement remains in effect, and to take any other
action which may be reasonably necessary to enable the Shareholders to
consummate the disposition in such jurisdictions of the Subject Shares under
such registration statement (provided, however, that the Company shall not be
required in connection therewith or as a condition thereto to qualify to do
business, subject itself to taxation in or to file a general consent to service
of process in any jurisdiction wherein it would not but for the requirements of
this Paragraph 24 be obligated to do so), and (vi) permit resales by the
Shareholders of the Subject Shares under such registration statement until the
earlier to occur of (a) one year from the date of consummation of the Proposed
Recapitalization plus the length of any Suspension Periods (as defined below)
and (b) the first date on which the Shareholders are permitted to sell or
transfer the Subject Shares under Rule 144 of the Securities Act, without
limitations on volume in any one sale or transfer; provided that if the Company
shall furnish to the Shareholders a certificate signed by its Chairman, Chief
Executive Officer or Chief Financial Officer stating that (y) filing a
registration statement or maintaining effectiveness of a current registration
statement would have a material adverse effect on the Company or its
shareholders in relation to any material financing, acquisition or other
corporate transaction, and the Company has determined in good faith that such
disclosure is not in the best interests of the Company and its shareholders or
(z) the Company has determined in good faith that the filing or maintaining
effectiveness of a current registration statement would require disclosure of
material information that the Company has a valid business purpose of retaining
as confidential, the Company shall be entitled to postpone filing or suspend
the use by the Shareholders for a reasonable period of time, but not in excess
of 45 consecutive calendar days (any period of such postponement or suspension,
a "Suspension Period"). The Company shall be entitled to exercise such
suspension right more than one time in any calendar year; provided that such
exercise shall not prevent the Shareholders from being entitled to at least 270
days of effective registration rights per year and that no Suspension Period
may commence if it is less than 30 days from the prior such Suspension Period.
The Shareholders agree to provide all information and materials and take all
such action as may be required in order to permit the Company to comply with
all applicable requirements of the SEC and to obtain any desired acceleration
of the effective date of such registration statement and shall be given a
reasonable opportunity to review and comment on the registration statement and
any amendments thereto before the filing thereof with the SEC, which shall be
not less than five business days in the case of the registration statement and
two business days in the case of any amendment. The Subject Shares of any
Shareholder who fails to provide such information or otherwise cooperate within
the foregoing time periods may be excluded by the Company from such
registration statement. The Company disclaims any liability for statements made
or incorporated by reference in such registration statement or prospectus based
on information and materials provided by or on behalf of the Shareholders
expressly for inclusion or incorporation by reference therein, provided that
all such statements in the registration statement, as filed with the SEC, are
reasonably satisfactory to the Shareholders.
25. (a) Subject to the provisions of Paragraphs 25(b) and 25(c), the
Company hereby agrees to reimburse the Shareholders and the GPA
Attorney-in-Fact (individually, a "Reimbursement Party" and, collectively, the
"Reimbursement Parties") for any and all out-of-pocket attorneys' fees and
their related expenses (collectively, the "Defense Costs") actually and
reasonably incurred by any of the Reimbursement Parties arising out of or
resulting from the defense of any third party allegation, claim, action, suit,
complaint, demand, litigation or legal or administrative proceeding, including
those brought derivatively on behalf of the Company alleging any wrongful
action or inaction by any Shareholder in his, her or its capacity as a
shareholder of the Company or any wrongful action or inaction by any of the
Reimbursement Parties taken in connection with any alleged wrongful action or
inaction by a Shareholder in his, her or its capacity as a shareholder of the
Company, in each case in connection with the authorization, execution, delivery
and performance of this Agreement by any of the Shareholders (collectively, the
"Claims"); provided, that Defense Costs shall not include amounts paid (x) to
satisfy judgments or settlements relating to Claims or (y) in respect of CWK
Claim Coverage. For purposes of this Paragraph 25, "reimbursement" shall be
deemed to include direct payment by the Company of bills that are submitted by
the Reimbursement Parties in compliance with Paragraph 25(b).
(b) The reimbursement obligation of the Company pursuant to
Paragraph 25(a) with respect to Defense Costs will be subject to the following
terms and conditions:
(i) the reimbursement of Defense Costs is conditioned on (A)
there having been no breach of this Agreement by any of the Reimbursement
Parties, (B) there not then existing a "QAT Disqualification" (as defined
below), (C) the Reimbursement Parties and their counsel not having claimed that
any provision of this Agreement is illegal or invalid for any reason, and
having reasonably cooperated with counsel to the Company or members of the
Board of Directors of the Company in the review and defense of any Claim, and
(D) there having been no determination by a court of competent jurisdiction
that any of the Reimbursement Parties has engaged in intentional misconduct or
has acted with gross negligence or in bad faith in connection with any matter
the subject of a Claim;
(ii) within ten business days of his, her or its receipt of
notice of such Claim, a Reimbursement Party must give the Company written
notice of any Claim asserted against such Reimbursement Party, directly or
indirectly, for which such Reimbursement Party expects to receive reimbursement
of Defense Costs under Paragraph 26(a), following which the Company may
determine at its election to undertake the defense thereof by representatives
of the Company's choosing which are reasonably satisfactory to the
Reimbursement Parties or permit the Reimbursement Parties to undertake the
defense thereof by representatives of their choosing which are reasonably
satisfactory to the Company, it being agreed that the Reimbursement Parties
shall be responsible for their own Defense Costs, except to the extent that the
Company has a reimbursement obligation as provided for under Paragraph 25(a),
and that a failure of a Reimbursement Party to give such notice shall not
result in a forfeiture of his, her or its reimbursement rights unless the
Company shall have been materially disadvantaged by such failure;
(iii) notwithstanding the provisions of Paragraph 25(b)(ii),
with respect to any Claim, the Reimbursement Parties will collectively have the
right, if the Company elects to undertake the defense, to employ one law firm
of their choice (in each applicable jurisdiction, if more than one jurisdiction
is involved) to represent the Reimbursement Parties if, in their collective
reasonable judgment, a conflict of interest between the Reimbursement Parties
and the Company exists in respect of such Claim, and in that event the Defense
Costs of such separate counsel shall be reimbursable by the Company pursuant to
and subject to the provisions of this Paragraph 25;
(iv) neither the Company nor any of the Reimbursement Parties
will, without the prior written consent of the other, settle or compromise any
Claim or consent to entry of any judgment relating to any such Claim if such
settlement or compromise will impose a liability or obligation on the other;
and
(v) the Company will reimburse the Defense Costs for which the
Reimbursement Parties are entitled to be reimbursed under Paragraph 25(a) only
after (A) the receipt by the Company of the related bill from counsel, together
with a reasonably detailed descriptions of hours worked and services provided
by counsel, (B) receipt by the Company of either evidence that the Defense
Costs to be reimbursed have actually been paid by the Reimbursement Parties
requesting reimbursement or written confirmation by the Reimbursement Parties
requesting reimbursement that such bill accurately represents an amount owed by
such Reimbursement Parties and (C) the satisfaction of the conditions set forth
in Paragraph 25(b)(i).
(c) Each of the Reimbursement Parties acknowledges and agrees that
the Company shall be entitled to rely upon the assurances of CWK and John C.
Yavis, Jr., acting jointly, as to their authority to act for and bind any other
Reimbursement Party for any action taken under this Paragraph 25.
(d) A "QAT Disqualification" shall be deemed to commence from the
time at which a QAT Termination Notice shall have been delivered to the Company
and shall be deemed to continue (i) indefinitely in the event that the proposed
Qualifying Alternative Transaction specified in such QAT Termination Notice
shall be completed, (ii) until such time as the Shareholders shall have
confirmed to the Company in writing that such proposed Qualifying Alternative
Transaction shall have been abandoned or (iii) until such time as the Company
shall have publicly announced a Substitute Recapitalization Proposal.
(e) Each of the Reimbursement Parties acknowledges and agrees
that, for so long as a QAT Disqualification shall remain in effect, he, she or
it will not seek or attempt to seek and hereby knowingly and irrevocably
releases and relinquishes any right he, she or it had, has or may in the future
have, directly or indirectly, for reimbursement, indemnification or
contribution of Defense Costs or liability from the Company, any of its
subsidiaries or affiliates, or any of their respective directors or officers,
including, without limitation, from any third party or self insurance
arrangement or policy of the Company or any of its subsidiaries or affiliates,
with respect to Claims; provided, however, that the foregoing release and
relinquishment shall not deprive CWK of any right of indemnification,
reimbursement, or any other right under Connecticut law, the Company Charter or
the Company's By-Laws to the extent of the CWK Claim Coverage. Nothing in this
Agreement shall be deemed to deprive any Shareholder of any right to
indemnification, reimbursement, or any other right or claim, in connection with
any litigation or other matter that does not arise from this Agreement, whether
such right or claim is against the Company or any other person, and whether
such right arises under contract, certificate of incorporation or by-laws,
statute, common law or otherwise.
26. Kaman represents and warrants that (i) the Durable Power of
Attorney is in full force and effect and the scope of powers granted thereunder
to the DPA Attorneys-in-Fact has not been revoked, limited, modified or amended
since the date of grant, (ii) the General Power of Attorney is in full force
and effect and the scope of powers granted thereunder to the GPA
Attorney-in-Fact has not been revoked, limited, modified or amended since the
date of grant, (iii) he has not granted any power of attorney (other than the
General Power of Attorney and the Durable Power of Attorney) or appointed any
proxy to vote or otherwise act for him with respect to the Kaman Shares (other
than the irrevocable proxy executed and delivered by him pursuant to Paragraph
4), (iv) this Agreement and the irrevocable proxies granted under Paragraphs 2
and 4 have been duly executed and delivered by Kaman, acting through the GPA
Attorney-in-Fact under the General Power of Attorney and the DPA
Attorneys-in-Fact under the Durable Power of Attorney, as the case may be, and
each constitutes the legal, valid and binding obligation of Kaman and is
enforceable against Kaman and his heirs, personal representatives, successors
and permitted assigns in accordance with its terms, and (v) he owns of record
and beneficially the Kaman Shares, free and clear of any lien, encumbrance,
option, pledge, security interest, right of first refusal or similar
restriction, including any restriction on voting, transfer or other exercise of
any other attribute of ownership thereof, except for the General Power of
Attorney and the Durable Power of Attorney and that the Indirectly Owned Kaman
Class B Shares are subject to the Voting Trust Agreement and are registered in
the name of John C. Yavis, Jr. as custodian.
27. Newgate represents and warrants that (i) the Newgate Partnership
Agreement is a valid and binding agreement of the parties thereto and is
enforceable in accordance with its terms, (ii) CWK is the sole General Partner
of Newgate, (iii) this Agreement and the irrevocable proxy executed under
Paragraph 5 have been duly executed and delivered by Newgate, acting through
CWK as its sole general partner, and each constitutes the legal, valid and
binding obligation of Newgate and is enforceable against Newgate and its
successors and permitted assigns in accordance with its terms, and (iv) that it
owns of record the Newgate Class A Shares and it owns beneficially the Newgate
Class B Shares, which are registered in the name of John C. Yavis, Jr. as
custodian, in each case free and clear of any lien, encumbrance, option,
pledge, security interest, right of first refusal or similar restriction,
including any restriction on voting, transfer or other exercise of any other
attribute of ownership thereof, except that the voting of the Newgate Class B
Shares are subject to the Voting Trust Agreement.
28. Oldgate represents and warrants that (i) the Oldgate Partnership
Agreement is a valid and binding agreement of the parties thereto and is
enforceable in accordance with its terms, (ii) CWK is the sole General Partner
of Oldgate, (iii) this Agreement and the irrevocable proxy executed under
Paragraph 6 have been duly executed and delivered by Oldgate, acting through
CWK as its sole general partner, and each constitutes the legal, valid and
binding obligation of Oldgate and is enforceable against Oldgate and its
successors and permitted assigns in accordance with its terms, and (iv) that it
owns of record and beneficially the Oldgate Shares, free and clear of any lien,
encumbrance, option, pledge, security interest, right of first refusal or
similar restriction, including any restriction on voting, transfer or other
exercise of any other attribute of ownership thereof.
29. Each of the Voting Trustees represents and warrants to his or her
knowledge that (i) the Voting Trust Agreement is a valid and binding agreement
of the parties thereto and is enforceable in accordance with its terms and (ii)
this Agreement and the irrevocable proxy executed under Paragraph 3 have been
duly executed and delivered by the Voting Trustees, and each constitutes the
legal, valid and binding obligation of the Voting Trustees and is enforceable
against the Voting Trustees and their respective heirs, personal
representatives, successors and permitted assigns in accordance with its terms.
30. Each of the Shareholders (other than Kaman, Newgate and Oldgate)
represents and warrants that (i) this Agreement and the irrevocable proxy
executed under Paragraph 7, 8, 9 or 10, as the case may be, have been duly
executed and delivered by such Shareholder, and each constitutes the legal,
valid and binding obligation of such Shareholder and is enforceable against
such Shareholder and his or her heirs, personal representatives, successors and
permitted assigns in accordance with its terms and (ii) he or she owns of
record and beneficially the Shares shown to be owned by such Shareholder on the
Schedules to this Agreement, free and clear of any lien, encumbrance, option,
pledge, security interest, right of first refusal or similar restriction,
including any restriction on voting, transfer or other exercise of any other
attribute of ownership thereof. Each of the Shareholders (other than Kaman)
represents and warrants that to his, her or its knowledge the representations
contained in Paragraphs 26(i), 26(ii) and 26(iii) are correct.
31. Each of the Shareholders acknowledges that (i) he, she or it has
(a) had an opportunity to request information, records and documentation from,
and ask questions of, the Company and the Special Committee in order to
facilitate his, her or its consideration of whether to enter into this
Agreement and (b) discussed and reviewed this Agreement with the persons for
which he, she or it acts in a fiduciary or advisory capacity in respect of all
or a portion of the Shares, (ii) the Board may determine to withdraw, modify,
propose to withdraw or modify or not implement one or more of the Proposed
Charter Governance Amendments or the Proposed Bylaw Governance Amendments or
terminate this Agreement under the circumstances permitted under Paragraph
21(b)(z). By reason of his, her or its business and financial experience, each
of the Shareholders has the capacity to protect his, her or its own interests
or that of his, her or its fiduciaries in connection with the transactions
contemplated by this Agreement. Each of the Shareholders is an "accredited
investor" or has been advised by a "purchaser representative", as such terms
are defined in Regulation D promulgated under the Securities Act, and is able
to bear the economic risk of an investment in the Subject Shares, has an
adequate income independent of any income produced from an investment in the
Subject Shares and has sufficient resources to sustain a loss of all of his,
her or its investment in the Subject Shares without economic hardship if such a
loss should occur.
32. In the event that any of the Shareholders acquires record or
beneficial ownership of additional shares of Class A Stock and/or Class B Stock
from and after the date of this Agreement and prior to the Expiration Date,
such additional shares of Class A Stock and/or Class B Stock shall immediately
upon such acquisition become subject to the terms of this Agreement.
33. This Agreement is the product of extensive discussions and
negotiations between and among the Parties and their respective advisors. Each
of the Parties was represented by or had the opportunity to consult with
counsel who either participated in the formulation and documentation of, or was
afforded the opportunity to review and provide comments on, this Agreement.
Accordingly, the general rule of contract construction known as "contra
proferentum" shall not apply to the interpretation of any provision of this
Agreement or any document generated in connection herewith.
34. Each of the Parties agrees that remedies at law are inadequate to
protect against his, her or its breach or threatened breach of this Agreement.
Each of the Parties agrees, in advance, without prejudice to any rights to
judicial relief such other Party may otherwise have, to the granting of
equitable relief, including injunction, in such other Party's favor without
proof of actual damages. Each of the Parties agrees to waive and not to seek
any requirement for the securing or posting of a bond in connection with any
other Party seeking or obtaining such relief.
35. If any term or provision of this Agreement, or any application
thereof to any circumstances, shall, to any extent and for any reason, be held
to be invalid or unenforceable, the remainder of this Agreement, or the
application of such term or provision to circumstances other than those to
which it is held invalid or unenforceable, shall not be affected thereby and
shall be construed as if such invalid or unenforceable provision had never been
contained herein and each term and provision of this Agreement shall be valid
and enforceable to the fullest extent permitted by applicable law.
36. This Agreement and the schedules and exhibits attached hereto
shall constitute the entire agreement between and among the Parties with regard
to the subject matter of this Agreement and supersede all prior agreements and
understandings, both written and oral, between and among the Parties with
respect to the subject matter hereof. No modification, amendment or waiver
shall be binding without the written consent of the Parties affected thereby.
Neither this Agreement nor any of the rights, interests or obligations under
this Agreement shall be assigned by any of the Parties (except by operation of
law) without the prior written consent of each of the other Parties affected
thereby. This Agreement shall inure to the benefit of and be binding upon each
of the Parties and their respective heirs, personal representatives, successors
and permitted assigns, and is not for the benefit of, nor may any provision
hereof be enforced by, any other person. It is further understood and agreed
that no failure or delay in exercising any right, power or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise
thereof preclude any other or further exercise thereof or the exercise of any
other right, power or privilege. All rights, powers and remedies provided under
this Agreement or otherwise available in respect hereof at law or in equity
shall be cumulative and not alternative, and the exercise of any thereof by any
Party shall not preclude the simultaneous or later exercise of any other right,
power or remedy by such Party.
37. This Agreement shall be governed by and construed in accordance
with the laws of the State of Connecticut, without regard to the conflict of
laws principles thereof. Apart from proceedings before the Arbiter, all actions
and proceedings regarding the rights and obligations under this Agreement shall
be heard and determined in any Connecticut state or federal court sitting in
the City of Hartford.
38. Any notice hereunder shall be made in writing and shall be
considered given when received, by first class mail, by overnight courier or by
facsimile with original copy to follow by first class mail or overnight courier
as follows: (i) if to the Company, to Kaman Corporation, attention: Candace A.
Clark, Senior Vice President, Chief Legal Officer and Secretary, 1332 Blue
Hills Avenue, Bloomfield, Connecticut 06002, facsimile no.: (860) 243-7397;
with a copy (which shall not constitute notice) to: (a) Eileen S. Kraus,
Chairperson of the Special Committee c/o Candace A. Clark, Senior Vice
President, Chief Legal Officer and Secretary at the address set forth above;
and (b) Skadden, Arps, Slate, Meagher & Flom LLP, attention: Randall H. Doud,
Esq., Four Times Square, New York, New York 10036-6522, facsimile no.: (917)
777-2524; or (ii) if to any of the Shareholders, to him, her or it at his, her
or its address on the books of the Company; with a copy (which shall not
constitute notice) to: (a) Murtha Cullina LLP, attention: John C. Yavis, Jr.,
Esq. and Charles E. Drummey, Esq., CityPlace I, 185 Asylum Street, Hartford,
Connecticut 06103, facsimile no.: (860) 240-6150; (b) Dechert LLP, attention:
Martin Nussbaum, Esq., 30 Rockefeller Plaza, New York, New York 10112-2200,
facsimile no.: (212) 212-698-3599; and (c) Day, Berry & Howard LLP, attention:
Thomas J. Groark, Jr., Esq., CityPlace I, Hartford, Connecticut 06103,
facsimile no.: (860) 275-0343.
39. This Agreement may be executed in counterparts and signature pages
exchanged by facsimile, and each counterpart shall be deemed to be an original,
but all counterparts of which shall constitute one and the same agreement.
40. Except as otherwise provided in this Agreement, each of the
Parties hereto shall pay his, her or its own costs and expenses in connection
with the review of and compliance with this Agreement.
41. From time to time, at the reasonable request of any Party and
without additional consideration, each other Party shall execute and deliver
such additional documents and take all such further action as may be necessary
or desirable to consummate and make effective, in the most expeditious manner
practicable, the transactions contemplated by this Agreement. Each of the
Parties agrees to cooperate and use its reasonable best efforts to contest and
resist any action, including administrative or judicial action, and to have
vacated, lifted, reversed or overturned any decree, judgment, injunction or
other order (whether temporary, preliminary or permanent) that is in effect
that restricts, prevents or prohibits the consummation of any of the
transactions contemplated by this Agreement or the approval and consummation of
any settlement of any litigation relating to this Agreement or the transactions
contemplated hereby, including, without limitation, by pursuing all reasonably
available avenues of administrative and judicial appeal.
42. The representations and warranties in this Agreement shall survive
until the Expiration Date and the reimbursement provisions of Paragraphs 21(c)
and 25 shall survive any termination of this Agreement by the Board pursuant to
Paragraph 21(b)(z).
43. Each of the Shareholders shall be responsible for the payment of
any stock transfer taxes in connection with the conversion of any shares of the
Class B Stock owned by them respectively into shares of the Class A Common
Stock.
44. Each of the Shareholders hereby designates each of CWK and John C.
Yavis, Jr., acting jointly, to act on behalf of the Shareholders collectively
as to any and all matters requiring action or approval by the Shareholders in
their capacities as Reimbursement Parties under Paragraph 25, in connection
with the registration rights provided for under Paragraph 24 or the disclosure
approval rights provided for under Paragraph 11.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the Parties have caused this Agreement to be
executed as of the date and year first above written.
KAMAN CORPORATION
By: /s/ Candace A. Clark
-----------------------------------------
Name: Candace A. Clark
Title: Senior Vice President, Chief Legal
Officer and Secretary
NEWGATE ASSOCIATES LIMITED PARTNERSHIP,
by its sole General Partner
By: /s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
Title: General Partner
OLDGATE ASSOCIATES LIMITED PARTNERSHIP,
by its sole General Partner
By /s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
Title: General Partner
CHARLES H. KAMAN, by his Attorney-in-Fact
under the General Power of Attorney,
dated February 11, 1998
By: /s/ John C. Yavis, Jr.
-----------------------------------------
Name: John C. Yavis, Jr.
Title: Attorney-in-Fact
ROBERTA C. KAMAN, in her capacity as an
Attorney-in-Fact under the Durable Power
of Attorney, dated May 4, 1996
By: /s/ Roberta C. Kaman
-----------------------------------------
Name: Roberta C. Kaman
Title: Attorney-in-Fact
ROBERTA C. KAMAN, in her capacity as a Voting
Trustee under the Voting Trust Agreement,
dated August 14, 2000 and as amended as
of June 7, 2005
By: /s/ Roberta C. Kaman
-----------------------------------------
Name: Roberta C. Kaman
Title: Voting Trustee
ROBERTA C. KAMAN, in her individual capacity
: /s/ Roberta C. Kaman
-----------------------------------------
Name: Roberta C. Kaman
C. WILLIAM KAMAN II, in
his capacity as an
Attorney-in-Fact under the
Durable Power of Attorney,
dated May 4, 1996
By: /s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
Title: Attorney-in-Fact
C. WILLIAM KAMAN II, in
his capacity as a Voting
Trustee under the Voting
Trust Agreement, dated
August 14, 2000 and as
amended as of June 7, 2005
By: /s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
Title: Voting Trustee
C. WILLIAM KAMAN II, in
his individual capacity
/s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
C. WILLIAM KAMAN II, in
his capacity as Trustee
for Charles Tyson Kaman
and Kathryn S. Kaman
By: /s/ C. William Kaman II
-----------------------------------------
Name: C. William Kaman II
Title: Trustee
STEVEN W. KAMAN, in his capacity as an
Attorney-in-Fact under the Durable Power
of Attorney, dated May 4, 1996
By: /s/ Steven W. Kaman
-----------------------------------------
Name: Steven W. Kaman
Title: Attorney-in-Fact
STEVEN W. KAMAN, in his capacity as a Voting
Trustee under the Voting Trust Agreement,
dated August 14, 2000 and as amended as
of June 7, 2005
By: /s/ Steven W. Kaman
-----------------------------------------
Name: Steven W. Kaman
Title: Voting Trustee
STEVEN W. KAMAN, in his individual capacity
/s/ Steven W. Kaman
-----------------------------------------
Name: Steven W. Kaman
STEVEN W. KAMAN, in his capacity as Trustee
for Cameryn H. Kaman
By: /s/ Steven W. Kaman
-----------------------------------------
Name: Steven W. Kaman
Title: Trustee
CATHLEEN H. KAMAN, in her capacity as an
Attorney-in-Fact under the Durable Power
of Attorney, dated May 4, 1996
By: /s/ Cathleen H. Kaman
-----------------------------------------
Name: Cathleen H. Kaman
Title: Attorney-in-Fact
CATHLEEN H. KAMAN, in her capacity as a
Voting Trustee under the Voting Trust
Agreement, dated August 14, 2000 and as
amended as of June 7, 2005
By: /s/ Cathleen H. Kaman
-----------------------------------------
Name: Cathleen H. Kaman
Title: Voting Trustee
CATHLEEN H. KAMAN, in her individual capacity
/s/ Cathleen H. Kaman
-----------------------------------------
Name: Cathleen H. Kaman
CATHLEEN H. KAMAN, in her capacity as Trustee
for Zane N. Kaman-Wood
By: /s/ Cathleen H. Kaman
-----------------------------------------
Name: Cathleen H. Kaman
Title: Trustee
Schedule A-1
------------
Share certificate numbers evidencing the 258,375 Directly Owned Kaman Class B
Shares:
B 1236
B 1270
B 1521
B 1631
B 1665
B 1723
B 2036
B 2074
B 2213
B 2737
B 2738
B 3214
B 3216
B 3436
B 4269
B 4323
B 4408
B 4512
B 4523
Schedule A-2
Stock certificate number evidencing the 96,601 Indirectly Owned Kaman Class B
Shares:
B 5279 (same stock certificate also represents the Newgate Class B Shares)
Voting trust certificate number evidencing the 96,601 Indirectly Owned Kaman
Class B Shares:
2
Schedule A-3
------------
Share certificate numbers evidencing the 234,626 Kaman Class A Shares:
A 183391
A 183614
A 221811
A 224490
A 224547
A 225822
A 225870
A 227344
A 228394
A 228516
A 228941
A 229516
A 230273
Schedule B-1
------------
Share certificate number evidencing the 103,201 Newgate Class B Shares:
B 5279 (same stock certificate also represents the Indirectly Owned Kaman Class
B Shares)
Voting trust certificate number evidencing the 103,201 Newgate Class B Shares:
3
Schedule B-2
------------
Share certificate numbers evidencing the 95,264 Newgate Class A Shares:
A 218351
A 218360
A 218363
A 218365
A 230274
Schedule C
----------
Share certificate numbers evidencing the 148,850 Oldgate Shares:
A 224496
A 224501
A 224503
Schedule D-1
------------
Share certificate numbers evidencing the 69,246 CWK Class B Shares:
Personal:
- --------
B 5275
Trustee for Kathryn S. Kaman:
- ----------------------------
B 4495
Trustee for Charles Tyson Kaman:
- -------------------------------
B 4496
Schedule D-2
------------
Share certificate numbers evidencing the 152,277 CWK Class A Shares:
Personal:
- --------
A 223586
A 224873
A 226286
A 228781
A 228782
A 228783
A 228784
A 228785
A 228786
A 229366
A 230223
A 230536
Trustee for Charles Tyson Kaman:
- -------------------------------
A 146765
A 149403
A 156230
A 156231
A 159270
A 160829
A 162837
A 166267
A 166268
A 170903
A 175174
A 178383
A 178384
A 183640
A 186330
A 193743
A 194276
A 196850
A 203483
A 203629
A 205796
A 208479
A 209021
A 211404
A 212608
A 218289
A 223794
A 223795
A 223796
A 224460
A 225819
A 226906
A 227754
A 228515
Trustee for Kathryn H. Kaman:
- ----------------------------
A 159271
A 160830
A 162838
A 166271
A 170904
A 175173
A 178386
A 183612
A 186329
A 193712
A 203610
A 208478
A 211403
A 212607
A 218290
A 220021
A 220064
A 221875
A 223361
A 224461
A 225820
A 226907
A 227756
A 227978
Schedule E-1
------------
Share certificate numbers evidencing the 1,471 RCK Class B Shares:
B 3139
B 3295
B 3438
B 3552
B 4524
Schedule E-2
------------
Share certificate numbers evidencing the 23,132 RCK Class A Shares:
A 121631
A 129403
A 139823
A 150064
A 166273
A 178389
A 193744
A 218362
A 224504
Schedule F-1
------------
Share certificate numbers evidencing the 10,183 SWK Class B Shares:
B 4507
B 4519
B 4617
Schedule F-2
------------
Share certificate numbers evidencing the 4,151 SWK Class A Shares:
A 228556
A 228939
A 229514
Schedule G-1
------------
Share certificate numbers evidencing the 12,634 CHK Class B Shares:
Personal:
- --------
B 5259
B 5260
B 5261
B 5262
B 5263
B 5264
B 5265
B 5266
B 5267
B 5268
B 5269
Trustee for Zane N. Kaman-Wood:
- ------------------------------
B 4502
Schedule G-2
------------
Share certificate numbers evidencing the 43,397 CHK Class A Shares:
Personal:
- --------
A 227678
A 227679
A 227680
A 227681
A 227682
A 227683
A 227684
A 227685
A 227686
A 227687
A 227688
A 227689
A 227690
A 227691
A 227692
A 227693
A 227694
A 227695
A 227696
A 227757
A 227977
A 228938
Trustee for Zane N. Kaman-Wood:
- ------------------------------
A 214204
A 218291
A 220065
A 221876
A 223365
A 224462
A 225821
A 226908
A 227753
A 227979
A 228940
A 229515
Exhibit A-1
-----------
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
KAMAN CORPORATION
The certificate of incorporation of Kaman Corporation, as amended to
this date, is further amended and restated in its entirety to read as follows:
FIRST
The name of the corporation is Kaman Corporation (the "corporation").
SECOND
The principal office of the corporation is located in the Town of
Bloomfield in the State of Connecticut.
THIRD
The nature of the business to be transacted and the purpose to be
promoted or carried out by the corporation are to engage in any lawful
business, act or activity for which corporations may be formed under the
Connecticut Business Corporation Act, Chapter 601 of the Connecticut General
Statutes (as the same may be amended from time to time, the "CBCA").
FOURTH
The authorized capital stock of the corporation is as follows:
A. General Authorization.
(1) Fifty Million (50,000,000) shares of Common Stock of the par value of
One Dollar ($1.00) per share, which, subject to any voting rights provided to
holders of Preferred Stock at any time outstanding, will be entitled to vote on
all matters with respect to which shareholders are entitled to vote under
applicable law, this Amended and Restated Certificate of Incorporation or the
By-laws of the corporation, or upon which a vote of shareholders is otherwise
duly called for by the corporation. At each annual or special meeting of
shareholders, each holder of record of shares of Common Stock on the relevant
record date shall be entitled to cast one vote in person or by proxy for each
share of the Common Stock standing in such holder's name on the stock transfer
records of the corporation; and
(2) Two Hundred Thousand (200,000) shares of Preferred Stock of the par
value of One Dollar ($1.00) per share. If so determined in accordance with
Paragraph B of this Article Fourth, such class shall be entitled to vote only
for the election of directors, with each share being entitled to one vote
thereon, and such voting right of such class to be limited to the election of
such number of directors (subject to the further limitations below) as may be
established by application of the following formula:
(a) If the number of issued and outstanding shares of Preferred Stock
is not more than one-fourth (1/4th) of the total number of authorized shares of
such class, such number as will result in the election by such shares of
one-tenth (1/10th) (to next lowest whole number) of the total number of
directors then fixed;
(b) If the number of issued and outstanding shares of Preferred Stock
is not more than one-half (1/2) of the total number of authorized shares of
such class, one-fifth (1/5th) (to the next lowest whole number) of the total
number of directors then fixed;
(c) If the number of issued and outstanding shares of Preferred Stock
is not more than three-fourths (3/4ths) of the total number of authorized
shares of such class, three-tenths (3/10ths) (to the next lowest whole number)
of the total number of directors then fixed;
(d) If the number of issued and outstanding shares of Preferred Stock
is more than three-fourths (3/4ths) of the total number of authorized shares of
such class, two-fifths (2/5ths) (to the next lowest whole number) of the total
number of directors then fixed;
provided, however, that notwithstanding anything herein to the contrary, (i)
such voting right of such class shall be applicable only in the event that an
arrearage in payment of dividends shall exist with respect to any series of
Preferred Stock equal to six quarterly dividends on such series (or dividends
otherwise payable over a period of 18 months in the case of any series,
dividends on which are payable other than on a quarterly basis), (ii) any such
right to elect directors shall cease upon the payment in full of any such
arrearage or arrearages, and (iii) such voting right of such class, when
applicable, shall not under any circumstances entitle the Preferred Stock to
elect less than one (1) nor more than two (2) directors.
B. Preferred Stock.
(1) The Board of Directors is authorized, subject to the limitations
prescribed by law and the provisions of this Paragraph B, to provide for the
issuance of a class of Preferred Stock in series and by amending this Amended
and Restated Certificate of Incorporation, as it may be amended or supplemented
from time to time, by its own resolution solely, to establish the number of
shares to be included in each such series and to fix the designation, terms,
limitations, and relative rights and preferences of the shares of each such
series. The authority of the Board of Directors with respect to each series
shall include, but not be limited to, determination of the following:
(a) The number of shares constituting that series and the distinctive
designation of that series;
(b) The dividend rate on the shares of that series and the times of
payment thereof, whether dividends shall be cumulative and, if so, from which
date or dates;
(c) Whether or not the shares of that series shall have conversion
privileges, and, if so, the terms and conditions of such conversion, including
provision for adjustment of the conversion rate in such events as the Board of
Directors shall determine;
(d) Whether or not the shares of that series shall be redeemable,
and, if so, the terms and conditions of such redemption, including the date or
dates upon or after which they shall be redeemable, and sinking fund
provisions, if any, providing for the redemption or purchase of shares of that
series and the amount per share payable in case of redemption which amount may
vary under different conditions and at different redemption dates; and
(e) Whether or not that series shall have voting rights, such voting
rights, if any, to be the voting rights described in subparagraph (2) of
Paragraph A of this Article Fourth.
(2) Dividends on outstanding shares of the class of Preferred Stock shall
be declared and paid, or set apart for payment, before any dividends shall be
declared and paid, or set apart for payment, on shares of Common Stock with
respect to the same dividend period.
C. Recapitalization.
(1) As provided for in the Agreement dated as of June 7, 2005, by and
among the corporation and various other parties (the "Recapitalization
Agreement"), upon the filing (the "Effective Time") of this Amended and
Restated Certificate of Incorporation pursuant to the CBCA, each share of the
corporation's Class A common stock, par value $1.00 per share, issued and
outstanding immediately prior to the Effective Time (the "Old Class A Common
Stock") will become one share of validly issued, fully paid, and non-assessable
Common Stock authorized by Paragraph A of this Article FOURTH without any
action by the holder thereof.
(2) As provided for in the Recapitalization Agreement, upon the Effective
Time, (a) each share of the corporation's Class B common stock, par value $1.00
per share, issued and outstanding immediately prior to the Effective Time (the
"Old Class B Common Stock"), other than the shares of Old Class B Common Stock
described in clause (b) below, shall be reclassified as and converted and
changed into 1.95 shares of validly issued, fully paid, and non-assessable
Common Stock authorized by Paragraph A of this Article FOURTH and (b) each
share of Old Class B Common Stock issued and outstanding immediately prior to
the Effective Time and held by record holder(s) who have validly elected to
accept the "Alternative Class B Stock Consideration" as to such shares of Old
Class B Common Stock in accordance with the Recapitalization Agreement, shall
be reclassified as and converted and changed into one share of validly issued,
fully paid, and non-assessable Common Stock authorized by Paragraph A of this
Article FOURTH and an amount in cash equal to $14.76, in each case without any
further action by the holder thereof. Notwithstanding anything to the contrary
set forth herein, (x) in lieu of any fractional shares of Common Stock to which
any holder of Old Class B Common Stock would otherwise be entitled pursuant to
this Paragraph C (aggregating for this purpose all of the shares of Old Class B
Common Stock owned of record by such shareholder), such shareholder shall be
entitled to receive a cash payment equal to the closing price of the Old Class
A Common Stock on the NASDAQ National Market on the last trading day occurring
prior to the date on which the Effective Time occurs multiplied by such
fraction, and (y) any cash payment to which any holder of Old Class B Common
Stock would otherwise be entitled pursuant to this Paragraph C (aggregating for
this purpose all of the shares of Old Class B Common Stock owned of record by
such shareholder) shall be rounded down to the nearest cent.
(3) Each certificate that prior to the Effective Time represented a share
or shares of Old Class A Common Stock shall thereafter represent that number of
shares of Common Stock which the share or shares of Old Class A Common Stock
represented by such certificate shall have become in accordance with this
Paragraph C, until such certificate is presented to the corporation or its
transfer agent for transfer or reissue in which event the corporation or its
transfer agent shall issue one or more stock certificates representing the
appropriate number of shares of Common Stock. Each certificate that prior to
the Effective Time represented a share or shares of Old Class B Common Stock
shall thereafter represent that number of shares of Common Stock into which the
share or shares of Old Class B Common Stock represented by such certificate
shall have been reclassified and converted in accordance with this Paragraph C.
Any required cash payment under this Paragraph C as to any shares of Old Class
B Common Stock will only be made following presentation to the corporation or
its transfer agent of all the certificates held of record by the owner of such
shares of Old Class B Common Stock.
D. No Preemptive Rights.
There shall be no preemptive rights to purchase or subscribe for any
unissued stock of the corporation. No stockholder shall be entitled as of right
to purchase or subscribe for any unissued stock of the corporation, whether now
or hereafter authorized or whether of a class now existing or of a class
hereafter created, or to purchase or subscribe for any bonds, certificates of
indebtedness, debentures or other obligations convertible into stock of the
corporation.
FIFTH
The amount of paid-in capital stock with which the corporation
commenced business was Seven Thousand Dollars ($7,000).
SIXTH
The duration of this corporation is unlimited.
SEVENTH
The following provisions are for the regulation of the business of the
corporation and for the purpose of defining and regulating the powers of the
corporation and its officers, directors and shareholders:
A. Issuance of Authorized Capital Stock.
The Board of Directors is hereby authorized and empowered to issue
from time to time all or any part of the shares of the unissued authorized
capital stock of the corporation, as then constituted, for such consideration,
not less than par, as is permissible under the CBCA, and, upon receipt of such
consideration by the corporation, all shares of the capital stock of this
corporation so issued shall be deemed fully paid and nonassessable and the
holders of such shares shall not be liable thereunder to this corporation or
its creditors.
B. Indemnification of Directors and Officers.
Each director and officer of the corporation shall be indemnified by
the corporation against Liabilities, as defined in Section 33-770 of the CBCA,
incurred by him or her in connection with any Proceeding, as defined in Section
33-770 of the CBCA, to which he or she may be made a party by reason of being
or having been a director or officer of the corporation to the fullest extent
permitted by the CBCA. The foregoing right of indemnification shall not be
exclusive of other rights to which he or she may be entitled.
C. Limitation of Personal Liability.
The personal liability of a director to the corporation or its
shareholders for monetary damages for breach of duty as a director shall be
limited to an amount equal to the amount of compensation received by the
director for serving the corporation during the calendar year in which the
violation occurred (and if the director received no such compensation from the
corporation during the calendar year of the violation, such director shall have
no liability to the corporation or its shareholders for breach of duty) if such
breach did not:
(1) involve a knowing and culpable violation of law by the director;
(2) enable the director or an associate, as defined in Section 33-840
of the CBCA, to receive an improper personal economic gain;
(3) show a lack of good faith and a conscious disregard for the duty of
the director to the corporation under circumstances in which the director was
aware that his or her conduct or omission created an unjustifiable risk of
serious injury to the corporation;
(4) constitute a sustained and unexcused pattern of inattention that
amounted to an abdication of the director's duty to the corporation; or
(5) create liability under Section 33-757 of the CBCA.
Any repeal or modification of this Paragraph C shall not adversely
affect any right or protection of a director of the corporation existing at the
time of such repeal or modification.
Nothing contained in this Paragraph C shall be construed to deny to
the directors of the corporation any of the benefits provided by subsection (d)
of Section 33-756 of the CBCA.
D. Board of Directors.
(1) Number. Subject to the rights of any holder of any class or series
of Preferred Stock, the Board of Directors shall consist of not less than three
or more than 15 members, the exact number of which shall be fixed from time to
time by the Board of Directors.
(2) Classes. The directors shall be divided into three classes,
designated Class I, Class II and Class III. Each class shall consist, as nearly
as may be possible, of one-third of the total number of directors constituting
the entire Board of Directors. The initial division of the Board of Directors
into classes shall be made by the affirmative vote of a majority of the entire
Board of Directors. The term of the initial Class I directors shall terminate
on the date of the 2006 annual meeting of shareholders; the term of the initial
Class II directors shall terminate on the date of the 2007 annual meeting of
shareholders; and the term of the initial Class III directors shall terminate
on the date of the 2008 annual meeting of shareholders. At each succeeding
annual meeting of shareholders beginning in 2006, successors to the class of
directors whose term expires at that annual meeting shall be elected for a
three-year term. If the number of directors is changed, any increase or
decrease shall be apportioned by the affirmative vote of a majority of the
entire Board of Directors among the classes so as to maintain the number of
directors in each class as nearly equal as possible, and any additional
director of any class elected by the shareholders at an annual meeting of
shareholders to fill a vacancy resulting from an increase in such class shall
hold office for a term that shall coincide with the remaining term of that
class, but in no case will a decrease in the number of directors shorten the
term of any incumbent director.
(3) Term. A director shall hold office until the annual meeting for the
year in which such director's term expires and until such director's successor
shall be elected and shall qualify, subject, however, to prior death,
resignation, retirement, disqualification or removal from office.
(4) Vacancies. Any vacancy on the Board of Directors, however
resulting, may be filled by the shareholders, or by a majority of the directors
then in office, even if less than a quorum, or by a sole remaining director,
provided, that the term of a director elected by the directors or the sole
remaining director expires at the next meeting of shareholders at which
directors are elected.
(5) Removal. Any director may be removed from office but only for cause
and only if the number of votes cast by holders of shares entitled to vote for
the election of directors in favor of the removal of such director exceeds the
number of votes cast by such shareholders against the removal of such director
and only at a meeting of shareholders called for the purpose of such removal,
the notice for which states that the purpose or one of the purposes of the
meeting is the removal of such director.
(6) Preferred Stock Directors. Notwithstanding the foregoing, whenever
the holders of any one or more classes or series of Preferred Stock shall have
the right, voting separately by class or series, to elect one or more directors
at an annual or special meeting of shareholders, the election, terms of office,
filling of vacancies, removal of directors and other features of the
directorships shall be governed by the terms of this Amended and Restated
Certificate of Incorporation or in any resolution or resolutions adopted by the
Board of Directors providing for the issuance of any class or series of
Preferred Stock, and such directors so elected shall not be divided into
classes pursuant to this Article SEVENTH unless expressly provided by such
terms.
EIGHTH
In furtherance and not in limitation of the powers conferred by
statute, a majority of the entire Board of Directors is expressly authorized to
adopt, repeal, alter, amend or rescind the By-laws of the corporation. As used
in this Article EIGHTH, the term "entire Board of Directors" means the total
number of directors which the corporation would have, as fixed by the Board of
Directors under Paragraph D of Article SEVENTH of this Amended and Restated
Certificate of Incorporation, if there were no vacancies. In addition, the
By-laws of the corporation may be amended, altered, repealed, or rescinded by
the affirmative vote of the holders of sixty-six and two-thirds percent (66
2/3%) of all capital stock of the corporation which by its terms may be voted
on all matters submitted to shareholders of the corporation generally, voting
together as a single class at a duly called meeting of the shareholders of the
corporation.
NINTH
Notwithstanding anything contained in this Amended and Restated
Certificate of Incorporation to the contrary, the affirmative vote of the
holders of at least sixty-six and two-thirds percent (66 2/3%) of all capital
stock of the corporation which by its terms may be voted on all matters
submitted to shareholders of the corporation generally, voting together as a
single class at a duly called meeting of the shareholders of the corporation,
shall be required to amend, alter, repeal, rescind or adopt any provision
inconsistent with Articles SEVENTH and EIGHTH of this Amended and Restated
Certificate of Incorporation and this Article NINTH.
Exhibit A-2
-----------
KAMAN CORPORATION
AMENDED AND RESTATED BY-LAWS
ARTICLE I
Offices
1. The principal office of this corporation shall be at such place in the
Town of Bloomfield in the State of Connecticut as the Board of Directors of the
corporation (the "Board of Directors" or the "Board") shall from time to time
designate. The corporation may have such other offices within or without the
State of Connecticut as the Board of Directors may from time to time determine.
ARTICLE II
Meetings of Stockholders
1. PLACE OF MEETINGS. All meetings of the stockholders shall be held at
the principal office or place of business of the corporation, or at such place
within or without the State of Connecticut as from time to time may be
designated by resolution of the Board of Directors.
2. ANNUAL MEETINGS. The annual meetings of the stockholders shall be held
on such day, other than a legal holiday, in the month of March or April of each
year and at such time and place as may be designated by the Board of Directors.
The purpose of such meeting shall be the election of directors by ballot and
the transaction of such other business as may properly come before such
meeting. If the annual meeting of the stockholders be not held as herein
prescribed, the election of directors may be held at any meeting thereafter
called pursuant to these by-laws or otherwise lawfully held.
3. NOTICE OF ANNUAL MEETING. A notice setting out the day, hour and place
of such annual meeting shall be mailed, postage prepaid, to each stockholder of
record at the stockholder's address as the same appears on the stock transfer
and registration records of the corporation or its agent, or if no such address
appears, at the stockholder's last known address, not less than ten (10) days
nor more than sixty (60) days before such annual meeting. Such notice shall
also state any proposed amendment or repeal of these by-laws and any other
proposed matter other than the election of directors which, under the
Connecticut Business Corporation Act ("CBCA"), expressly requires the vote of
stockholders.
4. SPECIAL MEETINGS. Special meetings of the stockholders may be called at
any time by the President or by majority vote of the Board of Directors. A
special meeting of the stockholders shall be called by the President upon the
written request of one (l) or more stockholders holding in the aggregate at
least thirty-five percent (35%) of the total number of shares entitled to vote
on any issue proposed to be considered at such meeting upon their delivery to
the Secretary of one (l) or more written demands for the special meeting
describing the purpose or purposes for which it is to be held. The Secretary
shall mail a notice of such meeting to each stockholder of record not less than
ten (10) days nor more than sixty (60) days before such meeting, and such
notice shall state the day, hour and place of such meeting and the purpose
thereof.
5. ADJOURNMENT OF STOCKHOLDERS' MEETING. If an annual or special stockholders'
meeting is adjourned to a different date, time or place, notice need not be
given of the new date, time or place if the new date, time or place is
announced at the meeting before adjournment. If a new record date for the
adjourned meeting is or must be fixed under Section 33-701 of the CBCA,
however, notice of the adjourned meeting must be given under these by-laws to
persons who are stockholders as of the new record date.
6. WAIVER OF NOTICE. (a) A stockholder may waive any notice required by
the CBCA, the certificate of incorporation of the corporation (the "Certificate
of Incorporation") or these by-laws before or after the date and time stated in
the notice. The waiver must be in writing, be signed by the stockholder
entitled to notice and be delivered to the corporation for inclusion in the
minutes or filing with the corporate records.
(b) A stockholder's attendance at a meeting: (1) waives objection to lack
of notice or defective notice of the meeting, unless the stockholder at the
beginning of the meeting objects to holding the meeting or transacting business
at the meeting; and (2) waives objection to consideration of a particular
matter at the meeting that is not within the purpose or purposes described in
the meeting notice, unless the stockholder objects to considering the matter
when it is presented.
7. STOCKHOLDER ACTION WITHOUT MEETING. (a) Any action which, under the
provisions of the CBCA, may be taken at a meeting of stockholders may be taken
without a meeting by one or more consents in writing, setting forth the action
so taken or to be taken, bearing the date of signature and signed by all of the
persons who would be entitled to vote upon such action at a meeting, or by
their duly authorized attorneys. The Secretary shall file such consent or
consents, or certify the tabulation of such consents and file such certificate,
with the minutes of the meetings of the stockholders. Any consent or consents
that become effective as provided herein shall have the same force and effect
as a vote of stockholders at a meeting duly held.
(b) If not otherwise fixed under Section 33-697 of the CBCA or in
accordance with Section 12 of this Article II, the record date for determining
stockholders entitled to take action without a meeting is the date the first
stockholder signs the consent under subsection (a) of this section. No written
consent shall be effective to take the corporate action referred to therein
unless, within sixty days of the earliest date appearing on a consent delivered
to the corporation in the manner required by this section, written consents
signed by all other stockholders entitled to vote on the matter are received by
the corporation. A written consent may be revoked by a writing to that effect,
provided such revocation shall not be effective if it is received by the
corporation after the corporation has received a sufficient number of unrevoked
written consents to take such corporate action from all other stockholders
entitled to vote on such action.
8. QUORUM. Shares entitled to vote as a separate voting group may take
action on a matter at a meeting only if a quorum of those shares exists with
respect to that matter. Unless the CBCA or the Certificate of Incorporation
otherwise provides, a majority of the votes entitled to be cast on a matter by
a voting group constitutes a quorum of that voting group for action on that
matter. Once a share is represented for any purpose at a meeting, it is deemed
present for quorum purposes for the remainder of the meeting and for any
adjournment of that meeting, unless a new record date is or must be set for
that adjourned meeting.
9. PROXIES. (a) A stockholder may vote each stockholder's shares in person
or by proxy.
(b) A stockholder may appoint a proxy to vote or otherwise act for such
stockholder by signing an appointment form, either personally or by such
stockholder's attorney-in-fact.
(c) An appointment of a proxy is effective when received by the Secretary
or other officer or agent authorized to tabulate votes. A photographic or
similar reproduction of an appointment, or a telegram, cablegram, facsimile
transmission, wireless or similar transmission of an appointment, received by
such person shall be sufficient to effect such appointment. An appointment is
valid for eleven (11) months unless a longer period is expressly provided in
the appointment form.
(d) An appointment of a proxy is revocable by the stockholder unless the
appointment form conspicuously states that it is irrevocable and the
appointment is coupled with an interest. Appointments coupled with an interest
include the appointment of (i) a pledgee; (ii) a person who purchased or agreed
to purchase the shares; (iii) a creditor of the corporation who extended it
credit under the terms requiring the appointment; (iv) an employee of the
corporation whose employment contract requires the appointment; or (v) a party
to a voting agreement created under Section 33-716 of the CBCA.
(e) The death or incapacity of the stockholder appointing a proxy does not
affect the right of the corporation to accept the proxy's authority unless
notice of the death or incapacity is received by the Secretary or other office
or agent authorized to tabulate votes before the proxy exercises authority
under the appointment.
(f) An appointment made irrevocable under subsection (d) of this Section 9
is revoked when the interest with which it is coupled is extinguished.
(g) A transferee for value of shares subject to an irrevocable appointment
may revoke the appointment if such transferee did not know of its existence
when such transferee acquired the shares and the existence of the irrevocable
appointment was not noted conspicuously on the certificate representing the
shares or on the information statement for shares without certificates. The
Secretary or other officer or agent authorized to tabulate votes may require
such transferee to represent such transferee's lack of knowledge of such
irrevocable appointment and may rely on such representation.
(h) Subject to Section 33-708 of the CBCA and to any express
limitation on the proxy's authority appearing on the face of the appointment
form, the corporation is entitled to accept the proxy's vote or other action as
that of the stockholder making the appointment.
10. NUMBER OF VOTES OF EACH STOCKHOLDER. Except as otherwise provided in
the Certificate of Incorporation, each stockholder, whether represented in
person or by proxy, shall be entitled to one (l) vote for each share of stock
standing in such stockholder's name on the books of the corporation on the
record date.
11. VOTING. In the election of directors and in voting on any question on
which a vote by ballot is required by law or is demanded by any stockholder,
the voting shall be by ballot; on all other questions it may be viva voce.
12. RECORD DATE. For the purpose of determining which stockholders are
entitled to notice of or to vote at any meeting of the stockholders or any
adjournment thereof, or which stockholders are entitled to receive payment of
any dividend or for any other proper purpose, the Board of Directors, and in
the absence of its action the Secretary of the corporation or any other person
lawfully acting, shall set a record date which shall not be any earlier than
the date on which the Board of Directors, the Secretary or such other
authorized party acts to set such record date and no more than seventy (70) nor
less than ten (10) days before the particular event requiring such
determination of stockholders is to occur.
13. ADVANCE NOTIFICATION OF BUSINESS TO BE TRANSACTED AT MEETINGS OF
STOCKHOLDERS. To be properly brought before the annual or any special meeting
of the stockholders, business must be either (a) specified in the notice of
meeting (or any supplement or amendment thereto) given by or at the direction
of the Board of Directors (or any duly authorized committee thereof), (b)
otherwise properly brought before the meeting by or at the direction of the
Board of Directors (or any duly authorized committee thereof), or (c) solely in
the case of the annual meeting, otherwise properly brought before the meeting
by any stockholder of the corporation (i) who is a stockholder of record on the
date of the giving of the notice provided for in this Section 13 and on the
record date for the determination of stockholders entitled to notice of and to
vote at an annual meeting and (ii) who complies with the advance notice
procedures set forth in this Section 13.
In addition to any other applicable requirements, for business to be
properly brought before an annual meeting by a stockholder, such stockholder
must have given timely notice thereof in proper written form to the Secretary
of the corporation.
To be timely, a stockholder's written notice to the Secretary of the
corporation must be delivered to or mailed and received at the principal
executive offices of the corporation not less than seventy-five (75) days nor
more than ninety (90) days prior to the first anniversary of the date of the
immediately preceding year's annual meeting of the stockholders; provided,
however, that if the date of the annual meeting is advanced more than thirty
(30) days prior to or delayed by more than thirty (30) days after the
anniversary of the preceding year's annual meeting, to be timely, notice by the
stockholder must be so received not later than the close of business on the
tenth (10th) day following the day on which notice of the date of the annual
meeting was mailed or public disclosure of the date of the annual meeting is
first given or made (which for this purpose shall include any and all filings
of the corporation made on the EDGAR system of the Securities and Exchange
Commission or any similar public database maintained by the Securities and
Exchange Commission), whichever first occurs.
To be in proper written form, a stockholder's notice to the Secretary
of the corporation must set forth as to each matter such stockholder proposes
to bring before the annual meeting (i) a brief description of the business
desired to be brought before the meeting and the reasons for conducting such
business at the meeting, (ii) the name and record address of such stockholder
proposing such business, (iii) the class or series and number of shares of
capital stock of the corporation which are owned beneficially or of record by
such stockholder, (iv) a description of all arrangements or understandings
between such stockholder and any other person or persons (including their
names) in connection with the proposal of such business by such stockholder and
any material interest of such stockholder in such business and (v) a
representation that such stockholder intends to appear in person or by proxy at
the meeting to bring such business before the meeting.
Notwithstanding anything in these by-laws to the contrary, no business
shall be conducted at the annual or any special meeting of the stockholders
except business brought before the meeting in accordance with the procedures
set forth in this Section 13; provided, however, that, once business has been
properly brought before the meeting in accordance with such procedures, nothing
in this Section 13 shall be deemed to preclude discussion by any stockholder of
any such business. The officer of the corporation presiding at the meeting
shall, if the facts warrant, determine and declare to the meeting that the
business was not properly brought before the meeting in accordance with the
provisions of this Section 13, and if such officer shall so determine, such
officer shall so declare to the meeting that any such business not properly
brought before the meeting shall not be transacted.
14. ADVANCE NOTIFICATION OF NOMINATION OF DIRECTORS. Only persons who
are nominated in accordance with the following procedures shall be eligible for
election as directors of the corporation, except as may be otherwise provided
in the Certificate of Incorporation with respect to the rights, if any, of the
holders of shares of preferred stock of the corporation to nominate and elect a
specified number of directors in certain circumstances.
Nominations of persons for election to the Board of Directors may be
made at any annual meeting of the stockholders, or at any special meeting of
the stockholders called for the purpose of electing directors, (a) by or at the
direction of the Board of Directors (or any duly authorized committee thereof),
or (b) by any stockholder of the corporation (i) who is a stockholder of record
on the date of the giving of the notice provided for in this Section 14 and on
the record date for the determination of stockholders entitled to notice of and
to vote at such meeting and (ii) who complies with the advance notice
procedures set forth in this Section 14.
In addition to any other applicable requirements, for a nomination to
be properly made by a stockholder, such stockholder must have given timely
notice thereof in proper written form to the Secretary of the corporation.
To be timely, a stockholder's written notice to the Secretary of the
corporation must be delivered to or mailed and received at the principal
executive offices of the corporation, in the case of: (x) an annual meeting,
not less than seventy-five (75) days nor more than ninety (90) days prior to
the first anniversary of the date of the immediately preceding year's annual
meeting of the stockholders; provided, however, that if the date of the annual
meeting is advanced more than thirty (30) days prior to or delayed by more than
thirty (30) days after the anniversary of the preceding year's annual meeting,
to be timely, notice by the stockholder must be so received not later than the
close of business on the tenth (10th) day following the day on which notice of
the date of the annual meeting was mailed or public disclosure of the date of
the annual meeting is first given or made (which for this purpose shall include
any and all filings of the corporation made on the EDGAR system of the
Securities and Exchange Commission or any similar public database maintained by
the Securities and Exchange Commission), whichever first occurs; and (y) a
special meeting of the stockholders called for the purpose of electing
directors, not later than the close of business on the tenth (10th) day
following the day on which notice of the date of the special meeting was mailed
or public disclosure of the date of the special meeting is first given or made
(which for this purpose shall include any and all filings of the corporation
made on the EDGAR system of the Securities and Exchange Commission or any
similar public database maintained by the Securities and Exchange Commission).
To be in proper written form, a stockholder's notice to the Secretary
of the corporation must set forth (a) as to each person whom the stockholder
proposes to nominate for election as a director (i) the name, age, business
address and residence address of the person, (ii) the principal occupation or
employment of the person, (iii) the class or series and number of shares of
capital stock of the corporation which are owned beneficially or of record by
the person, if any, and (iv) any other information relating to the person that
would be required to be disclosed in a proxy statement or other filings
required to be made in connection with solicitations of proxies for election of
directors pursuant to Section 14 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and the rules and regulations promulgated
thereunder and (b) as to the stockholder giving the notice (i) the name and
record address of such stockholder proposing such nomination, (ii) the class or
series and number of shares of capital stock of the corporation which are owned
beneficially or of record by such stockholder, (iii) a description of all
arrangements or understandings between such stockholder and each proposed
nominee and any other person or persons (including their names) pursuant to
which the nomination(s) are to be made by such stockholder, (iv) a
representation that such stockholder intends to appear in person or by proxy at
the meeting to nominate the persons named in its notice and (v) any other
information relating to such stockholder that would be required to be disclosed
in a proxy statement or other filings required to be made in connection with
solicitations of proxies for election of directors pursuant to Section 14 of
the Exchange Act and the rules and regulations promulgated thereunder. Such
notice must be accompanied by a written consent of each proposed nominee to
being named or referred to as a nominee and to serve as a director if elected.
The corporation may require any proposed nominee to furnish such other
information (which may include meetings to discuss the furnished information)
as may reasonably be required by the corporation to determine the eligibility
of such proposed nominee to serve as a director of the corporation.
No person shall be eligible for election as a director of the
corporation unless nominated in accordance with the procedures set forth in
this Section 14. The officer of the corporation presiding at the meeting shall,
if the facts warrant, determine and declare to the meeting that the nomination
was not made in accordance with the provisions of this Section 14, and if such
officer shall also determine, such officer shall so declare to the meeting that
any such defective nomination shall be disregarded.
ARTICLE III
Directors
1. NUMBER, ELECTION AND TERM OF OFFICE. The property, business and
affairs of the corporation shall be managed by or under the direction of a
Board of Directors composed of that number of directors as shall be specified
as provided in Article SEVENTH of the Certificate of Incorporation. The
directors shall be divided into classes, shall be elected to staggered terms by
ballot by the stockholders at their annual meeting and shall hold office all as
provided by Article SEVENTH of the Certificate of Incorporation.
2. VACANCIES. Any vacancy in the Board of Directors by reason of death,
resignation or other cause may be filled as provided by Article SEVENTH of the
Certificate of Incorporation.
3. POWERS OF DIRECTORS. The directors shall have the general management
and control of the property, business and affairs of this corporation and shall
exercise all the powers that may be exercised or performed by this corporation
under the statutes, the Certificate of Incorporation and these by-laws.
4. PLACE OF MEETINGS. The directors may hold their meetings at such place
or places within or without the State of Connecticut as the Board may from time
to time determine.
5. REGULAR MEETINGS. A meeting of the directors for the election of
officers and the transaction of any other business that may come before such
meeting shall be held with or without notice immediately following each annual
meeting of the stockholders at the place designated therefor. Other regular
meetings of the Board of Directors may be scheduled at any meeting of the
Board, duly called and held, and such regular meetings may be held with or
without notice.
6. OTHER MEETINGS. Other meetings of the directors may be held whenever
the President or a majority of the directors may deem it advisable, notice
thereof to be mailed or given orally, by facsimile or by electronic mail to
each director at least two (2) days prior to such meeting. Any such notice
shall be effective in accordance with Section 603 of the CBCA.
7. WAIVER OF NOTICE. A director may waive any notice required by the
CBCA, the Certificate of Incorporation or these by-laws before or after the
date and time stated in the notice. Except as provided in the next sentence of
this Section, the waiver shall be in writing, signed by the director entitled
to the notice and filed with the minutes or corporate records. A director's
attendance at or participation in a meeting waives any required notice to that
director of the meeting unless the director at the beginning of the meeting, or
promptly upon arrival, objects to holding the meeting or transacting business
at the meeting and does not thereafter vote for or assent to action taken at
the meeting.
8. DIRECTORS' CONSENT. (a) Any action required or permitted by the CBCA
to be taken at a Board of Director's meeting may be taken without a meeting if
the action is taken by all members of the Board. The action shall be evidenced
by one or more written consents describing the action taken, signed by each
director, and included in the minutes or filed with the corporate records
reflecting the action taken.
(b) Action taken under this Section 8 is effective when the last
director signs the consent, unless the consent specifies a different effective
date.
(c) A consent signed under this Section 8 has the effect of a meeting
vote and may be described as such in any document.
9. QUORUM. A majority of the number of directors fixed from time to time
by the Board of Directors pursuant to Section D of Article Seventh of the
Certificate of Incorporation and Section 1 of this Article III shall constitute
a quorum for the transaction of business at all meetings of the Board of
Directors, but any number less than a quorum may adjourn such meeting to a
specified date. The act of a majority of the directors present at a meeting at
which a quorum is present at the time of the act shall be the act of the Board
of Directors.
10. COMPENSATION OF DIRECTORS. Directors may receive such compensation or
salary for their services as determined by resolution of the Board of
Directors, including but not limited to a fixed sum and expenses of attendance
for attendance at each regular or special meeting of the Board and any
committee of the Board. Any director may also serve the corporation in any
other capacity and receive compensation therefor.
11. COMMITTEES. The Board of Directors may, by resolution adopted by the
affirmative vote of directors constituting a majority of the entire Board of
Directors, create one or more committees comprising in each case two or more
directors, which committee or committees shall have and may exercise all such
authority of the Board as may be delegated to it in such resolution or
thereafter by similar resolution, provided, however, that a committee may not
(i) authorize or approve distributions, except according to a formula or
method, or within limits, prescribed by the Board of Directors; (ii) approve or
propose to stockholders action that the CBCA requires to be approved by the
stockholders; (iii) fill vacancies on the Board of Directors or on any of its
committees; or (iv) adopt, amend or repeal these by-laws. Any such committee
shall conduct its meetings or other actions in accordance with the notice,
waiver of notice, action by written consent and quorum provisions as apply to
the Board of Directors under Sections 5, 6, 7, 8 and 9 of this Article III.
12. DIRECTOR EMERITUS. The Board of Directors may, from time to time,
appoint any former director of the corporation who shall have retired from the
board for reasons of age, health or similar reasons, as Director Emeritus of
the corporation. A Director Emeritus shall be entitled to attend such meetings
of the directors and be compensated therefor as the Board may determine.
13. VICE CHAIRMAN. The Board of Directors may, from time to time, appoint
a Vice Chairman of the Board of Directors from among the then serving members
of the board who, in the absence or incapacity of the Chairman, shall have the
powers and responsibilities of the Chairman with respect to meetings of the
Board of Directors and of the stockholders and shall also assist the Chairman
with respect to meetings of the Board of Directors and of the stockholders as
the Chairman may request. The position of Vice Chairman shall not be a
corporate office or carry with it any of the powers or responsibilities of any
corporate office of the corporation, however, the same individual may
simultaneously serve as Vice Chairman and as a corporate officer of the
corporation. The Vice Chairman shall serve for a term of one year and until his
or her successor is duly appointed and qualified but may be removed by the
Board of Directors at any time with or without cause and with or without notice
or hearing. The Vice Chairman may be compensated for his or her services as
such as the Board may determine.
14. MANDATORY RETIREMENT AGE. The mandatory retirement age for a director
shall be age seventy-two (72); provided that directors serving on November 14,
2000 shall be eligible to serve until age seventy-five (75).
15. CHAIRMAN EMERITUS. The Board of Directors has created the honorary
position of Chairman Emeritus of the corporation and has designated Charles H.
Kaman the Chairman Emeritus of the Board of Directors of the corporation in
appreciation of his service as Chairman of the Board of Directors from the
inception of the corporation in 1945 to the date of his retirement from the
Board of Directors in 2001. Mr. Kaman's appointment as Chairman Emeritus shall
endure for the duration of his life during which he shall have the right to
attend and observe all meetings of the Board of Directors.
ARTICLE IV
Officers
1. GENERAL: The Board of Directors shall elect a Chairman, a President,
one or more Vice Presidents, a Treasurer and a Secretary, and may from time to
time appoint such other officers as the Board, deems expedient. Any two or more
offices may be held by the same person. The duties of officers of the
corporation shall be such as are prescribed by these by-laws and as may be
prescribed by the Board.
2. CHAIRMAN. The Chairman shall preside at all meetings of the Board of
Directors and of the stockholders and, unless the Board otherwise determines,
he or she shall be the chief executive officer of the corporation. As Chief
Executive Officer, he or she shall have general control and management of the
corporation's business and affairs, subject to the direction of the Board of
Directors. The Chairman shall consult with and advise the President concerning
the operations of the corporation. The Chairman shall perform such additional
duties as may be assigned to him or her from time to time by the Board of
Directors.
3. PRESIDENT. The President shall perform all duties incident to the
office of President and shall have full authority and responsibility for the
operation of the business of the corporation, subject to the direction of the
Board of Directors and the Chief Executive Officer. In the event of the absence
or disability of the Chairman, the President shall perform the duties and have
the power of the Chairman. The President shall perform such additional duties
as may be assigned to him or her from time to time by the Board of Directors or
the Chief Executive Officer.
4. VICE PRESIDENT. Any Vice President shall have the powers and perform
such duties as may be assigned to him or her or by the Board of Directors or
the Chief Executive Officer.
5. SECRETARY. The Secretary shall keep a record of the minutes of the
proceedings of all meetings of stockholders and directors and shall issue all
notices required by law or by these by-laws, and he or she shall discharge all
other duties required of such officer by law or designated from time to time by
the Board of Directors or by the Chief Executive Officer or as are incident to
the office of Secretary. The Secretary shall have the custody of the seal of
this corporation and all books, records and papers of this corporation, except
such as shall be in the charge of the Treasurer or of some other person
authorized to have custody and possession thereof by a resolution of the Board
of Directors.
6. TREASURER. The Treasurer shall have charge and custody of and be
responsible for all funds and securities of the corporation, keep full and
accurate accounts of receipts and disbursements and books belonging to the
corporation, deposit all moneys and valuable effects in the name and to the
credit of the corporation in depositories approved by the Board of Directors,
and, in general, perform such other duties as may from time to time be assigned
to him or her by the Board of Directors or by the Chief Executive Officer or as
are incident to the office of Treasurer.
7. TERM OF OFFICE. Each of such officers shall serve for the term of one
year and until his or her successor is duly appointed and qualified, but any
officer may be removed by the Board of Directors at any time with or without
cause and with or without notice or hearing. Vacancies among the officers by
reason of death, resignation or other causes shall be filled by the Board of
Directors.
8. COMPENSATION. The compensation of all officers shall be fixed by the
Board of Directors, and may be changed from time to time by a majority vote of
the Board.
ARTICLE V
Issue and Transfer of Stock
1. CERTIFICATES. Certificates of stock shall be in form authorized or
adopted by the Board of Directors and shall be consecutively numbered, provided
that each certificate shall set forth upon its face as at the time of issue:
the name of this corporation, a statement that this corporation is organized
under the laws of the State of Connecticut, the name of the person to whom
issued, the number of shares represented thereby and the par value of each such
share; and provided that each certificate shall be signed by the President or a
Vice President and by the Secretary or an Assistant Secretary or the Treasurer
or an Assistant Treasurer, and shall be sealed with the seal of the
corporation. Any such signature may be affixed manually or in facsimile.
2. TRANSFER. The stock of the corporation shall be transferred only upon
the books of the corporation either by the stockholder in person, or by power
of attorney executed by the stockholder for that purpose, upon the surrender
for cancellation of the old stock certificate. Prior to due presentment for
registration of transfer of a security, the corporation shall treat the
registered owner of a security as the person exclusively entitled to vote,
receive notifications and dividends, and otherwise to exercise all the rights
and powers of the shares represented by such security.
The form of transfer shall be as follows:
For value received________________________hereby sell, assign and transfer unto
____________ ______shares of the capital stock represented by the within
certificate and do hereby irrevocably constitute and appoint _______________to
transfer the said stock on the books of the within named corporation with full
power of substitution in the premises.
Dated_________________, 2__.
In the presence
of:________________________________________________________________
New certificates shall thereupon be issued to the purchaser or assignee.
ARTICLE VI
Seal
1. The seal of the corporation shall have inscribed thereon the name of
the corporation, the word "Seal" and the word "Connecticut", and shall be in
the custody of the Secretary.
ARTICLE VII
Fiscal Year
1. The fiscal year of the corporation shall commence on January 1.
ARTICLE VIII
Amendments
1. These by-laws may be adopted, amended or repealed at any validly
called and convened meeting of the Board of Disrectors by the affirmative vote
of Directors holding a majority of the number of directorships at the time or
by the unanimous written consent of the Board of Directors as provided in
Article III, Section 8 of these by-laws. Any notice of a meeting of the Board
of Directors at which by-laws are to be adopted, amended or repealed shall
include notice of such proposed action.
Exhibit B
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Each of Roberta C. Kaman, C. William Kaman II, Steven W. Kaman and
Cathleen H. Kaman (individually a "DPA Attorney-in-Fact" and collectively, the
"DPA Attorneys-in-Fact") in his or her capacity as an Attorney-in-Fact under
the Durable Power of Attorney, dated May 4, 1996 granted by Charles H. Kaman
(the "Durable Power of Attorney") hereby irrevocably (to the fullest extent
permitted by the Connecticut Business Corporation Act) appoints Eileen S. Kraus
and Walter H. Monteith, Jr., and each of them (collectively, the "Proxies"), as
his or her sole and exclusive proxies, with full power of substitution and
resubstitution, to vote and exercise all voting rights (to the fullest extent
that each of the DPA Attorneys-in-Fact is entitled to do so) with respect to
the 258,375 shares of Class B Common Stock, par value $1.00 per share (the
"Class B Stock"), of Kaman Corporation (the "Company"), evidenced by
certificate numbers set forth on Annex A, registered in the name of Charles H.
Kaman on the books and records of the Company over which the DPA
Attorneys-in-Fact have voting power under the terms of the Durable Power of
Attorney, and any additional shares of Class B Stock that the Durable Power of
Attorney may thereafter govern (collectively, the "Shares"). Upon execution and
delivery of this Irrevocable Proxy by each of the DPA Attorneys-in-Fact, any
and all prior proxies given by the DPA Attorneys-in-Fact with respect to any
Shares are hereby revoked and each of the DPA Attorneys-in-Fact agrees not to
grant any subsequent proxies with respect to the Shares until after the
Expiration Date that are inconsistent with the purpose and intent of this
Irrevocable Proxy, as set forth in clauses (i), (ii) and (iii) of the fourth
Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent provided
in the Connecticut Business Corporation Act), is coupled with an interest,
which each of the DPA Attorneys-in-Fact hereby acknowledges, and is granted in
consideration of each of the DPA Attorneys-in-Fact, the Company and others
entering into the Agreement, dated as of June 7, 2005 (the "Agreement").
Capitalized terms used but not defined in this Irrevocable Proxy shall have the
meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon the
occurrence of the end of the Permitted Termination Period and terminate on the
Expiration Date.
The Proxies named above are hereby authorized and empowered by each of
the DPA Attorneys-in-Fact, at any time and from time to time on or prior to the
Expiration Date, to act as the DPA Attorneys-in-Fact's proxy to vote the
Shares, and to exercise all voting rights of the DPA Attorneys-in-Fact with
respect to the Shares (including, without limitation, the power to execute and
deliver written consents pursuant to the Connecticut Business Corporation Act
and to be counted in determining whether a quorum is present at any meeting of
the shareholders of the Company), at any annual, special or adjourned meeting
of the shareholders of the Company for the purpose of (i) approving whichever
of the Proposed Recapitalization or the Substitute Recapitalization Proposal is
then recommended by the Board in accordance with the Agreement and all other
actions required in furtherance thereof, (ii) approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of the DPA Attorneys-in-Fact or any other Party
contained in the Agreement.
All authority herein conferred shall survive the death or incapacity
of any of the DPA Attorneys-in-Fact and any obligation of any of the DPA
Attorneys-in-Fact hereunder shall be binding upon his or her heirs, personal
representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
Each of the DPA Attorneys-in-Fact acknowledges and agrees that
performance of his or her respective obligations hereunder will confer a unique
benefit on the Company and that a failure of performance will not be
compensable by money damages. Each of the DPA Attorneys-in-Fact agrees that
this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
Each of the DPA Attorneys-in-Fact shall, upon request, execute and
deliver any additional documents or instruments and take such actions as may
reasonably be deemed by the Company to be necessary or desirable to complete
the Irrevocable Proxy granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this Irrevocable
Proxy is held by a court of competent jurisdiction to be invalid, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and signature
pages exchanged by facsimile, and each counterpart shall be deemed to be an
original, but all counterparts of which shall constitute one and the same
agreement.
Notwithstanding any other provision of this Irrevocable Proxy, each of
the DPA Attorneys-in-Fact is executing and delivering this Irrevocable Proxy in
his or her capacity as a fiduciary of Kaman and not in his or her capacity as a
director or officer of the Company, and nothing herein shall require any such
person to act in his or her capacity as a director or officer of the Company or
any of its subsidiaries in a manner contrary to the proper discharge of his or
her fiduciary duties to the Company or any of its subsidiaries.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, each of the undersigned has duly executed this
Irrevocable Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is
coupled with an interest as aforesaid and is irrevocable.
ROBERTA C. KAMAN, in her capacity as an
Attorney-in-Fact under the Durable
Power of Attorney, dated May 4, 1996
By:____________________________
Name: Roberta C. Kaman
Title: Attorney-in-Fact
C. WILLIAM KAMAN II, in
his capacity as an
Attorney-in-Fact under the
Durable Power of Attorney,
dated May 4, 1996
By:____________________________
Name: C. William Kaman II
Title: Attorney-in-Fact
STEVEN W. KAMAN, in his capacity as an
Attorney-in-Fact under the Durable
Power of Attorney, dated May 4, 1996
By:____________________________
Name: Steven W. Kaman
Title: Attorney-in-Fact
CATHLEEN H. KAMAN, in her capacity as
an Attorney-in-Fact under the Durable
Power of Attorney, dated May 4, 1996
By:____________________________
Name: Cathleen H. Kaman
Title: Attorney-in-Fact
Annex A
-------
Share certificate numbers evidencing the 258,375 Directly Owned Kaman
Class B Shares:
B 1236
B 1270
B 1521
B 1631
B 1665
B 1723
B 2036
B 2074
B 2213
B 2737
B 2738
B 3214
B 3216
B 3436
B 4269
B 4323
B 4408
B 4512
B 4523
5
Exhibit C
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Each of Roberta C. Kaman, C. William Kaman II, Steven W.
Kaman, and Cathleen H. Kaman (individually a "Voting Trustee" and collectively,
the "Voting Trustees") in his or her capacity as a Voting Trustee under a
Voting Trust Agreement, dated August 14, 2000 and as amended as of June 7, 2005
(the "Voting Trust Agreement") hereby irrevocably (to the fullest extent
permitted by the Connecticut Business Corporation Act) appoints Eileen S. Kraus
and Walter H. Monteith, Jr., and each of them (collectively, the "Proxies"), as
his or her sole and exclusive proxies, with full power of substitution and
resubstitution, to vote and exercise all voting rights (to the fullest extent
that each of the Voting Trustees is entitled to do so) with respect to the
199,802 shares of Class B Common Stock, par value $1.00 per share (the "Class B
Stock"), of Kaman Corporation (the "Company"), evidenced by certificate no.
5279, registered in the name of John C. Yavis, Jr. as Custodian under the
Voting Trust Agreement on the books and records of the Company over which the
Voting Trustees have voting power under the terms of the Voting Trust
Agreement, and any additional shares of Class B Stock or other voting
securities of the Company that the Voting Trust Agreement may thereafter govern
(collectively, the "Shares"). Upon execution and delivery of this Irrevocable
Proxy by each of the Voting Trustees, any and all prior proxies given by the
Voting Trustees with respect to any Shares are hereby revoked and each of the
Voting Trustees agrees not to grant any subsequent proxies with respect to the
Shares until after the Expiration Date that are inconsistent with the purpose
and intent of this Irrevocable Proxy, as set forth in clauses (i), (ii) and
(iii) of the fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which each of the Voting Trustees hereby acknowledges, and is granted
in consideration of each of the Voting Trustees, the Company and others
entering into the Agreement, dated as of June 7, 2005 (the "Agreement").
Capitalized terms used but not defined in this Irrevocable Proxy shall have the
meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by each of the Voting Trustees, at any time and from time to time on or prior
to the Expiration Date, to act as the Voting Trustees' proxy to vote the
Shares, and to exercise all voting rights of the Voting Trustees with respect
to the Shares (including, without limitation, the power to execute and deliver
written consents pursuant to the Connecticut Business Corporation Act and to be
counted in determining whether a quorum is present at any meeting of the
shareholders of the Company), at any annual, special or adjourned meeting of
the shareholders of the Company for the purpose of (i) approving whichever of
the Proposed Recapitalization or the Substitute Recapitalization Proposal is
then recommended by the Board in accordance with the Agreement and all other
actions required in furtherance thereof, (ii) approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of the Voting Trustees or any other Party contained in
the Agreement.
All authority herein conferred shall survive the death or
incapacity of any of the Voting Trustees and any obligation of any of the
Voting Trustees hereunder shall be binding upon his or her heirs, personal
representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
Each of the Voting Trustees acknowledges and agrees that
performance of his or her respective obligations hereunder will confer a unique
benefit on the Company and that a failure of performance will not be
compensable by money damages. Each of the Voting Trustees agrees that this
Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
Each of the Voting Trustees shall, upon request, execute and
deliver any additional documents or instruments and take such actions as may
reasonably be deemed by the Proxies to be necessary or desirable to complete
the Irrevocable Proxy granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
Notwithstanding any other provision of this Irrevocable
Proxy, each of the Voting Trustees is executing and delivering this Irrevocable
Proxy in his or her capacity as a fiduciary of Newgate and not in his or her
capacity as a director or officer of the Company, and nothing herein shall
require any such person to act in his or her capacity as a director or officer
of the Company or any of its subsidiaries in a manner contrary to the proper
discharge of his or her fiduciary duties to the Company or any of its
subsidiaries.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, each of the undersigned has duly executed this
Irrevocable Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is
coupled with an interest as aforesaid and is irrevocable.
ROBERTA C. KAMAN, in her
capacity as a Voting
Trustee under the Voting
Trust Agreement, dated
August 14, 2000 and as
amended as of June 7, 2005
By:____________________________
Name: Roberta C. Kaman
Title: Voting Trustee
C. WILLIAM KAMAN II, in
his capacity as a Voting
Trustee under the Voting
Trust Agreement, dated
August 14, 2000 and as
amended as of June 7, 2005
By:____________________________
Name: C. William Kaman II
Title: Voting Trustee
STEVEN W. KAMAN, in his capacity as a
Voting Trustee under the Voting Trust
Agreement, dated August 14, 2000 and as
amended as of June 7, 2005
By:____________________________
Name: Steven W. Kaman
Title: Voting Trustee
CATHLEEN H. KAMAN, in her capacity as a
Voting Trustee under the Voting Trust
Agreement, dated August 14, 2000 and as
amended as of June 7, 2005
By:____________________________
Name: Cathleen H. Kaman
Title: Voting Trustee
Exhibit D
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Charles H. Kaman ("Kaman"), acting through the
Attorney-in-Fact (the "GPA Attorney-in-Fact") under the General Power of
Attorney, dated February 11, 1998 (the "General Power of Attorney"), granted by
Kaman, hereby irrevocably (to the fullest extent permitted by the Connecticut
Business Corporation Act) appoints Eileen S. Kraus and Walter H. Monteith, Jr.,
and each of them (collectively, the "Proxies"), as his sole and exclusive
proxies, with full power of substitution and resubstitution, to vote and
exercise all voting rights (to the fullest extent that Kaman is entitled to do
so) with respect to the 234,626 shares of Class A Common Stock, par value $1.00
per share (the "Class A Stock"), of Kaman Corporation (the "Company"),
evidenced by the certificate numbers set forth on Annex A, registered in the
name of Kaman on the books and records of the Company over which the GPA
Attorney-in-Fact has voting power under the terms of the General Power of
Attorney, and any additional shares of Class A Stock that the General Power of
Attorney may thereafter govern (collectively, the "Shares"). Upon execution and
delivery of this Irrevocable Proxy by Kaman, any and all prior proxies given by
Kaman with respect to any Shares are hereby revoked and Kaman agrees not to
grant any subsequent proxies with respect to the Shares until after the
Expiration Date that are inconsistent with the purpose and intent of this
Irrevocable Proxy, as set forth in clauses (i) and (ii) of the fourth Paragraph
hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which Kaman hereby acknowledges, and is granted in consideration of
Kaman, the Company and others entering into the Agreement, dated as of June 7,
2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by Kaman, at any time and from time to time on or prior to the Expiration Date,
to act as Kaman's proxy to vote the Shares, and to exercise all voting rights
of Kaman with respect to the Shares (including, without limitation, the power
to execute and deliver written consents pursuant to the Connecticut Business
Corporation Act and to be counted in determining whether a quorum is present at
any meeting of the shareholders of the Company), at any annual, special or
adjourned meeting of the shareholders of the Company for the purpose of (i)
approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, and (ii)
disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of Kaman or any other Party contained in the Agreement.
All authority herein conferred shall survive the death or
incapacity of Kaman and any obligation of Kaman hereunder shall be binding upon
his heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
Kaman acknowledges and agrees that performance of his
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. Kaman agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
Kaman shall, upon request, execute and deliver any additional
documents or instruments and take such actions as may reasonably be deemed by
the Company to be necessary or desirable to complete the Irrevocable Proxy
granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable
Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is coupled with
an interest as aforesaid and is irrevocable.
CHARLES H. KAMAN, acting through
JOHN C. YAVIS, JR., in his capacity as
the Attorney-in-Fact under the General
Power of Attorney, dated February 11, 1998
By:____________________________
Name: John C. Yavis, Jr.
Title: Attorney-in-Fact
Annex A
-------
Share certificate numbers evidencing the 234,626 Kaman Class A Shares:
A 183391
A 183614
A 221811
A 224490
A 224547
A 225822
A 225870
A 227344
A 228394
A 228516
A 228941
A 229516
A 230273
Exhibit E
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Newgate Associates Limited Partnership, a Connecticut limited
partnership (the "Limited Partnership"), acting through its sole general
partner (the "General Partner"), hereby irrevocably (to the fullest extent
permitted by the Connecticut Business Corporation Act) appoints Eileen S. Kraus
and Walter H. Monteith, Jr., and each of them (collectively, the "Proxies"), as
its sole and exclusive proxies, with full power of substitution and
resubstitution, to vote and exercise all voting rights (to the fullest extent
that Newgate is entitled to do so) with respect to the 95,264 shares of Class A
Common Stock, par value $1.00 per share (the "Class A Stock"), of Kaman
Corporation (the "Company"), evidenced by the certificate numbers set forth on
Annex A, registered in the name of Newgate on the books and records of the
Company over which Newgate has voting power under Section 4.01 of the Limited
Partnership Agreement, dated December 23, 1992, as amended on June 16, 1999, on
July 16, 2004 and on June 7, 2005 (as so amended, the "Newgate Partnership
Agreement"), and any additional shares of Class A Stock that the Limited
Partnership Agreement may thereafter govern (collectively, the "Shares"). Upon
execution and delivery of this Irrevocable Proxy by Newgate, any and all prior
proxies given by Newgate with respect to any Shares are hereby revoked and
Newgate agrees not to grant any subsequent proxies with respect to the Shares
until after the Expiration Date that are inconsistent with the purpose and
intent of this Irrevocable Proxy, as set forth in clauses (i) and (ii) of the
fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which Newgate hereby acknowledges, and is granted in consideration of
Newgate, the Company and others entering into the Agreement, dated as of June
7, 2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by Newgate, at any time and from time to time on or prior to the Expiration
Date, to act as Newgate's proxy to vote the Shares, and to exercise all voting
rights of Newgate with respect to the Shares (including, without limitation,
the power to execute and deliver written consents pursuant to the Connecticut
Business Corporation Act and to be counted in determining whether a quorum is
present at any meeting of the shareholders of the Company), at any annual,
special or adjourned meeting of the shareholders of the Company for the purpose
of (i) approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, and (ii)
disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of Newgate or any other Party contained in the
Agreement.
All authority herein conferred shall survive the death or
incapacity (if a natural person) or the liquidation or dissolution (if not a
natural person) of Newgate and the General Partner and any obligation of
Newgate or the General Partner hereunder shall be binding upon his or its
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
Newgate acknowledges and agrees that performance of its
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. Newgate agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
Newgate shall, upon request, execute and deliver any
additional documents or instruments and take such actions as may reasonably be
deemed by the Company to be necessary or desirable to complete the Irrevocable
Proxy granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable
Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is coupled with
an interest as aforesaid and is irrevocable.
NEWGATE ASSOCIATES LIMITED PARTNERSHIP,
by its sole General Partner
By:____________________________
Name: C. William Kaman II
Title: General Partner
Annex A
-------
Share certificate numbers evidencing the 95,264 Newgate Class A Shares:
A 218351
A 218360
A 218363
A 218365
A 230274
5
Exhibit F
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Oldgate Associates Limited Partnership, a Connecticut limited
partnership ("Oldgate"), acting through its sole general partner (the "General
Partner"), hereby irrevocably (to the fullest extent permitted by the
Connecticut Business Corporation Act) appoints Eileen S. Kraus and Walter H.
Monteith, Jr., and each of them (collectively, the "Proxies"), as its sole and
exclusive proxies, with full power of substitution and resubstitution, to vote
and exercise all voting rights (to the fullest extent that Oldgate is entitled
to do so) with respect to the 148,850 shares of Class A Common Stock, par value
$1.00 per share (the "Class A Stock"), of Kaman Corporation (the "Company"),
evidenced by the certificate numbers set forth on Annex A, registered in the
name of Oldgate on the books and records of the Company over which Oldgate has
voting power under Sections 4.01 and 4.02 of the Oldgate Limited Partnership
Agreement of Limited Partnership, dated December 18, 1996 (the "Oldgate
Partnership Agreement"), and any additional shares of Class A Stock that the
Oldgate Partnership Agreement may thereafter govern (collectively, the
"Shares"). Upon execution and delivery of this Irrevocable Proxy by Oldgate,
any and all prior proxies given by Oldgate with respect to any Shares are
hereby revoked and Oldgate agrees not to grant any subsequent proxies with
respect to the Shares until after the Expiration Date that are inconsistent
with the purpose and intent of this Irrevocable Proxy, as set forth in clauses
(i) and (ii) of the fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which Oldgate hereby acknowledges, and is granted in consideration of
Oldgate, the Company and others entering into the Agreement, dated as of June
7, 2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by Oldgate, at any time and from time to time on or prior to the Expiration
Date, to act as Oldgate's proxy to vote the Shares, and to exercise all voting
rights of Oldgate with respect to the Shares (including, without limitation,
the power to execute and deliver written consents pursuant to the Connecticut
Business Corporation Act and to be counted in determining whether a quorum is
present at any meeting of the shareholders of the Company), at any annual,
special or adjourned meeting of the shareholders of the Company for the purpose
of (i) approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, and (ii)
disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of Oldgate or any other Party contained in the
Agreement.
All authority herein conferred shall survive the death or
incapacity (if a natural person) or the liquidation or dissolution (if not a
natural person) of Oldgate and the General Partner and any obligation of
Oldgate or the General Partner hereunder shall be binding upon his or its
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
Oldgate acknowledges and agrees that performance of its
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. Oldgate agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
Oldgate shall, upon request, execute and deliver any
additional documents or instruments and take such actions as may reasonably be
deemed by the Company to be necessary or desirable to complete the Irrevocable
Proxy granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable
Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is coupled with
an interest as aforesaid and is irrevocable.
OLDGATE ASSOCIATES LIMITED PARTNERSHIP,
by its sole General Partner
By:____________________________
Name: C. William Kaman II
Title: General Partner
Annex A
-------
Share certificate numbers:
A 224496
A 224501
A 224503
Exhibit G
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
C. William Kaman II ("CWK") hereby irrevocably (to the
fullest extent permitted by the Connecticut Business Corporation Act) appoints
Eileen S. Kraus and Walter H. Monteith, Jr., and each of them (collectively,
the "Proxies"), as his sole and exclusive proxies, with full power of
substitution and resubstitution, to vote and exercise all voting rights (to the
fullest extent that CWK is entitled to do so) with respect to (i) the 62,388
shares of Class A Common Stock, par value $1.00 per share (the "Class A
Stock"), of Kaman Corporation (the "Company"), evidenced by the certificate
numbers set forth on Annex A-1, registered in the name of CWK on the books and
records of the Company and over which CWK has sole voting power, (ii) the
64,446 shares of Class B Common Stock, par value $1.00 per share (the "Class B
Stock") of the Company evidenced by the certificate numbers set forth on Annex
A-2, registered in the name of CWK on the books and records of the Company and
over which CWK has sole voting power, (iii) 52,614 shares of Class A Common
Stock, evidenced by the certificate numbers set forth on Annex A-3, registered
in the name of CWK as trustee for Charles Tyson Kaman on the books and records
of the Company and over which CWK has sole voting power, (iv) 2,400 shares of
Class B Common Stock, evidenced by the certificate numbers set forth on Annex
A-4, registered in the name of CWK as trustee for Charles Tyson Kaman on the
books and records of the Company and over which CWK has sole voting power, (v)
37,275 shares of Class A Common Stock, evidenced by the certificate numbers set
forth on Annex A-5, registered in the name of CWK as trustee for Kathryn S.
Kaman on the books and records of the Company and over which CWK has sole
voting power, (vi) 2,400 shares of Class B Common Stock, evidenced by the
certificate numbers set forth on Annex A-6, registered in the name of CWK as
trustee for Kathryn S. Kaman on the books and records of the Company and over
which CWK has sole voting power, and (vii) any additional shares of Class A
Stock or Class B Stock for which CWK may hereafter acquire the right to vote
(collectively, the "Shares"). Upon execution and delivery of this Irrevocable
Proxy by CWK, any and all prior proxies given by CWK with respect to any Shares
are hereby revoked and CWK agrees not to grant any subsequent proxies with
respect to the Shares until after the Expiration Date that are inconsistent
with the purpose and intent of this Irrevocable Proxy, as set forth in clauses
(i), (ii) and (iii) of the fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which CWK hereby acknowledges, and is granted in consideration of
CWK, the Company and others entering into the Agreement, dated as of June 7,
2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by CWK, at any time and from time to time on or prior to the Expiration Date,
to act as CWK's proxy to vote the Shares, and to exercise all voting rights of
CWK with respect to the Shares (including, without limitation, the power to
execute and deliver written consents pursuant to the Connecticut Business
Corporation Act and to be counted in determining whether a quorum is present at
any meeting of the shareholders of the Company), at any annual, special or
adjourned meeting of the shareholders of the Company for the purpose of (i)
approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, (ii) as to
all of the Shares that are Class B Stock, approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of CWK or any other Party contained in the Agreement.
All authority herein conferred shall survive the death or
incapacity of CWK and any obligation of CWK hereunder shall be binding upon his
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
CWK acknowledges and agrees that performance of his
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. CWK agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
CWK shall, upon request, execute and deliver any additional
documents or instruments and take such actions as may reasonably be deemed by
the Company to be necessary or desirable to complete the Irrevocable Proxy
granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable
Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is coupled with
an interest as aforesaid and is irrevocable.
____________________________
Name: C. William Kaman II
Annex A-1
---------
Share certificate numbers evidencing the 62,388 CWK Class A Shares held
personally:
A 223586
A 224873
A 226286
A 228781
A 228782
A 228783
A 228784
A 228785
A 228786
A 229366
A 230223
A 230536
Annex A-2
---------
Share certificate numbers evidencing the 64,446 CWK Class B Shares held
personally:
B 5275
Annex A-3
---------
Share certificate numbers evidencing the 52,614 CWK Class A Shares held as
Trustee for Charles Tyson Kaman:
A 146765
A 149403
A 156230
A 156231
A 159270
A 160829
A 162837
A 166267
A 166268
A 170903
A 175174
A 178383
A 178384
A 183640
A 186330
A 193743
A 194276
A 196850
A 203483
A 203629
A 205796
A 208479
A 209021
A 211404
A 212608
A 218289
A 223794
A 223795
A 223796
A 224460
A 225819
A 226906
A 227754
A 228515
Annex A-4
---------
Share certificate numbers evidencing the 2,400 CWK Class B Shares held as
Trustee for Charles Tyson Kaman:
B 4496
Annex A-5
---------
Share certificate numbers for the 37,275 CWK Class A Shares held as
Trustee for Kathryn S. Kaman:
A 159271
A 160830
A 162838
A 166271
A 170904
A 175173
A 178386
A 183612
A 186329
A 193712
A 203610
A 208478
A 211403
A 212607
A 218290
A 220021
A 220064
A 221875
A 223361
A 224461
A 225820
A 226907
A 227756
A 227978
Annex A-6
---------
Share certificate numbers for the 2,400 CWK Class B Shares held as Trustee for
Kathryn S. Kaman:
B 4495
Exhibit H
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Roberta C. Kaman ("RCK") hereby irrevocably (to the fullest
extent permitted by the Connecticut Business Corporation Act) appoints Eileen
S. Kraus and Walter H. Monteith, Jr., and each of them (collectively, the
"Proxies"), as her sole and exclusive proxies, with full power of substitution
and resubstitution, to vote and exercise all voting rights (to the fullest
extent that RCK is entitled to do so) with respect to (i) the 23,132 shares of
Class A Common Stock, par value $1.00 per share (the "Class A Stock"), of Kaman
Corporation (the "Company"), evidenced by the certificate numbers set forth on
Annex A-1, registered in the name of RCK on the books and records of the
Company and over which RCK has sole voting power, (ii) the 1,471 shares of
Class B Common Stock, par value $1.00 per share (the "Class B Stock") of the
Company evidenced by the certificate numbers set forth on Annex A-2, registered
in the name of RCK on the books and records of the Company and over which RCK
has sole voting power, and (iii) any additional shares of Class A Stock or
Class B Stock for which RCK may hereafter acquire the right to vote
(collectively, the "Shares"). Upon execution and delivery of this Irrevocable
Proxy by RCK, any and all prior proxies given by RCK with respect to any Shares
are hereby revoked and RCK agrees not to grant any subsequent proxies with
respect to the Shares until after the Expiration Date that are inconsistent
with the purpose and intent of this Irrevocable Proxy, as set forth in clauses
(i), (ii) and (iii) of the fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which RCK hereby acknowledges, and is granted in consideration of
RCK, the Company and others entering into the Agreement, dated as of June 7,
2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by RCK, at any time and from time to time on or prior to the Expiration Date,
to act as RCK's proxy to vote the Shares, and to exercise all voting rights of
RCK with respect to the Shares (including, without limitation, the power to
execute and deliver written consents pursuant to the Connecticut Business
Corporation Act and to be counted in determining whether a quorum is present at
any meeting of the shareholders of the Company), at any annual, special or
adjourned meeting of the shareholders of the Company for the purpose of (i)
approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, (ii) as to
all of the Shares that are Class B Stock, approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of RCK or any other Party contained in the Agreement.
All authority herein conferred shall survive the death or
incapacity of RCK and any obligation of RCK hereunder shall be binding upon her
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
RCK acknowledges and agrees that performance of her
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. RCK agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
RCK shall, upon request, execute and deliver any additional
documents or instruments and take such actions as may reasonably be deemed by
the Company to be necessary or desirable to complete the Irrevocable Proxy
granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable
Proxy as of the 7th day of June 7, 2005. This Irrevocable Proxy is coupled with
an interest as aforesaid and is irrevocable.
____________________________
Name: Roberta C. Kaman
Annex A-1
---------
Share certificate numbers evidencing the 23,132 RCK Class A Shares:
A 121631
A 129403
A 139823
A 150064
A 166273
A 178389
A 193744
A 218362
A 224504
Annex A-2
---------
Share certificate numbers evidencing the 1,471 RCK Class B Shares:
B 3139
B 3295
B 3438
B 3552
B 4524
Exhibit I
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Steven W. Kaman ("SWK") hereby irrevocably (to the fullest
extent permitted by the Connecticut Business Corporation Act) appoints Eileen
S. Kraus and Walter H. Monteith, Jr., and each of them (collectively, the
"Proxies"), as his sole and exclusive proxies, with full power of substitution
and resubstitution, to vote and exercise all voting rights (to the fullest
extent that SWK is entitled to do so) with respect to (i) the 10,183 shares of
Class B Common Stock, par value $1.00 per share (the "Class B Stock") of Kaman
Corporation (the "Company"), evidenced by the certificate numbers set forth on
Annex A-1, registered in the name of SWK on the books and records of the
Company and over which SWK has sole voting power, (ii) 4,151 shares of Class A
Common Stock, par value $1.00 per share (the "Class A Stock"), of the Company,
evidenced by the certificate numbers set forth on Annex A-2, registered in the
name of SWK as trustee for Cameryn H. Kaman on the books and records of the
Company and over which SWK has sole voting power, and (iii) any additional
shares of Class A Stock or Class B Stock for which SWK may hereafter acquire
the right to vote (collectively, the "Shares"). Upon execution and delivery of
this Irrevocable Proxy by SWK, any and all prior proxies given by SWK with
respect to any Shares are hereby revoked and SWK agrees not to grant any
subsequent proxies with respect to the Shares until after the Expiration Date
that are inconsistent with the purpose and intent of this Irrevocable Proxy, as
set forth in clauses (i), (ii) and (iii) of the fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which SWK hereby acknowledges, and is granted in consideration of
SWK, the Company and others entering into the Agreement, dated as of June 7,
2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by SWK, at any time and from time to time on or prior to the Expiration Date,
to act as SWK's proxy to vote the Shares, and to exercise all voting rights of
SWK with respect to the Shares (including, without limitation, the power to
execute and deliver written consents pursuant to the Connecticut Business
Corporation Act and to be counted in determining whether a quorum is present at
any meeting of the shareholders of the Company), at any annual, special or
adjourned meeting of the shareholders of the Company for the purpose of (i)
approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, (ii) as to
all of the Shares that are Class B Stock, approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of SWK or any other Party contained in the Agreement.
All authority herein conferred shall survive the death or
incapacity of SWK and any obligation of SWK hereunder shall be binding upon his
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
SWK acknowledges and agrees that performance of his
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. SWK agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
SWK shall, upon request, execute and deliver any additional
documents or instruments and take such actions as may reasonably be deemed by
the Company to be necessary or desirable to complete the Irrevocable Proxy
granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this Irrevocable Proxy as
of the 7th day of June, 2005. This Irrevocable Proxy is coupled with an
interest as aforesaid and is irrevocable.
____________________________
Name: Steven W. Kaman
Annex A-1
---------
Share certificate numbers evidencing the 4,151 SWK Class A Shares:
A 228556
A 228939
A 229514
Annex A-2
---------
Share certificate numbers evidencing the 10,183 SWK Class B Shares:
B 4507
B 4519
B 4617
Exhibit J
---------
IRREVOCABLE PROXY
TO VOTE STOCK OF
KAMAN CORPORATION
Cathleen H. Kaman ("CHK") hereby irrevocably (to the fullest
extent permitted by the Connecticut Business Corporation Act) appoints Eileen
S. Kraus and Walter H. Monteith, Jr., and each of them (collectively, the
"Proxies"), as her sole and exclusive proxies, with full power of substitution
and resubstitution, to vote and exercise all voting rights (to the fullest
extent that CHK is entitled to do so) with respect to (i) the 23,252 shares of
Class A Common Stock, par value $1.00 per share (the "Class A Stock"), of Kaman
Corporation (the "Company"), evidenced by the certificate numbers set forth on
Annex A-1, registered in the name of CHK on the books and records of the
Company and over which CHK has sole voting power, (ii) the 10,234 shares of
Class B Common Stock, par value $1.00 per share (the "Class B Stock") of the
Company evidenced by the certificate numbers set forth on Annex A-2, registered
in the name of CHK on the books and records of the Company and over which CHK
has sole voting power, (iii) the 20,145 shares of Class A Common Stock,
evidenced by the certificate numbers set forth on Annex A-3, registered in the
name of CHK as trustee for Zane N. Kaman-Wood on the books and records of the
Company and over which CHK has sole voting power, (iv) 2,400 shares of Class B
Common Stock, evidenced by the certificate numbers set forth on Annex A-4,
registered in the name of CHK as trustee for Zane N. Kaman-Wood on the books
and records of the Company and over which CHK has sole voting power, and (v)
any additional shares of Class A Stock or Class B Stock for which CHK may
hereafter acquire the right to vote (collectively, the "Shares"). Upon
execution and delivery of this Irrevocable Proxy by CHK, any and all prior
proxies given by CHK with respect to any Shares are hereby revoked and CHK
agrees not to grant any subsequent proxies with respect to the Shares until
after the Expiration Date that are inconsistent with the purpose and intent of
this Irrevocable Proxy, as set forth in clauses (i), (ii) and (iii) of the
fourth Paragraph hereof.
This Irrevocable Proxy is irrevocable (to the fullest extent
provided in the Connecticut Business Corporation Act), is coupled with an
interest, which CHK hereby acknowledges, and is granted in consideration of
CHK, the Company and others entering into the Agreement, dated as of June 7,
2005 (the "Agreement"). Capitalized terms used but not defined in this
Irrevocable Proxy shall have the meanings ascribed thereto in the Agreement.
This Irrevocable Proxy shall become effective promptly upon
the occurrence of the end of the Permitted Termination Period and terminate on
the Expiration Date.
The Proxies named above are hereby authorized and empowered
by CHK, at any time and from time to time on or prior to the Expiration Date,
to act as CHK's proxy to vote the Shares, and to exercise all voting rights of
CHK with respect to the Shares (including, without limitation, the power to
execute and deliver written consents pursuant to the Connecticut Business
Corporation Act and to be counted in determining whether a quorum is present at
any meeting of the shareholders of the Company), at any annual, special or
adjourned meeting of the shareholders of the Company for the purpose of (i)
approving whichever of the Proposed Recapitalization or the Substitute
Recapitalization Proposal is then recommended by the Board in accordance with
the Agreement and all other actions required in furtherance thereof, (ii) as to
all of the Shares that are Class B Stock, approving the Proposed Charter
Governance Amendments and all other actions required in furtherance thereof and
(iii) disapproving or rejecting any proposal that (a) is inconsistent with or
contrary to the terms and conditions of whichever of the Proposed
Recapitalization or the Substitute Recapitalization Proposal is then
recommended by the Board in accordance with the Agreement, the Proposed Charter
Governance Amendments or the Proposed Bylaw Governance Amendments or (b) would
result in a breach of any covenant, representation or warranty or any other
obligation or agreement of CHK or any other Party contained in the Agreement.
All authority herein conferred shall survive the death or
incapacity of CHK and any obligation of CHK hereunder shall be binding upon her
heirs, personal representatives, successors and assigns.
This Irrevocable Proxy shall be governed by and construed in
accordance with the laws of the State of Connecticut, without regard to the
conflict of laws principles thereof. All actions and proceedings regarding the
rights and obligations under this Irrevocable Proxy shall be heard and
determined in any Connecticut state or federal court sitting in the City of
Hartford.
CHK acknowledges and agrees that performance of her
obligations hereunder will confer a unique benefit on the Company and that a
failure of performance will not be compensable by money damages. CHK agrees
that this Irrevocable Proxy shall be specifically enforceable and that specific
enforcement and injunctive relief shall be available to the Company for any
breach of any agreement, covenant or representation hereunder. This Irrevocable
Proxy may not be amended, restated or modified or any provision hereof waived
without the written consent of the Company.
CHK shall, upon request, execute and deliver any additional
documents or instruments and take such actions as may reasonably be deemed by
the Company to be necessary or desirable to complete the Irrevocable Proxy
granted herein or to carry out the provisions hereof.
If any term, provision, covenant, or restriction of this
Irrevocable Proxy is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Irrevocable Proxy shall remain in full force and effect
and shall not in any way be affected, impaired or invalidated.
This Irrevocable Proxy may be executed in counterparts and
signature pages exchanged by facsimile, and each counterpart shall be deemed to
be an original, but all counterparts of which shall constitute one and the same
agreement.
(The remainder of this page has been intentionally left blank.)
IN WITNESS WHEREOF, the undersigned has duly executed this
Irrevocable Proxy as of the 7th day of June, 2005. This Irrevocable Proxy is
coupled with an interest as aforesaid and is irrevocable.
____________________________
Name: Cathleen H. Kaman
Annex A-1
---------
Share certificate numbers evidencing the 23,252 CHK Class A Shares owned
personally:
A 227678
A 227679
A 227680
A 227681
A 227682
A 227683
A 227684
A 227685
A 227686
A 227687
A 227688
A 227689
A 227690
A 227691
A 227692
A 227693
A 227694
A 227695
A 227696
A 227757
A 227977
A 228938
Annex A-2
---------
Share certificate numbers evidencing the 10,234 CHK Class B Shares owned
personally:
B 5259
B 5260
B 5261
B 5262
B 5263
B 5264
B 5265
B 5266
B 5267
B 5268
B 5269
Annex A-3
---------
Share certificate numbers evidencing the 20,145 CHK Class A Shares owned as
Trustee for Zane N. Kaman-Wood:
A 214204
A 218291
A 220065
A 221876
A 223365
A 224462
A 225821
A 226908
A 227753
A 227979
A 228940
A 229515
Annex A-4
---------
Share certificate numbers evidencing the 2,400 CHK Class B Shares owned as
Trustee for Zane N. Kaman-Wood:
B 4502
Exhibit 10.1
INDEMNIFICATION AGREEMENT
AGREEMENT dated as of the ____ day of _____, 2005 between KAMAN
CORPORATION, a Connecticut corporation (the "Company"), and ___________ of
___________ (the "Indemnitee").
W I T N E S S E T H:
WHEREAS, at the request of the Company, the Indemnitee serves as a
trustee of a voting trust (the "Voting Trust") established under a Voting Trust
Agreement dated August 14, 2000 in which has been deposited 199,802 shares of
the Company's Class B Common Stock; and
WHEREAS, the Company and the Indemnitee recognize to need for
substantial protection against individual liability arising out of the
Indemnitee's service in such capacity; and
WHEREAS, the Company wishes to provide in this Agreement for the
indemnification of, and the advancing of expenses to the Indemnitee as
hereinafter provided;
NOW, THEREFORE, in consideration of the premises and the mutual
benefits to be derived from this Agreement, and intending to be legally bound
hereby, the parties hereto agree as follows:
1. Indemnification.
(a) The Company hereby agrees to indemnify the Indemnitee in the
event the Indemnitee is or becomes a party to or witness or other participant
in, or is threatened to be made a party to or witness or other participant in,
any action, suit or proceedings (including any appeal), whether civil,
criminal, administrative, investigative or other, relating to any occurrence or
event before or after the date hereof, by reason of the fact that the
Indemnitee is or was serving at the request of the Company as a trustee of the
Voting Trust, and with respect to any action taken or not taken in good faith
by the Indemnitee in such capacity, including but not limited to any such
action, suit or proceeding (including any appeal), whether civil, criminal,
administrative, investigative or other by any third party or by or in the right
of the Company or the Voting Trust (hereinafter called a "Claim"), for and
against expenses, including attorneys' fees, and all other costs, charges and
expenses paid, incurred by or assessable against the Indemnitee in connection
with investigating, defending, being a witness in or participating in, or
preparing to defend, be a witness in or participate in, any Claim
(collectively, "Expenses") and judgments, fines, penalties, taxes (including
excise taxes), and amounts paid or to be paid in settlement (including all
interest, assessments and other charges paid or payable in respect of the
foregoing) incurred by the Indemnitee in connection with any Claim
(collectively, "Damages").
(b) If requested by the Indemnitee, the Company shall, upon
presentation of bills, statements of account or invoices for Expenses relating
to a Claim, advance to or pay on behalf of the Indemnitee, within 30 days of
such request, any and all Expenses shown on such bills, statements or invoices
relating to such Claim (an "Expenses Advance"), upon (i) receipt of a written
affirmation of the Indemnitee's good faith belief that the conduct of the
Indemnitee was (A) not opposed to the Company's best interests; (B) in the case
of any criminal proceeding, the Indemnitee had no reasonable cause to believe
the Indemnitee's conduct was unlawful; or (C) that the proceeding involves
conduct for which liability has been limited under a provision of the Company's
Amended and Restated Certificate of Incorporation authorized by the Connecticut
Business Corporation Act (the "CBCA"); (ii) receipt of a written undertaking by
or on behalf of the Indemnitee to repay such Expense Advance in the event of a
final determination, adjudication or judgment (as to which all rights of appeal
have been exhausted or have lapsed) that the Indemnitee is not entitled to
indemnification pursuant to this Agreement; and (iii) if required under
applicable law, a determination is made that the facts then known to those
making the determination would not preclude indemnification under the CBCA.
(c) In the event that the Indemnitee demands indemnification
hereunder as a result of any Claim, the Indemnitee shall provide the Company
with notice of such Claim and shall make available to the Company all
information in the Indemnitee's possession that reasonably relates to such
Claim. The Company shall have the right, but not the obligation, to control the
defense of the Indemnitee from such Claim at the Company's sole cost and
expense and by counsel mutually acceptable to the Company and the Indemnitee.
In the event that the Company shall elect to exercise such right to control
such defense, the Indemnitee shall have the right to participate in such
defense at the Indemnitee's sole expense and through counsel of its choice. No
Claim shall be settled or compromised without the consent of the Company, which
shall not be unreasonably withheld, unless the Company shall have failed, after
the lapse of a reasonable time, but in no event more than 30 days after notice
to the Company of such proposed settlement or compromise, to notify the
Indemnitee of the Company's reasonable objection thereto. The Indemnitee's
failure to give timely notice or to provide copies of documents or to furnish
information in connection with any Claim shall not constitute a defense to any
claim for indemnification by the Indemnitee hereunder except, and only to the
extent, that the Company is materially prejudiced thereby.
(d) If there has not been a Change in Control (as defined in
Section 2(b) hereof), any determination required by the CBCA that
indemnification of the Indemnitee is permissible in the circumstances shall be
made by the Company's Board of Directors (the "Board"), a committee of the
Board, special legal counsel, or the Company's shareholders (the "Reviewing
Party") in accordance with the CBCA, with the method of determination to be
chosen by the Board. If there has been a Change in Control, the Reviewing Party
shall be the special legal counsel selected by the Company in accordance with
the CBCA and approved by the Indemnitee (which approval shall not be
unreasonably withheld) unless (i) the Change in Control has been approved by a
majority of the Board who were directors immediately prior to such Change in
Control and (ii) the individuals who were directors prior to the Change in
Control constitute at least two-thirds of the members of the Board as of the
date of the determination. If there has been no determination by the Reviewing
Party or if the Reviewing Party determines that the Indemnitee would not be
permitted to be indemnified in whole or in part under applicable law, the
Indemnitee shall have the right to commence litigation in any court in the
State of Connecticut having subject matter jurisdiction thereof and in which
venue is proper seeking an initial determination by the court or challenging
any such determination by the Reviewing Party or any aspect thereof, or the
legal or factual bases therefor, and the Company hereby consents to service of
process and to appear in any such proceeding. Any determination by the
Reviewing Party otherwise shall be conclusive and binding on the Company and
the Indemnitee.
2. Change in Control.
(a) If there has been a Change in Control, except as otherwise
provided in Section 1(d) of this Agreement, special legal counsel shall be
selected by the Company in accordance with the CBCA and approved by the
Indemnitee (which approval shall not be unreasonable withheld) and such special
legal counsel shall determine whether the officer or director is entitled to
indemnity payments and Expense Advances under this Agreement or any other
agreement or Certificate of Incorporation or By-laws of the Company now or
hereafter in effect relating to Claims for Indemnifiable Events. Such special
legal counsel, among other things, shall render its written opinion to the
Company and the Indemnitee as to whether and to what extent the Indemnitee will
be permitted to be indemnified. The Company agrees to pay the reasonable fees
of the special legal counsel and to indemnify fully such special legal counsel
against any and all expenses (including attorneys' fees), claims, liabilities
and damages arising out of or relating to this Agreement or the engagement of
special legal counsel pursuant hereto.
(b) For purposes of this Agreement, a "Change in Control" shall
mean any of the following events:
(i) any Person (as defined below) is or becomes the
Beneficial Owner, as defined in Rule 13d-3 under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), directly or indirectly, of securities of
the Company representing 35% or more of the then outstanding securities of the
Company generally entitled to vote in the election of directors of the Company,
excluding any Person who becomes such a Beneficial Owner in connection with a
transaction described in clause (A) of paragraph (iii) below; or
(ii) the following individuals cease for any reason to
constitute a majority of the number of directors then serving: individuals who,
on November 1, 2003, constituted the Board and any new director (other than a
director whose initial assumption of office is a result of an actual or
threatened election contest, including but not limited to a consent
solicitation, relating to the election of directors of the Company and whose
appointment or election was not approved by at least two-thirds (2/3) of the
directors of the Company in office immediately prior to any such contest) whose
appointment or election by the Board or nomination for election by the
Company's stockholders was approved or recommended by a vote of at least
two-thirds (2/3) of the directors then in office; or
(iii) there is consummated a Merger, as defined below, of the
Company with any other business entity, other than (A) a Merger which would
result in the securities of the Company generally entitled to vote in the
election of directors of the Company outstanding immediately prior to such
Merger continuing to represent (either by remaining outstanding or by being
converted into such securities of the surviving entity or any parent thereof),
in combination with the ownership of any trustee or other fiduciary holding
such securities under an employee benefit plan of the Company or any Subsidiary
of the Company, at least 65% of the securities of the Company or such surviving
entity or any parent thereof outstanding immediately after such Merger,
generally entitled to vote in the election of directors of the Company or such
surviving entity or any parent thereof and, in the case of such surviving
entity or any parent thereof, of a class registered under Section 12 of the
Exchange Act, or (B) a Merger effected to implement a recapitalization of the
Company (or similar transaction) in which no Person is or becomes the
Beneficial Owner, directly or indirectly, of securities of the Company
representing 35% or more of the then outstanding securities of the Company
generally entitled to vote in the election of directors of the Company; or
(iv) (A) the stockholders of the Company approve a plan of
complete liquidation or dissolution of the Company or there is consummated the
sale or disposition by the Company of all or substantially all of the Company's
assets, other than a sale or disposition by the Company of all or substantially
all of the Company's assets to an entity where the outstanding securities
generally entitled to vote in the election of directors of the Company
immediately prior to the sale continue to represent (either by remaining
outstanding or by being converted into such securities of the surviving entity
or any parent thereof) 65% or more of the outstanding securities of such entity
generally entitled to vote in the election of directors immediately after such
sale and of a class registered under Section 12 of the Exchange Act, or (B) a
disposition or divestiture by the Company or any Subsidiary of the Company to
any Person of either Kaman Aerospace Corporation or Kaman Industrial
Technologies Corporation, including, without intending to limit the foregoing,
any such disposition or divestiture effected by (x) a sale of all or
substantially all of the securities or all or substantially all of the assets
of either Kaman Aerospace Corporation or Kaman Industrial Technologies
Corporation, (y) the Merger of either Kaman Aerospace Corporation or Kaman
Industrial Technologies Corporation with or into any Person, other than a
Merger which would result in the voting securities of the Subsidiary party to
such Merger outstanding immediately prior to such Merger continuing to
represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity or any parent thereof) at least 65% of the
securities of such Subsidiary or such surviving entity or any parent thereof
outstanding immediately after such Merger and generally entitled to vote in the
election of directors of the Subsidiary or such surviving entity or parent
thereof, or (z) a spin off, dividend or other distribution of all or
substantially all of the securities or all or substantially all of the assets
(or of the stock of a business entity owning such securities or assets) of
either Kaman Aerospace Corporation or Kaman Industrial Technologies Corporation
to the Company's stockholders.
(v) As used herein, "Merger" means a merger, share exchange,
consolidation or similar business combination under applicable law.
(vi) As used herein, "Person" shall have the meaning given in
Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and
14(d) thereof, except that such term shall not include (A) the Company or any
of its direct or indirect Subsidiaries, (B) a trustee or other fiduciary
holding securities under an employee benefit plan of the Company, (C) an
underwriter temporarily holding securities pursuant to an offering of such
securities, (D) a corporation owned, directly or indirectly, by the
stockholders of the Company in substantially the same proportions and with
substantially the same voting rights as their ownership and voting rights with
respect to the Company, (E) the voting trust established pursuant to a Voting
Trust Agreement dated August 14, 2000 between John C. Yavis, Jr., as General
Partner of Newgate Associates Limited Partnership and the trustees named
therein (the "Newgate Voting Trust"), provided that the following individuals
continue to constitute a majority of the voting trustees of that voting trust:
individuals serving as trustees of the Newgate Voting Trust as of November 1,
2003 and individuals designated by the Board in accordance with the terms of
that voting trust, provided no Change in Control pursuant to Section 2(b)(2) of
this Agreement has occurred, (F) the individuals referred to in the immediately
preceding subsection (E) solely with respect to their status as Beneficial
Owners of securities of the Company subject to the Newgate Voting Trust, (G)
Charles H. Kaman, any individual to whom he has directly granted a general
power of attorney, or any entity created or controlled by him, provided that he
and/or any attorneys-in-fact appointed directly by him possess and exercise, in
person or by proxy solicited by the Board, the right to vote all securities of
the Company generally entitled to vote in the election of directors of the
Company, of which he, any such holder of his general power of attorney, or any
such entity is the Beneficial Owner, and (H) the holder of a general power of
attorney and the attorneys-in-fact referred to in the immediately preceding
subsection (G) solely with respect to their status as Beneficial Owners of
securities of the Company because of their appointment as such.
3. Indemnification for Additional Expenses. The Company shall
indemnify the Indemnitee against any and all Expenses and, if requested by the
Indemnitee, shall, upon presentation of bills, statements of account or
invoices for Expenses, within 30 days of such request advance such Expenses
shown on such bills, statements or invoices to the Indemnitee, which are
incurred by the Indemnitee in connection with any claim asserted by or action
brought by the Indemnitee for (a) indemnification or advance payment of
Expenses in accordance with Section 1(b) hereof by the Company under this
Agreement, any other agreement to which the Company and the Indemnitee are
parties, any provision of the Company's Certificate of Incorporation or By-laws
now or hereafter in effect relating to Claims and/or (b) recovery under any
directors' and officers' liability insurance policies maintained by the Company
relating to Claims, upon receipt of a written undertaking by or on behalf of
the Indemnitee to repay such expenses in the event of a final determination,
adjudication or judgment (as to which all rights of appeal have been exhausted
or have lapsed) that the Indemnitee is not entitled to indemnification.
4. Partial Indemnity; Successful Defense; Burden of Proof. If the
Indemnitee is entitled under any provisions of this Agreement to
indemnification by the Company for some or a portion of the Expenses and
Damages but not, however, for the total amount thereof, the Company shall
nevertheless indemnify the Indemnitee for the portion thereof to the maximum
amount permitted under applicable law. Moreover, notwithstanding any other
provision of this Agreement, to the extent that the Indemnitee has been
successful on the merits or otherwise in defense of any or all Claims or in
defense of any issue or matter therein, the Indemnitee shall be indemnified
against any and all Expenses and Damages. In connection with any determination
by action of the Board of Directors of the Company, arbitration agency or court
of competent jurisdiction regarding whether the Indemnitee is or is not
entitled to be indemnified hereunder, the burden of proof shall be on the
Company to establish that the Indemnitee is not so entitled.
5. No Presumption. For purposes of this Agreement, the termination of
any Claim by judgment, order or settlement (whether with or without court
approval), conviction or upon a plea of nolo contendere or its equivalent,
shall not create a presumption that the Indemnitee did not meet any particular
standard of conduct or had any particular belief or that a court has determined
that indemnification is not permitted by this Agreement or applicable law.
6. Contribution. In the event that the indemnification provided for in
this Agreement is unavailable to the Indemnitee for any reason whatsoever, the
Company, in lieu of indemnifying the Indemnitee, shall contribute to the
Expenses and Damages, in such proportion as is deemed fair and reasonable in
light of all of the circumstances of the related Claim by the Board of
Directors of the Company or by the arbitrator, agency or court before which
such Claim was brought in order to reflect (a) the relative benefits received
by the Company, or any subsidiary or affiliate of the Company, and the
Indemnitee as a result of the events and/or transactions giving rise to such
Claim and/or (b) the relative fault of the Company or any subsidiary or
affiliate of the Company (and its directors, officers, employees and agents
other than the Indemnittee) and the Indemnitee in connection with such events
and/or transactions.
7. Interpretation of Indemnity. It is agreed between the parties that,
although the indemnities and other protections given by the Company to the
Indemnitee are considered necessary, fair and reasonable, if it should be found
that any of the provisions are void as going beyond that which is permitted by
law and if, by deleting part of the wording or by substituting a more
restricted indemnity or protection than that set out in Section 1, such
provision would be valid and enforceable, there shall be substituted such more
restricted indemnity or other provision or such deletions shall be made as
shall render Section 1 or such part thereof valid and enforceable; provided,
however, that the terms of such substituted indemnity or other provision or
such deletions shall be consistent with the provisions of Section 12.
8. Notices to the Company by the Indemnitee. The Indemnitee agrees to
notify the Company promptly in writing upon being served with or having actual
knowledge of any citation, summons, complaint, indictment or any other similar
document relating to any action which may result in a claim for indemnification
or contribution hereunder.
9. Non-exclusivity. The rights of the Indemnitee hereunder shall be in
addition to any other rights the Indemnitee may have under the Certificate of
Incorporation or By-laws of the Company or of any subsidiary or affiliate of
the Company, or under applicable law or otherwise, and nothing herein shall be
deemed to diminish or otherwise restrict the Indemnitee's right to
indemnification under any such other provision. It is the intention of the
Company that the Indemnitee be indemnified hereunder to the maximum extent that
a corporation organized under the laws of Connecticut may indemnify its
officers, directors, employees and agents pursuant to the CBCA, or if
applicable law prohibits indemnification to such extent, to the maximum extent
permitted hereunder by causing any subsidiary or affiliate of the Company to
satisfy such obligation on behalf of the Company.
10. Amendments, Waiver. No supplement, modification or amendment of
this Agreement shall be binding unless executed in writing by all of the
parties hereto. No waiver of any of the provisions of this Agreement shall be
deemed or shall constitute a waiver of any other provisions hereof (whether or
not similar) nor shall such waiver constitute a continuing waiver.
11. Binding Effect. This Agreement shall be binding upon and inure to
the benefit of and be enforceable against the parties hereto and, in the case
of the Company, its successors and assigns (including any direct or indirect
successor by purchase, merger, consolidation or otherwise to all or
substantially all of the business and/or assets of the Company) or, in the case
of the Indemnitee, his or her heirs and legal representatives. This Agreement
shall continue in effect regardless of whether the Indemnitee continues to
serve as a director, officer, employee, agent or fiduciary of the Company, or
any subsidiary or affiliate of the Company, or any other enterprise at the
Company's request.
12. Severability. Subject to Section 4, if a court of competent
jurisdiction shall determine that any provision of this Agreement is void and
of no effect, the provisions of this Agreement shall be deemed amended to
delete or modify, as necessary, the offending provision, and this Agreement as
so amended or modified shall not be rendered unenforceable or impaired but
shall remain in force to the fullest extent possible in keeping with the
intention of the parties hereto.
13. Governing Law. The validity, interpretation and performance of
this Agreement shall be governed by the laws of the State of Connecticut
applicable to agreements made and to be performed entirely within such State.
14. Liability Insurance. To the extent the Company maintains at any
time an insurance policy or policies providing directors' and officers'
liability insurance, the Indemnitee shall be covered by such policy or
policies, in accordance with the terms of such policy or policies, to the
maximum extent of the coverage available for any other director or officer of
the Company under such insurance policy or policies. The purchase and
maintenance of such insurance shall not in any way limit or affect the rights
and obligations of the parties hereto, and the execution and delivery of this
Agreement shall not in any way be construed to limit or affect the rights and
obligations of the Company and/or of the other parties under any such insurance
policy.
15. Notices. All notices, requests, demands and other communications
required or permitted hereunder shall be in writing and shall be deemed to have
been duly given when delivered by hand, seven business days after mailing by
certified or registered mail, return receipt requested, with postage prepaid,
upon delivery when delivered by facsimile and the sender has confirmation of
delivery, or upon delivery by a courier service:
(a) If to the Indemnitee:
At the address for the Indemnitee shown in the Company's
records
(b) If to the Company:
Kaman Corporation
1332 Blue Hills Avenue
Bloomfield, CT 06002
Attention: Candace A. Clark, Esq.
Senior Vice President and Secretary
or to such other address as the Indemnitee or the Company shall designate in
writing pursuant to the above.
IN WITNESS WHEREOF, the parties hereto have duly executed and
delivered this Agreement as of the date first written above.
KAMAN CORPORATION
By: ____________________________
INDEMNITEE:
__________________________________
Exhibit 10.2
INDEMNIFICATION AGREEMENT
AGREEMENT dated as of the ____ day of _____, 2005 between KAMAN
CORPORATION, a Connecticut corporation (the "Company"), and ___________ of
___________ (the "Indemnitee").
W I T N E S S E T H:
WHEREAS, at the request of the Company, the Indemnitee serves as a
trustee of a voting trust (the "Voting Trust") established under a Voting Trust
Agreement dated August 14, 2000 in which has been deposited 199,802 shares of
the Company's Class B Common Stock; and
WHEREAS, the Indemnitee further serves as an attorney-in-fact under a
Durable Power of Attorney, dated May 7, 1996, given by Charles H. Kaman (the
"Durable Power of Attorney"); and
WHEREAS, the Company and the Indemnitee recognize to need for
substantial protection against individual liability arising out of the
Indemnitee's service in such capacities; and
WHEREAS, the Company wishes to provide in this Agreement for the
indemnification of, and the advancing of expenses to the Indemnitee as
hereinafter provided;
NOW, THEREFORE, in consideration of the premises and the mutual
benefits to be derived from this Agreement, and intending to be legally bound
hereby, the parties hereto agree as follows:
1. Indemnification.
(a) The Company hereby agrees to indemnify the Indemnitee in the
event the Indemnitee is or becomes a party to or witness or other participant
in, or is threatened to be made a party to or witness or other participant in,
any action, suit or proceedings (including any appeal), whether civil,
criminal, administrative, investigative or other, relating to any occurrence or
event before or after the date hereof, by reason of the fact that the
Indemnitee is or was serving at the request of the Company as a trustee of the
Voting Trust and/or an attorney-in-fact under the Durable Power of Attorney,
and with respect to any action taken or not taken in good faith by the
Indemnitee in either such capacity, including but not limited to any such
action, suit or proceeding (including any appeal), whether civil, criminal,
administrative, investigative or other by any third party or by or in the right
of the Company, the Voting Trust or Charles H. Kaman (hereinafter called a
"Claim"), for and against expenses, including attorneys' fees, and all other
costs, charges and expenses paid, incurred by or assessable against the
Indemnitee in connection with investigating, defending, being a witness in or
participating in, or preparing to defend, be a witness in or participate in,
any Claim (collectively, "Expenses") and judgments, fines, penalties, taxes
(including excise taxes), and amounts paid or to be paid in settlement
(including all interest, assessments and other charges paid or payable in
respect of the foregoing) incurred by the Indemnitee in connection with any
Claim (collectively, "Damages").
(b) If requested by the Indemnitee, the Company shall, upon
presentation of bills, statements of account or invoices for Expenses relating
to a Claim, advance to or pay on behalf of the Indemnitee, within 30 days of
such request, any and all Expenses shown on such bills, statements or invoices
relating to such Claim (an "Expenses Advance"), upon (i) receipt of a written
affirmation of the Indemnitee's good faith belief that the conduct of the
Indemnitee was (A) not opposed to the Company's best interests; (B) in the case
of any criminal proceeding, the Indemnitee had no reasonable cause to believe
the Indemnitee's conduct was unlawful; or (C) that the proceeding involves
conduct for which liability has been limited under a provision of the Company's
Amended and Restated Certificate of Incorporation authorized by the Connecticut
Business Corporation Act (the "CBCA"); (ii) receipt of a written undertaking by
or on behalf of the Indemnitee to repay such Expense Advance in the event of a
final determination, adjudication or judgment (as to which all rights of appeal
have been exhausted or have lapsed) that the Indemnitee is not entitled to
indemnification pursuant to this Agreement; and (iii) if required under
applicable law, a determination is made that the facts then known to those
making the determination would not preclude indemnification under the CBCA.
(c) In the event that the Indemnitee demands indemnification
hereunder as a result of any Claim, the Indemnitee shall provide the Company
with notice of such Claim and shall make available to the Company all
information in the Indemnitee's possession that reasonably relates to such
Claim. The Company shall have the right, but not the obligation, to control the
defense of the Indemnitee from such Claim at the Company's sole cost and
expense and by counsel mutually acceptable to the Company and the Indemnitee.
In the event that the Company shall elect to exercise such right to control
such defense, the Indemnitee shall have the right to participate in such
defense at the Indemnitee's sole expense and through counsel of its choice. No
Claim shall be settled or compromised without the consent of the Company, which
shall not be unreasonably withheld, unless the Company shall have failed, after
the lapse of a reasonable time, but in no event more than 30 days after notice
to the Company of such proposed settlement or compromise, to notify the
Indemnitee of the Company's reasonable objection thereto. The Indemnitee's
failure to give timely notice or to provide copies of documents or to furnish
information in connection with any Claim shall not constitute a defense to any
claim for indemnification by the Indemnitee hereunder except, and only to the
extent, that the Company is materially prejudiced thereby.
(d) If there has not been a Change in Control (as defined in
Section 2(b) hereof), any determination required by the CBCA that
indemnification of the Indemnitee is permissible in the circumstances shall be
made by the Company's Board of Directors (the "Board"), a committee of the
Board, special legal counsel, or the Company's shareholders (the "Reviewing
Party") in accordance with the CBCA, with the method of determination to be
chosen by the Board. If there has been a Change in Control, the Reviewing Party
shall be the special legal counsel selected by the Company in accordance with
the CBCA and approved by the Indemnitee (which approval shall not be
unreasonably withheld) unless (i) the Change in Control has been approved by a
majority of the Board who were directors immediately prior to such Change in
Control and (ii) the individuals who were directors prior to the Change in
Control constitute at least two-thirds of the members of the Board as of the
date of the determination. If there has been no determination by the Reviewing
Party or if the Reviewing Party determines that the Indemnitee would not be
permitted to be indemnified in whole or in part under applicable law, the
Indemnitee shall have the right to commence litigation in any court in the
State of Connecticut having subject matter jurisdiction thereof and in which
venue is proper seeking an initial determination by the court or challenging
any such determination by the Reviewing Party or any aspect thereof, or the
legal or factual bases therefor, and the Company hereby consents to service of
process and to appear in any such proceeding. Any determination by the
Reviewing Party otherwise shall be conclusive and binding on the Company and
the Indemnitee.
2. Change in Control.
(a) If there has been a Change in Control, except as otherwise
provided in Section 1(d) of this Agreement, special legal counsel shall be
selected by the Company in accordance with the CBCA and approved by the
Indemnitee (which approval shall not be unreasonable withheld) and such special
legal counsel shall determine whether the officer or director is entitled to
indemnity payments and Expense Advances under this Agreement or any other
agreement or Certificate of Incorporation or By-laws of the Company now or
hereafter in effect relating to Claims for Indemnifiable Events. Such special
legal counsel, among other things, shall render its written opinion to the
Company and the Indemnitee as to whether and to what extent the Indemnitee will
be permitted to be indemnified. The Company agrees to pay the reasonable fees
of the special legal counsel and to indemnify fully such special legal counsel
against any and all expenses (including attorneys' fees), claims, liabilities
and damages arising out of or relating to this Agreement or the engagement of
special legal counsel pursuant hereto.
(b) For purposes of this Agreement, a "Change in Control" shall
mean any of the following events:
(i) any Person (as defined below) is or becomes the
Beneficial Owner, as defined in Rule 13d-3 under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), directly or indirectly, of securities of
the Company representing 35% or more of the then outstanding securities of the
Company generally entitled to vote in the election of directors of the Company,
excluding any Person who becomes such a Beneficial Owner in connection with a
transaction described in clause (A) of paragraph (iii) below; or
(ii) the following individuals cease for any reason to
constitute a majority of the number of directors then serving: individuals who,
on November 1, 2003, constituted the Board and any new director (other than a
director whose initial assumption of office is a result of an actual or
threatened election contest, including but not limited to a consent
solicitation, relating to the election of directors of the Company and whose
appointment or election was not approved by at least two-thirds (2/3) of the
directors of the Company in office immediately prior to any such contest) whose
appointment or election by the Board or nomination for election by the
Company's stockholders was approved or recommended by a vote of at least
two-thirds (2/3) of the directors then in office; or
(iii) there is consummated a Merger, as defined below, of the
Company with any other business entity, other than (A) a Merger which would
result in the securities of the Company generally entitled to vote in the
election of directors of the Company outstanding immediately prior to such
Merger continuing to represent (either by remaining outstanding or by being
converted into such securities of the surviving entity or any parent thereof),
in combination with the ownership of any trustee or other fiduciary holding
such securities under an employee benefit plan of the Company or any Subsidiary
of the Company, at least 65% of the securities of the Company or such surviving
entity or any parent thereof outstanding immediately after such Merger,
generally entitled to vote in the election of directors of the Company or such
surviving entity or any parent thereof and, in the case of such surviving
entity or any parent thereof, of a class registered under Section 12 of the
Exchange Act, or (B) a Merger effected to implement a recapitalization of the
Company (or similar transaction) in which no Person is or becomes the
Beneficial Owner, directly or indirectly, of securities of the Company
representing 35% or more of the then outstanding securities of the Company
generally entitled to vote in the election of directors of the Company; or
(iv) (A) the stockholders of the Company approve a plan of
complete liquidation or dissolution of the Company or there is consummated the
sale or disposition by the Company of all or substantially all of the Company's
assets, other than a sale or disposition by the Company of all or substantially
all of the Company's assets to an entity where the outstanding securities
generally entitled to vote in the election of directors of the Company
immediately prior to the sale continue to represent (either by remaining
outstanding or by being converted into such securities of the surviving entity
or any parent thereof) 65% or more of the outstanding securities of such entity
generally entitled to vote in the election of directors immediately after such
sale and of a class registered under Section 12 of the Exchange Act, or (B) a
disposition or divestiture by the Company or any Subsidiary of the Company to
any Person of either Kaman Aerospace Corporation or Kaman Industrial
Technologies Corporation, including, without intending to limit the foregoing,
any such disposition or divestiture effected by (x) a sale of all or
substantially all of the securities or all or substantially all of the assets
of either Kaman Aerospace Corporation or Kaman Industrial Technologies
Corporation, (y) the Merger of either Kaman Aerospace Corporation or Kaman
Industrial Technologies Corporation with or into any Person, other than a
Merger which would result in the voting securities of the Subsidiary party to
such Merger outstanding immediately prior to such Merger continuing to
represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity or any parent thereof) at least 65% of the
securities of such Subsidiary or such surviving entity or any parent thereof
outstanding immediately after such Merger and generally entitled to vote in the
election of directors of the Subsidiary or such surviving entity or parent
thereof, or (z) a spin off, dividend or other distribution of all or
substantially all of the securities or all or substantially all of the assets
(or of the stock of a business entity owning such securities or assets) of
either Kaman Aerospace Corporation or Kaman Industrial Technologies Corporation
to the Company's stockholders.
(v) As used herein, "Merger" means a merger, share exchange,
consolidation or similar business combination under applicable law.
(vi) As used herein, "Person" shall have the meaning given in
Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and
14(d) thereof, except that such term shall not include (A) the Company or any
of its direct or indirect Subsidiaries, (B) a trustee or other fiduciary
holding securities under an employee benefit plan of the Company, (C) an
underwriter temporarily holding securities pursuant to an offering of such
securities, (D) a corporation owned, directly or indirectly, by the
stockholders of the Company in substantially the same proportions and with
substantially the same voting rights as their ownership and voting rights with
respect to the Company, (E) the voting trust established pursuant to a Voting
Trust Agreement dated August 14, 2000 between John C. Yavis, Jr., as General
Partner of Newgate Associates Limited Partnership and the trustees named
therein (the "Newgate Voting Trust"), provided that the following individuals
continue to constitute a majority of the voting trustees of that voting trust:
individuals serving as trustees of the Newgate Voting Trust as of November 1,
2003 and individuals designated by the Board in accordance with the terms of
that voting trust, provided no Change in Control pursuant to Section 2(b)(2) of
this Agreement has occurred, (F) the individuals referred to in the immediately
preceding subsection (E) solely with respect to their status as Beneficial
Owners of securities of the Company subject to the Newgate Voting Trust, (G)
Charles H. Kaman, any individual to whom he has directly granted a general
power of attorney, or any entity created or controlled by him, provided that he
and/or any attorneys-in-fact appointed directly by him possess and exercise, in
person or by proxy solicited by the Board, the right to vote all securities of
the Company generally entitled to vote in the election of directors of the
Company, of which he, any such holder of his general power of attorney, or any
such entity is the Beneficial Owner, and (H) the holder of a general power of
attorney and the attorneys-in-fact referred to in the immediately preceding
subsection (G) solely with respect to their status as Beneficial Owners of
securities of the Company because of their appointment as such.
3. Indemnification for Additional Expenses. The Company shall
indemnify the Indemnitee against any and all Expenses and, if requested by the
Indemnitee, shall, upon presentation of bills, statements of account or
invoices for Expenses, within 30 days of such request advance such Expenses
shown on such bills, statements or invoices to the Indemnitee, which are
incurred by the Indemnitee in connection with any claim asserted by or action
brought by the Indemnitee for (a) indemnification or advance payment of
Expenses in accordance with Section 1(b) hereof by the Company under this
Agreement, any other agreement to which the Company and the Indemnitee are
parties, any provision of the Company's Certificate of Incorporation or By-laws
now or hereafter in effect relating to Claims and/or (b) recovery under any
directors' and officers' liability insurance policies maintained by the Company
relating to Claims, upon receipt of a written undertaking by or on behalf of
the Indemnitee to repay such expenses in the event of a final determination,
adjudication or judgment (as to which all rights of appeal have been exhausted
or have lapsed) that the Indemnitee is not entitled to indemnification.
4. Partial Indemnity; Successful Defense; Burden of Proof. If the
Indemnitee is entitled under any provisions of this Agreement to
indemnification by the Company for some or a portion of the Expenses and
Damages but not, however, for the total amount thereof, the Company shall
nevertheless indemnify the Indemnitee for the portion thereof to the maximum
amount permitted under applicable law. Moreover, notwithstanding any other
provision of this Agreement, to the extent that the Indemnitee has been
successful on the merits or otherwise in defense of any or all Claims or in
defense of any issue or matter therein, the Indemnitee shall be indemnified
against any and all Expenses and Damages. In connection with any determination
by action of the Board of Directors of the Company, arbitration agency or court
of competent jurisdiction regarding whether the Indemnitee is or is not
entitled to be indemnified hereunder, the burden of proof shall be on the
Company to establish that the Indemnitee is not so entitled.
5. No Presumption. For purposes of this Agreement, the termination
of any Claim by judgment, order or settlement (whether with or without court
approval), conviction or upon a plea of nolo contendere or its equivalent,
shall not create a presumption that the Indemnitee did not meet any particular
standard of conduct or had any particular belief or that a court has determined
that indemnification is not permitted by this Agreement or applicable law.
6. Contribution. In the event that the indemnification provided for in
this Agreement is unavailable to the Indemnitee for any reason whatsoever, the
Company, in lieu of indemnifying the Indemnitee, shall contribute to the
Expenses and Damages, in such proportion as is deemed fair and reasonable in
light of all of the circumstances of the related Claim by the Board of
Directors of the Company or by the arbitrator, agency or court before which
such Claim was brought in order to reflect (a) the relative benefits received
by the Company, or any subsidiary or affiliate of the Company, and the
Indemnitee as a result of the events and/or transactions giving rise to such
Claim and/or (b) the relative fault of the Company or any subsidiary or
affiliate of the Company (and its directors, officers, employees and agents
other than the Indemnittee) and the Indemnitee in connection with such events
and/or transactions.
7. Interpretation of Indemnity. It is agreed between the parties that,
although the indemnities and other protections given by the Company to the
Indemnitee are considered necessary, fair and reasonable, if it should be found
that any of the provisions are void as going beyond that which is permitted by
law and if, by deleting part of the wording or by substituting a more
restricted indemnity or protection than that set out in Section 1, such
provision would be valid and enforceable, there shall be substituted such more
restricted indemnity or other provision or such deletions shall be made as
shall render Section 1 or such part thereof valid and enforceable; provided,
however, that the terms of such substituted indemnity or other provision or
such deletions shall be consistent with the provisions of Section 12.
8. Notices to the Company by the Indemnitee. The Indemnitee agrees to
notify the Company promptly in writing upon being served with or having actual
knowledge of any citation, summons, complaint, indictment or any other similar
document relating to any action which may result in a claim for indemnification
or contribution hereunder.
9. Non-exclusivity. The rights of the Indemnitee hereunder shall be in
addition to any other rights the Indemnitee may have under the Certificate of
Incorporation or By-laws of the Company or of any subsidiary or affiliate of
the Company, or under applicable law or otherwise, and nothing herein shall be
deemed to diminish or otherwise restrict the Indemnitee's right to
indemnification under any such other provision. It is the intention of the
Company that the Indemnitee be indemnified hereunder to the maximum extent that
a corporation organized under the laws of Connecticut may indemnify its
officers, directors, employees and agents pursuant to the CBCA, or if
applicable law prohibits indemnification to such extent, to the maximum extent
permitted hereunder by causing any subsidiary or affiliate of the Company to
satisfy such obligation on behalf of the Company.
10. Amendments, Waiver. No supplement, modification or amendment of
this Agreement shall be binding unless executed in writing by all of the
parties hereto. No waiver of any of the provisions of this Agreement shall be
deemed or shall constitute a waiver of any other provisions hereof (whether or
not similar) nor shall such waiver constitute a continuing waiver.
11. Binding Effect. This Agreement shall be binding upon and inure to
the benefit of and be enforceable against the parties hereto and, in the case
of the Company, its successors and assigns (including any direct or indirect
successor by purchase, merger, consolidation or otherwise to all or
substantially all of the business and/or assets of the Company) or, in the case
of the Indemnitee, his or her heirs and legal representatives. This Agreement
shall continue in effect regardless of whether the Indemnitee continues to
serve as a director, officer, employee, agent or fiduciary of the Company, or
any subsidiary or affiliate of the Company, or any other enterprise at the
Company's request.
12. Severability. Subject to Section 4, if a court of competent
jurisdiction shall determine that any provision of this Agreement is void and
of no effect, the provisions of this Agreement shall be deemed amended to
delete or modify, as necessary, the offending provision, and this Agreement as
so amended or modified shall not be rendered unenforceable or impaired but
shall remain in force to the fullest extent possible in keeping with the
intention of the parties hereto.
13. Governing Law. The validity, interpretation and performance of
this Agreement shall be governed by the laws of the State of Connecticut
applicable to agreements made and to be performed entirely within such State.
14. Liability Insurance. To the extent the Company maintains at any
time an insurance policy or policies providing directors' and officers'
liability insurance, the Indemnitee shall be covered by such policy or
policies, in accordance with the terms of such policy or policies, to the
maximum extent of the coverage available for any other director or officer of
the Company under such insurance policy or policies. The purchase and
maintenance of such insurance shall not in any way limit or affect the rights
and obligations of the parties hereto, and the execution and delivery of this
Agreement shall not in any way be construed to limit or affect the rights and
obligations of the Company and/or of the other parties under any such insurance
policy.
15. Notices. All notices, requests, demands and other communications
required or permitted hereunder shall be in writing and shall be deemed to have
been duly given when delivered by hand, seven business days after mailing by
certified or registered mail, return receipt requested, with postage prepaid,
upon delivery when delivered by facsimile and the sender has confirmation of
delivery, or upon delivery by a courier service:
(a) If to the Indemnitee:
At the address for the Indemnitee shown in the Company's
records
(b) If to the Company:
Kaman Corporation
1332 Blue Hills Avenue
Bloomfield, CT 06002
Attention: Candace A. Clark, Esq.
Senior Vice President and Secretary
or to such other address as the Indemnitee or the Company shall designate in
writing pursuant to the above.
IN WITNESS WHEREOF, the parties hereto have duly executed and
delivered this Agreement as of the date first written above.
KAMAN CORPORATION
By: ____________________________
INDEMNITEE:
__________________________________
Exhibit 99.1
Kaman Corporation
Bloomfield, CT 06002
(860) 243-7100 NEWS
- -------------------------------------------------------------------------------
KAMAN [GRAPHIC OMITTED]
KAMAN CORPORATION ANNOUNCES PROPOSAL TO SIMPLIFY CAPITAL
STRUCTURE TO ONE SHARE/ONE VOTE
SEPARATELY, THE COMPANY INCREASES ANNUAL DIVIDEND BY 13.6%
BLOOMFIELD, CONNECTICUT, (June 7, 2005) - Kaman Corporation (NASDAQ:
KAMNA) today announced that it has entered into an agreement with certain
members of the Kaman family that contemplates a proposed recapitalization
which would simplify the corporation's capital structure and enhance its
corporate governance by eliminating the existing two-class structure of common
stock.
In the proposed recapitalization, a single class of voting common
stock will replace the existing non-voting Class A common stock and voting
Class B common stock. Specifically, the approximately 22.1 million shares of
Class A common stock would each remain outstanding as one share of voting
common stock and the approximately 668,000 shares of Class B common stock
would each be converted into 1.95 shares of voting common stock.
Alternatively, the Class B common stockholders would be able to elect instead
to convert each of their Class B shares into one share of voting common stock
and receive $14.76 (which represents .95 times the average closing price of
one share of Class A common stock over the last ten trading days).
At the closing of the proposed recapitalization, the holders of the
existing Class A non-voting common stock will own approximately 94.5% to 97.1%
of the then outstanding voting common stock of Kaman, depending on the extent
to which holders of the Class B common stock make the part stock/part cash
election. The proposed recapitalization is anticipated to be completed by the
end of the third quarter of 2005.
The corporation's Board of Directors also approved an increase in its
expected annual dividend from $.44 to $.50 per share. The dividend increase is
effective immediately and is not contingent on the completion of the proposed
recapitalization. The corporation expects that the annual dividend will be
declared and paid in quarterly dividends of equal amounts, subject to the
Board's periodic review of its dividend policy and consistent with Kaman's
recent dividend payment schedule. Accordingly, the board today declared a
regular quarterly dividend of 12.5 cents per share on shares of Kaman common
stock. The dividend will be paid on July 11, 2005 to shareholders of record on
June 27, 2005.
Page 2 of 5
Kaman Corporation
June 7, 2005
"We are very pleased to come to this agreement with the Kaman family
to simplify Kaman's capital structure," stated Paul R. Kuhn, Kaman's chairman,
president and chief executive officer. Kuhn added, "The proposed
recapitalization will provide Kaman with a more traditional capital structure
with a minimal impact on current Class A shareholders, and will provide equal
voting rights to all shareholders.
Mr. Kuhn added, "For the past few years, we have taken the actions
necessary to position Kaman for the future. Our strong operational and
financial performance in the first quarter of 2005 reflects the benefits of
these efforts, and we believe the proposed recapitalization will better enable
this performance to be reflected in the price of the company's shares."
Kuhn also noted, "Kaman has paid a cash dividend to its shareholders
each quarter since 1971 and has maintained the current dividend rate for the
past sixteen years. The increase we are announcing today is a reflection of
the progress the Board and management believe has been made over the past
several years and our confidence in the company's competitive position in the
principal markets we serve."
The proposed recapitalization is subject to customary closing
conditions, including the vote of more shares of Class A common stock in favor
than against the recapitalization and the vote of more shares of Class B
common stock in favor than against the recapitalization, each such class
voting separately. The members of the Kaman family that are party to the
recapitalization agreement have agreed to vote all of their shares of Kaman
stock, representing approximately 81.5% of the outstanding shares of Class B
common stock and approximately 2.7% of the outstanding shares of Class A
common stock, in favor of the transaction. They have also agreed to vote their
Class B common stock in favor of certain amendments to the corporation's
certificate of incorporation that would become effective only if the
recapitalization were to be completed and as to which only Class B shareholder
approval would be required, and the Kaman family's vote would be sufficient to
assure approval.
Until Kaman distributes the proxy statement/prospectus for the
proposed recapitalization to stockholders (but in any event for a period of
not less than 35 days), and subject to certain conditions, the members of the
Kaman family would be permitted under the recapitalization agreement to
withdraw their support of the proposed recapitalization in order to accept a
"qualifying alternative transaction" with a minimum value in cash or
marketable publicly traded securities of not less than $46.62 per Class B
common share, which would be made available to all Class B shareholders. Prior
to being permitted to do so, however, the corporation's Board of Directors
would be given the opportunity to approve a "substitute recapitalization
proposal" with a minimum value per Class B common share of at least the value
per share of the "qualifying alternative
Page 3 of 5
Kaman Corporation
June 7, 2005
transaction" plus $.65, with both all stock and part cash/part stock
alternatives and subject to the same shareholder class votes as noted above.
The Kaman family has agreed to support any "substitute recapitalization
proposal" approved by the Board of Directors.
A special committee of the corporation's Board of Directors comprised
of independent directors who are also unaffiliated with the Kaman family was
formed to evaluate and negotiate the recapitalization agreement with the Kaman
family. The special committee retained separate advisors to consider the
proposed recapitalization from the perspective of its two classes of common
stock. Specifically, the special committee was advised by Evercore Partners,
which delivered an opinion that the proposed recapitalization is fair, from a
financial point of view, to the holders of the Class A stock (solely with
respect to such Class A stock). The special committee was also advised by
Houlihan Lokey Howard & Zukin, which delivered an opinion that the
consideration to be received by the holders of the Class B stock in the
proposed recapitalization is fair, from a financial point of view, to the
holders of the Class B stock (solely with respect to such Class B stock). The
special committee's legal advisor is Skadden Arps. The corporation's Board of
Directors has approved the recapitalization agreement, based in part on the
recommendation of the special committee that it do so.
Additional details of the recapitalization and related matters,
including the proposed amendments to Kaman's certificate of incorporation and
by-laws, the terms and conditions of the Kaman family's ability to accept any
"qualifying alternative transaction", the terms and conditions of any
"substitute recapitalization proposal" and other provisions of the
recapitalization agreement, including indemnification and expense
reimbursement provisions, can be found by reviewing the recapitalization
agreement, which is being filed with the Securities and Exchange Commission
today by Kaman as an exhibit to a Form 8-K.
Kaman will host an investor call at 9:00 AM EDT, on June 8, 2005 to
discuss the proposed recapitalization, the dividend increase, and related
matters. Interested parties can access the call by dialing (888) 277-8128.
This conference call will also be simultaneously broadcast live over
the Internet. Listeners can access the conference call live and archived over
the Internet through a link at:
http://www.kaman.com
--------------------
Please allow 15 minutes prior to the call to visit the site,
download, and install any necessary audio software. A replay of this call will
be available approximately one hour after the live call ends, through June 15,
2005. The replay will be available on the Company's website or by dialing
(877) 519-4471, passcode: 6136358.
Page 4 of 5
Kaman Corporation
June 7, 2005
Based in Bloomfield, Conn., Kaman Corporation conducts business in
the aerospace, industrial distribution and music markets. Kaman operates its
aerospace business through its Aerostructures, Fuzing, and Helicopters
divisions and its Kamatics subsidiary providing subcontract aerostructure
manufacturing for military and commercial aircraft, missile and bomb fuzing
products, SH-2G and K-MAX helicopters, and proprietary aircraft bearings and
products. Principal aerospace facilities are located in Connecticut, Florida
and Kansas. Kaman is the third largest North American distributor of power
transmission, motion control, material handling and electrical components and
a wide range of bearings offered to a customer base of more than 50,000
customers representing a highly diversified cross-section of North American
industry, with principal facilities in Alabama, California, Connecticut, New
York, Indiana, Kentucky and Utah. Kaman is also the largest independent
distributor of musical instruments and accessories, offering more than 17,500
products for amateurs and professionals, with principal facilities in Arizona,
Connecticut, California, New Jersey and Tennessee.
* * *
Forward-Looking Statements
- --------------------------
This release may contain forward-looking information relating to the
corporation's business and prospects, including aerostructures and helicopter
subcontract programs and components, advanced technology products, the SH-2G
and K-MAX helicopter programs, the industrial distribution and music
businesses, operating cash flow, the benefits of the recapitalization
transaction, and other matters that involve a number of uncertainties that may
cause actual results to differ materially from expectations. Those
uncertainties include, but are not limited to: 1) the successful conclusion of
competitions for government programs and thereafter contract negotiations with
government authorities, both foreign and domestic; 2) political conditions in
countries where the corporation does or intends to do business; 3) standard
government contract provisions permitting renegotiation of terms and
termination for the convenience of the government; 4) economic and competitive
conditions in markets served by the corporation, particularly defense,
commercial aviation, industrial production and consumer market for music
products, as well as global economic conditions; 5) satisfactory completion of
the Australian SH-2G(A)program, including successful completion and
integration of the full ITAS software; 6) receipt and successful execution of
production orders for the JPF U.S. government contract including the exercise
of all contract options and receipt of orders from allied militaries, as both
have been assumed in connection with goodwill impairment evaluations; 7)
satisfactory resolution of the EODC/University of Arizona litigation; 8)
achievement of enhanced business base in the Aerospace segment in order to
better absorb overhead and general and administrative expenses, including
successful execution of the contract with Sikorsky for the BLACK HAWK
Helicopter program;
Page 5 of 5
Kaman Corporation
June 7, 2005
9) satisfactory results of negotiations with NAVAIR concerning the
corporation's leased facility in Bloomfield, Conn.; 10) profitable integration
of acquired businesses into the corporation's operations; 11) changes in
supplier sales or vendor incentive policies; 12) the effect of price increases
or decreases; 13) pension plan assumptions and future contributions; 14)
continued availability of raw materials in adequate supplies; 15) satisfactory
resolution of the supplier switch and incorrect part issues at Dayron and the
DCIS investigation; 16) cost growth in connection with potential environmental
remediation activities related to the Bloomfield and Moosup facilities; 17)
successful replacement of the Corporation's revolving credit facility upon its
expiration in November 2005; 18) risks associated with the course of
litigation; 19) changes in laws and regulations, taxes, interest rates,
inflation rates, general business conditions and other factors; 20) the
effects of currency exchange rates and foreign competition on future
operations; and 21) other risks and uncertainties set forth in Kaman's annual,
quarterly and current reports, and proxy statements. Any forward-looking
information provided in this release should be considered with these factors
in mind. The corporation assumes no obligation to update any forward-looking
statements contained in this release.
Kaman intends to file with the Securities and Exchange Commission a
Registration Statement on Form S-4, which will contain a proxy
statement/prospectus in connection with the proposed recapitalization. The
proxy statement/prospectus will be mailed to the stockholders of Kaman when it
is finalized. STOCKHOLDERS OF KAMAN ARE ADVISED TO READ THE PROXY
STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, BECAUSE IT WILL CONTAIN
IMPORTANT INFORMATION. Such proxy statement/prospectus (when available) and
other relevant documents may also be obtained, free of charge, on the
Securities and Exchange Commission's website (http://www.sec.gov) or by
request from the contact listed below.
Kaman and certain persons may be deemed to be participants in the
solicitation of proxies relating to the proposed recapitalization. The
participants in such solicitation may include Kaman's executive officers and
directors. Further information regarding persons who may be deemed
participants will be available in Kaman's proxy statement/prospectus to be
filed with the Securities and Exchange Commission in connection with the
proposed recapitalization.
Contact: Russell H. Jones
SVP, Chief Investment Officer & Treasurer
(860) 243-6307
rhj-corp@kaman.com
www.kaman.com
Exhibit 99.2
- -------------------------------------------------------------------------------
NOTICE TO EMPLOYEES
June 7, 2005
- -------------------------------------------------------------------------------
KAMAN CORPORATION ANNOUNCES PROPOSAL TO SIMPLIFY
CAPITAL STRUCTURE TO ONE SHARE/ONE VOTE
As this notice goes out to you, a press release is going simultaneously to the
public to announce that the company has entered into an agreement with certain
members of the Kaman family that contemplates a proposed recapitalization
which would simplify our capital structure and enhance our corporate
governance by eliminating the existing two-class structure of common stock.
The press release contains many of the details involved in the transaction,
and is available on the Kaman Web site. The release is also being distributed
for posting on company bulletin boards, so you should be able to see it soon.
What I would like you to know is that the proposed transaction has the full
support of management, the Board, and the Kaman family, as an important and
valuable step forward for this company. If the shareholders approve this
proposed recapitalization - and that process will take at least a couple of
months to complete - Kaman Corporation would join the vast majority of public
companies with a one share/one vote capital structure.
Many believe that non-voting shares, such as we have traditionally offered the
public, bear a discount that reflects the lack of voting control. By giving
all shareholders voting rights equivalent to their economic interest in the
company, I believe the market will find it easier to value the company
appropriately. That, in turn, should provide us greater opportunities to
access capital markets and use our stock to pursue our strategies for each of
the business segments - and finance growth opportunities.
We have all done a lot of work over the past several years to position this
company for the future, and I am proud of the progress that has been made in
each of our segments. What we are doing now is the next logical step forward
for Kaman Corporation.
Thank you for your continued efforts in support of the company.
Sincerely,
Paul R. Kuhn
Chairman, President & CEO
Kaman intends to file with the Securities and Exchange Commission a
Registration Statement on Form S-4, which will contain a proxy
statement/prospectus in connection with the proposed recapitalization. The
proxy statement/prospectus will be mailed to the stockholders of Kaman when it
is finalized. STOCKHOLDERS OF KAMAN ARE ADVISED TO READ THE PROXY
STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, BECAUSE IT WILL CONTAIN
IMPORTANT INFORMATION. Such proxy statement/prospectus (when available) and
other relevant documents may also be obtained, free of charge, on the
Securities and Exchange Commission's website (http://www.sec.gov) or from
Kaman by contacting Russell H. Jones, SVP, Chief Investment Officer &
Treasurer, by telephone at (860) 243-6307 or by email at rhj-corp@kaman.com.
Kaman and certain persons may be deemed to be participants in the solicitation
of proxies relating to the proposed recapitalization. The participants in such
solicitation may include Kaman's executive officers and directors. Further
information regarding persons who may be deemed participants will be available
in Kaman's proxy statement/prospectus to be filed with the Securities and
Exchange Commission in connection with the proposed recapitalization.